pmid,year,mesh,meshTreeNumber
23281597,2013-01-02T00:00:00,Anesthesia,E03.155
23281597,2013-01-02T00:00:00,Animals,B01.050
23281597,2013-01-02T00:00:00,"Pain, Postoperative",C23.550.767.700
23281597,2013-01-02T00:00:00,"Pain, Postoperative",C23.888.646.530
23281597,2013-01-02T00:00:00,Perioperative Care,E02.760.722
23281597,2013-01-02T00:00:00,Perioperative Care,E04.604
23281597,2013-01-02T00:00:00,Perioperative Care,N02.421.585.722
23281597,2013-01-02T00:00:00,Swine,B01.050.150.900.649.077.880
23281597,2013-01-02T00:00:00,"Swine, Miniature",B01.050.150.900.649.077.880.399.800
23283355,2013-01-02T00:00:00,Animals,B01.050
23283355,2013-01-02T00:00:00,Bayes Theorem,E05.318.740.600.200
23283355,2013-01-02T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23283355,2013-01-02T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23283355,2013-01-02T00:00:00,Cell Line,A11.251.210
23283355,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23283355,2013-01-02T00:00:00,"Models, Biological",E05.599.395
23283355,2013-01-02T00:00:00,Peptide Fragments,D12.644.541
23283355,2013-01-02T00:00:00,Podocytes,A05.810.453.324.359.720
23283355,2013-01-02T00:00:00,Podocytes,A05.810.453.736.520.720
23283355,2013-01-02T00:00:00,Podocytes,A11.436.720
23283355,2013-01-02T00:00:00,Renin-Angiotensin System,G03.495.805
23283355,2013-01-02T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
23283355,2013-01-02T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
23284071,2013-01-02T00:00:00,Aged,M01.060.116.100
23284071,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23284071,2013-01-02T00:00:00,Incidence,E05.318.308.985.525.375
23284071,2013-01-02T00:00:00,Incidence,L01.280.975.525.375
23284071,2013-01-02T00:00:00,Incidence,N01.224.935.597.500
23284071,2013-01-02T00:00:00,Incidence,N06.850.505.400.975.525.375
23284071,2013-01-02T00:00:00,Incidence,N06.850.520.308.985.525.375
23284071,2013-01-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23284071,2013-01-02T00:00:00,Risk Factors,N05.715.350.200.700
23284071,2013-01-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23284071,2013-01-02T00:00:00,Risk Factors,N06.850.490.625.750
23284071,2013-01-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23284071,2013-01-02T00:00:00,Stroke,C10.228.140.300.775
23284071,2013-01-02T00:00:00,Stroke,C14.907.253.855
23290460,2013-01-02T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
23290460,2013-01-02T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
23290460,2013-01-02T00:00:00,Gastric Bypass,E02.065.062.249
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.035.398.385
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.062.249
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.210.457.430
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.100.376.475
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.928.220.390
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.936.450.475
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E04.050.430
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E07.695.300.300
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E07.858.082.374.300
23290460,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23290460,2013-01-02T00:00:00,Laparoscopy,E01.370.388.250.520
23290460,2013-01-02T00:00:00,Laparoscopy,E04.800.250.520
23290460,2013-01-02T00:00:00,Obesity,C18.654.726.500
23290460,2013-01-02T00:00:00,Obesity,C23.888.144.699.500
23290460,2013-01-02T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23290460,2013-01-02T00:00:00,Obesity,G07.100.100.160.120.699.500
23290460,2013-01-02T00:00:00,Young Adult,M01.060.116.815
23290934,2013-01-02T00:00:00,Animals,B01.050
23290934,2013-01-02T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
23290934,2013-01-02T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
23290934,2013-01-02T00:00:00,Dopamine,D02.092.211.215.311.342
23290934,2013-01-02T00:00:00,Dopamine,D02.092.311.342
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
23290934,2013-01-02T00:00:00,Motor Activity,F01.145.632
23290934,2013-01-02T00:00:00,Motor Activity,G11.427.590.530.698
23290934,2013-01-02T00:00:00,Oxidative Stress,G03.495.710
23290934,2013-01-02T00:00:00,Oxidative Stress,G07.700.830.750
23290934,2013-01-02T00:00:00,Recombinant Proteins,D12.776.828
23290934,2013-01-02T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
23290934,2013-01-02T00:00:00,Substantia Nigra,A08.186.211.653.822.731
23290934,2013-01-02T00:00:00,Superoxide Dismutase,D08.811.682.881
23290934,2013-01-02T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
23290934,2013-01-02T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
23301082,2013-01-03T00:00:00,Albumins,D12.776.034
23301082,2013-01-03T00:00:00,Animals,B01.050
23301082,2013-01-03T00:00:00,Cell Separation,E05.200.500.363
23301082,2013-01-03T00:00:00,"Disease Models, Animal",C22.232
23301082,2013-01-03T00:00:00,"Disease Models, Animal",E05.598.500
23301082,2013-01-03T00:00:00,"Disease Models, Animal",E05.599.395.080
23301082,2013-01-03T00:00:00,Enzyme Inhibitors,D27.505.519.389
23301082,2013-01-03T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23301082,2013-01-03T00:00:00,Flow Cytometry,E05.200.500.386.350
23301082,2013-01-03T00:00:00,Inflammation,C23.550.470
23301082,2013-01-03T00:00:00,Kidney Glomerulus,A05.810.453.324.359
23301082,2013-01-03T00:00:00,Kidney Glomerulus,A05.810.453.736.520
23301082,2013-01-03T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C17.300.480.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C20.111.590.560
23301082,2013-01-03T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
23301082,2013-01-03T00:00:00,Pyridines,D03.383.725
23301082,2013-01-03T00:00:00,Sphingolipids,D10.570.877
23301082,2013-01-03T00:00:00,Sphingolipids,D10.808
23301082,2013-01-03T00:00:00,Spleen,A10.549.700
23301082,2013-01-03T00:00:00,Spleen,A15.382.520.604.700
23301082,2013-01-03T00:00:00,Thromboxane B2,D10.251.355.255.100.825.810
23301082,2013-01-03T00:00:00,Thromboxane B2,D23.469.050.175.800.810
23287455,2013-01-04T00:00:00,Animals,B01.050
23287455,2013-01-04T00:00:00,Extracellular Matrix,A11.284.295.310
23287455,2013-01-04T00:00:00,Fibrosis,C23.550.355
23287455,2013-01-04T00:00:00,Heart Failure,C14.280.434
23287455,2013-01-04T00:00:00,Hemodynamics,G09.330.190.400
23287455,2013-01-04T00:00:00,Hemodynamics,G09.330.380
23287455,2013-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23287455,2013-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23287455,2013-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23287455,2013-01-04T00:00:00,Myocardium,A02.633.580
23287455,2013-01-04T00:00:00,Myocardium,A07.541.704
23287455,2013-01-04T00:00:00,Myocardium,A10.690.552.750
23287455,2013-01-04T00:00:00,Signal Transduction,G02.111.087.800
23287455,2013-01-04T00:00:00,Signal Transduction,G02.149.115.800
23287455,2013-01-04T00:00:00,Signal Transduction,G04.299.880
23287455,2013-01-04T00:00:00,Ventricular Remodeling,C23.300.985
23287455,2013-01-04T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23305825,2013-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305825,2013-01-07T00:00:00,Liver Cirrhosis,C06.552.630
23305825,2013-01-07T00:00:00,Wound Healing,G16.100.856.891
23308122,2013-01-07T00:00:00,Animals,B01.050
23308122,2013-01-07T00:00:00,"Disease Models, Animal",C22.232
23308122,2013-01-07T00:00:00,"Disease Models, Animal",E05.598.500
23308122,2013-01-07T00:00:00,"Disease Models, Animal",E05.599.395.080
23308122,2013-01-07T00:00:00,Mammaplasty,E02.218.565
23308122,2013-01-07T00:00:00,Mammaplasty,E04.680.500
23308122,2013-01-07T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
23308122,2013-01-07T00:00:00,Obesity,C18.654.726.500
23308122,2013-01-07T00:00:00,Obesity,C23.888.144.699.500
23308122,2013-01-07T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23308122,2013-01-07T00:00:00,Obesity,G07.100.100.160.120.699.500
23308122,2013-01-07T00:00:00,Surgical Flaps,A10.850.710
23308122,2013-01-07T00:00:00,Surgical Flaps,E07.862.710
23140227,2013-01-08T00:00:00,Animals,B01.050
23140227,2013-01-08T00:00:00,Biocompatible Materials,D25.130
23140227,2013-01-08T00:00:00,Biocompatible Materials,D27.720.102.130
23140227,2013-01-08T00:00:00,Biocompatible Materials,J01.637.051.130
23140227,2013-01-08T00:00:00,Cell Differentiation,G04.299.151
23140227,2013-01-08T00:00:00,Cell Survival,G04.299.316
23140227,2013-01-08T00:00:00,DNA,D13.444.308
23140227,2013-01-08T00:00:00,Extracellular Matrix,A11.284.295.310
23140227,2013-01-08T00:00:00,Glycosaminoglycans,D09.698.373
23140227,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23140227,2013-01-08T00:00:00,Hydrogel,D02.033.455.250.700.485
23140227,2013-01-08T00:00:00,Hydrogel,D05.750.741.485
23140227,2013-01-08T00:00:00,Hydrogel,D25.720.741.485
23140227,2013-01-08T00:00:00,Hydrogel,D26.255.165.320.375.375
23140227,2013-01-08T00:00:00,Hydrogel,J01.637.051.720.741.485
23140227,2013-01-08T00:00:00,Materials Testing,E05.570
23140227,2013-01-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23140227,2013-01-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23140227,2013-01-08T00:00:00,"RNA, Messenger",D13.444.735.544
23140227,2013-01-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23140227,2013-01-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23140227,2013-01-08T00:00:00,Regeneration,G16.100.856
23140227,2013-01-08T00:00:00,Stem Cells,A11.872
23140227,2013-01-08T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
23140227,2013-01-08T00:00:00,Tissue Scaffolds,E07.206.627
23140227,2013-01-08T00:00:00,Tissue Scaffolds,E07.695.825
23140227,2013-01-08T00:00:00,Water,D01.455.900
23140227,2013-01-08T00:00:00,Water,D01.650.550.925
23295278,2013-01-08T00:00:00,Adult,M01.060.116
23295278,2013-01-08T00:00:00,Aged,M01.060.116.100
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23295278,2013-01-08T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23295278,2013-01-08T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23295278,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23295278,2013-01-08T00:00:00,Indomethacin,D03.438.473.420
23295278,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23295278,2013-01-08T00:00:00,Pancreatitis,C06.689.750
23295278,2013-01-08T00:00:00,Risk Factors,E05.318.740.600.800.725
23295278,2013-01-08T00:00:00,Risk Factors,N05.715.350.200.700
23295278,2013-01-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23295278,2013-01-08T00:00:00,Risk Factors,N06.850.490.625.750
23295278,2013-01-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23295278,2013-01-08T00:00:00,Stents,E07.695.750
23295278,2013-01-08T00:00:00,Treatment Outcome,E01.789.800
23295278,2013-01-08T00:00:00,Treatment Outcome,N04.761.559.590.800
23295278,2013-01-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23296454,2013-01-08T00:00:00,African Americans,M01.686.508.100.100
23296454,2013-01-08T00:00:00,African Americans,M01.686.754.100
23296454,2013-01-08T00:00:00,Age Factors,N05.715.350.075
23296454,2013-01-08T00:00:00,Age Factors,N06.850.490.250
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23296454,2013-01-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
23296454,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23296454,2013-01-08T00:00:00,Incidence,E05.318.308.985.525.375
23296454,2013-01-08T00:00:00,Incidence,L01.280.975.525.375
23296454,2013-01-08T00:00:00,Incidence,N01.224.935.597.500
23296454,2013-01-08T00:00:00,Incidence,N06.850.505.400.975.525.375
23296454,2013-01-08T00:00:00,Incidence,N06.850.520.308.985.525.375
23296454,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23296454,2013-01-08T00:00:00,South Carolina,Z01.107.567.875.075.662
23296454,2013-01-08T00:00:00,South Carolina,Z01.107.567.875.750.700
23298188,2013-01-08T00:00:00,Age Factors,N05.715.350.075
23298188,2013-01-08T00:00:00,Age Factors,N06.850.490.250
23298188,2013-01-08T00:00:00,Alcohol Drinking,F01.145.317.269
23298188,2013-01-08T00:00:00,Animals,B01.050
23298188,2013-01-08T00:00:00,"Behavior, Animal",F01.145.113
23298188,2013-01-08T00:00:00,Central Nervous System Depressants,D27.505.696.277
23298188,2013-01-08T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
23298188,2013-01-08T00:00:00,Ethanol,D02.033.375
23298713,2013-01-08T00:00:00,Adult,M01.060.116
23298713,2013-01-08T00:00:00,Aged,M01.060.116.100
23298713,2013-01-08T00:00:00,Attention,F02.830.104.214
23298713,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23298713,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23298713,2013-01-08T00:00:00,Neuropsychological Tests,F04.711.513
23298713,2013-01-08T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23305649,2013-01-08T00:00:00,Adult,M01.060.116
23305649,2013-01-08T00:00:00,Aged,M01.060.116.100
23305649,2013-01-08T00:00:00,Attitude to Health,F01.100.150
23305649,2013-01-08T00:00:00,Attitude to Health,N05.300.150
23305649,2013-01-08T00:00:00,Cellular Phone,L01.178.847.698.300
23305649,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305649,2013-01-08T00:00:00,Internet,L01.224.230.110.500
23305649,2013-01-08T00:00:00,Kidney Transplantation,E02.870.500
23305649,2013-01-08T00:00:00,Kidney Transplantation,E04.936.450.485
23305649,2013-01-08T00:00:00,Kidney Transplantation,E04.950.774.400
23305649,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23305649,2013-01-08T00:00:00,Patient Compliance,F01.145.488.500
23305649,2013-01-08T00:00:00,Patient Compliance,N05.300.150.600.600
23305649,2013-01-08T00:00:00,Questionnaires,E05.318.308.750
23305649,2013-01-08T00:00:00,Questionnaires,L01.280.800
23305649,2013-01-08T00:00:00,Questionnaires,N05.715.360.300.695
23305649,2013-01-08T00:00:00,Questionnaires,N06.850.520.308.750
23305649,2013-01-08T00:00:00,Telemedicine,H02.403.840
23305649,2013-01-08T00:00:00,Telemedicine,L01.178.847.652
23305649,2013-01-08T00:00:00,Telemedicine,N04.590.374.800
23281651,2013-01-09T00:00:00,Animals,B01.050
23281651,2013-01-09T00:00:00,Biological Transport,G03.495.166
23281651,2013-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23281651,2013-01-09T00:00:00,Luminescence,G01.201.875.770.578.665
23281651,2013-01-09T00:00:00,Luminescence,G01.590.540.665
23281651,2013-01-09T00:00:00,Nanocapsules,D26.255.260.575
23281651,2013-01-09T00:00:00,Nanocapsules,D27.720.280.260.575
23281651,2013-01-09T00:00:00,Nanocapsules,E02.319.300.380.575
23281651,2013-01-09T00:00:00,Nanocapsules,J01.637.512.600.575
23281651,2013-01-09T00:00:00,Optical Processes,G01.590.770
23281651,2013-01-09T00:00:00,Optical Processes,G01.595.640
23281651,2013-01-09T00:00:00,Photons,G01.201.875.770.578.782
23281651,2013-01-09T00:00:00,Photons,G01.249.705
23281651,2013-01-09T00:00:00,Photons,G01.590.540.782
23281651,2013-01-09T00:00:00,X-Rays,G01.201.875.750.918
23303956,2013-01-09T00:00:00,Animals,B01.050
23303956,2013-01-09T00:00:00,Biological Markers,D23.101
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",E05.245.380
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23303956,2013-01-09T00:00:00,Electric Stimulation,E05.723.402
23303956,2013-01-09T00:00:00,Limbic System,A08.186.211.464
23303956,2013-01-09T00:00:00,Neuronal Plasticity,G11.561.600.635
23303956,2013-01-09T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23303956,2013-01-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23303956,2013-01-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23303956,2013-01-09T00:00:00,Synapses,A08.850
23303956,2013-01-09T00:00:00,Synapses,A11.284.149.165.420.780
23303956,2013-01-09T00:00:00,Toluene,D02.455.426.559.389.832
23303956,2013-01-09T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
23303956,2013-01-09T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
23303956,2013-01-09T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
23303956,2013-01-09T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
23395283,2013-01-09T00:00:00,Algorithms,G17.035
23395283,2013-01-09T00:00:00,Algorithms,L01.224.050
23395283,2013-01-09T00:00:00,Computer Simulation,L01.224.160
23395283,2013-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23395283,2013-01-09T00:00:00,Image Enhancement,E01.370.350.600.350
23395283,2013-01-09T00:00:00,Image Enhancement,L01.224.308.380
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23395283,2013-01-09T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23395283,2013-01-09T00:00:00,"Microscopy, Confocal",E05.595.395
23395283,2013-01-09T00:00:00,"Models, Biological",E05.599.395
23395283,2013-01-09T00:00:00,"Pattern Recognition, Automated",L01.725
23307036,2013-01-10T00:00:00,Health Services,N02.421
23307036,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23307036,2013-01-10T00:00:00,Middle Aged,M01.060.116.630
23307036,2013-01-10T00:00:00,Motivation,F01.658
23307036,2013-01-10T00:00:00,Motivation,F01.752.543.500.750
23307036,2013-01-10T00:00:00,Neoplasms,C04
23307036,2013-01-10T00:00:00,Quality of Life,I01.800
23307036,2013-01-10T00:00:00,Quality of Life,K01.752.400.750
23307036,2013-01-10T00:00:00,Smoking,F01.145.466.753
23307036,2013-01-10T00:00:00,Smoking Cessation,F01.145.940.700
23307036,2013-01-10T00:00:00,Survivors,M01.643.836
23307036,2013-01-10T00:00:00,Survivors,M01.860
23314242,2013-01-10T00:00:00,Dietary Supplements,J02.500.456
23314242,2013-01-10T00:00:00,Double-Blind Method,E05.318.780.300
23314242,2013-01-10T00:00:00,Double-Blind Method,E05.581.500.300
23314242,2013-01-10T00:00:00,Double-Blind Method,N05.715.360.780.320
23314242,2013-01-10T00:00:00,Double-Blind Method,N06.850.520.445.300
23314242,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23314242,2013-01-10T00:00:00,"Infant, Newborn",M01.060.703.520
23314242,2013-01-10T00:00:00,Pregnancy,G08.686.785.760.769
23314242,2013-01-10T00:00:00,Pregnancy Complications,C13.703
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23314242,2013-01-10T00:00:00,Vitamin D,D04.808.812.768
23314242,2013-01-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23325143,2013-01-10T00:00:00,Adolescent,M01.060.057
23325143,2013-01-10T00:00:00,African Americans,M01.686.508.100.100
23325143,2013-01-10T00:00:00,African Americans,M01.686.754.100
23325143,2013-01-10T00:00:00,Blood Pressure,E01.370.600.875.249
23325143,2013-01-10T00:00:00,Blood Pressure,G09.330.380.076
23325143,2013-01-10T00:00:00,DNA Methylation,G02.111.087.029.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G02.111.087.218
23325143,2013-01-10T00:00:00,DNA Methylation,G02.149.115.029.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G02.149.115.218
23325143,2013-01-10T00:00:00,DNA Methylation,G03.495.130.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G05.355.190
23325143,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23325143,2013-01-10T00:00:00,Hypertension,C14.907.489
23325143,2013-01-10T00:00:00,Inflammation,C23.550.470
23325143,2013-01-10T00:00:00,Young Adult,M01.060.116.815
23312977,2013-01-11T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
23312977,2013-01-11T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
23312977,2013-01-11T00:00:00,Biological Markers,D23.101
23312977,2013-01-11T00:00:00,Case-Control Studies,E05.318.760.500.500
23312977,2013-01-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23312977,2013-01-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23312977,2013-01-11T00:00:00,"Diagnosis, Differential",E01.171
23312977,2013-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23312977,2013-01-11T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23312977,2013-01-11T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23312977,2013-01-11T00:00:00,MicroRNAs,D13.150.650.319
23312977,2013-01-11T00:00:00,MicroRNAs,D13.444.735.150.319
23312977,2013-01-11T00:00:00,MicroRNAs,D13.444.735.790.099
23312977,2013-01-11T00:00:00,Risk Factors,E05.318.740.600.800.725
23312977,2013-01-11T00:00:00,Risk Factors,N05.715.350.200.700
23312977,2013-01-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23312977,2013-01-11T00:00:00,Risk Factors,N06.850.490.625.750
23312977,2013-01-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23312977,2013-01-11T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
23315939,2013-01-11T00:00:00,Animals,B01.050
23315939,2013-01-11T00:00:00,Arrestins,D12.776.306.090
23315939,2013-01-11T00:00:00,Arrestins,D12.776.543.090
23315939,2013-01-11T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
23315939,2013-01-11T00:00:00,Bone Development,G11.427.590.560.100
23315939,2013-01-11T00:00:00,Bone and Bones,A02.835.232
23315939,2013-01-11T00:00:00,Bone and Bones,A10.165.265
23315939,2013-01-11T00:00:00,Cell Movement,G04.299.283
23315939,2013-01-11T00:00:00,Cell Movement,G07.700.560.500.180
23315939,2013-01-11T00:00:00,Cell Proliferation,G04.299.233.750
23315939,2013-01-11T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23315939,2013-01-11T00:00:00,Cell Survival,G04.299.316
23315939,2013-01-11T00:00:00,Osteoblasts,A11.329.629
23315939,2013-01-11T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23315939,2013-01-11T00:00:00,Osteogenesis,G11.427.590.560.100.729
23315939,2013-01-11T00:00:00,Parathyroid Hormone,D06.472.699.590
23315939,2013-01-11T00:00:00,Parathyroid Hormone,D12.644.548.587
23315939,2013-01-11T00:00:00,Peptide Fragments,D12.644.541
23315939,2013-01-11T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.314.400.250
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C19.053.500.270
23318275,2013-01-11T00:00:00,Animals,B01.050
23318275,2013-01-11T00:00:00,Astrocytes,A08.637.200
23318275,2013-01-11T00:00:00,Astrocytes,A11.650.200
23318275,2013-01-11T00:00:00,Child,M01.060.406
23318275,2013-01-11T00:00:00,Fibroblasts,A11.329.228
23318275,2013-01-11T00:00:00,Fibroblasts,A11.872.228
23318275,2013-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23318275,2013-01-11T00:00:00,Inflammation,C23.550.470
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.260.600
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.660.600
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.930.600
23326546,2013-01-11T00:00:00,Alleles,G05.360.340.024.340.030
23326546,2013-01-11T00:00:00,Animals,B01.050
23326546,2013-01-11T00:00:00,HIV-1,B04.820.650.589.650.350.400
23326546,2013-01-11T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23326546,2013-01-11T00:00:00,Malaria,C03.752.530
23326546,2013-01-11T00:00:00,Pregnancy,G08.686.785.760.769
23229778,2013-01-14T00:00:00,African Continental Ancestry Group,M01.686.508.100
23229778,2013-01-14T00:00:00,Aged,M01.060.116.100
23229778,2013-01-14T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23229778,2013-01-14T00:00:00,Blood Pressure,E01.370.600.875.249
23229778,2013-01-14T00:00:00,Blood Pressure,G09.330.380.076
23229778,2013-01-14T00:00:00,European Continental Ancestry Group,M01.686.508.400
23229778,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23229778,2013-01-14T00:00:00,Hypertension,C14.907.489
23229778,2013-01-14T00:00:00,Incidence,E05.318.308.985.525.375
23229778,2013-01-14T00:00:00,Incidence,L01.280.975.525.375
23229778,2013-01-14T00:00:00,Incidence,N01.224.935.597.500
23229778,2013-01-14T00:00:00,Incidence,N06.850.505.400.975.525.375
23229778,2013-01-14T00:00:00,Incidence,N06.850.520.308.985.525.375
23229778,2013-01-14T00:00:00,Middle Aged,M01.060.116.630
23229778,2013-01-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23229778,2013-01-14T00:00:00,Risk Factors,N05.715.350.200.700
23229778,2013-01-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23229778,2013-01-14T00:00:00,Risk Factors,N06.850.490.625.750
23229778,2013-01-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23229778,2013-01-14T00:00:00,Stroke,C10.228.140.300.775
23229778,2013-01-14T00:00:00,Stroke,C14.907.253.855
23229778,2013-01-14T00:00:00,United States,Z01.107.567.875
23319662,2013-01-14T00:00:00,Contrast Media,D27.720.259
23319662,2013-01-14T00:00:00,Diagnostic Imaging,E01.370.350
23319662,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23319662,2013-01-14T00:00:00,Kidney Diseases,C12.777.419
23319662,2013-01-14T00:00:00,Kidney Diseases,C13.351.968.419
23341932,2013-01-14T00:00:00,Adult,M01.060.116
23341932,2013-01-14T00:00:00,Child,M01.060.406
23341932,2013-01-14T00:00:00,"Child, Preschool",M01.060.406.448
23341932,2013-01-14T00:00:00,Demography,I01.240
23341932,2013-01-14T00:00:00,Demography,N01.224
23341932,2013-01-14T00:00:00,Demography,N06.850.505.400
23341932,2013-01-14T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
23341932,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23341932,2013-01-14T00:00:00,Infant,M01.060.703
23341932,2013-01-14T00:00:00,Middle Aged,M01.060.116.630
23341932,2013-01-14T00:00:00,Perfusion,E05.680
23341932,2013-01-14T00:00:00,Seizures,C10.228.140.490.631
23341932,2013-01-14T00:00:00,Seizures,C10.597.742
23341932,2013-01-14T00:00:00,Seizures,C23.888.592.742
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D01.632.825.562
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D02.092.570.665.810
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D02.691.825.562
23341932,2013-01-14T00:00:00,Young Adult,M01.060.116.815
23342106,2013-01-14T00:00:00,Animals,B01.050
23342106,2013-01-14T00:00:00,Embryonic Development,G07.700.320.500.325.180
23342106,2013-01-14T00:00:00,Embryonic Development,G08.686.785.760.170.104
23342106,2013-01-14T00:00:00,Heart,A07.541
23072722,2013-01-15T00:00:00,Animals,B01.050
23072722,2013-01-15T00:00:00,Cell Proliferation,G04.299.233.750
23072722,2013-01-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23072722,2013-01-15T00:00:00,DNA Methylation,G02.111.087.029.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G02.111.087.218
23072722,2013-01-15T00:00:00,DNA Methylation,G02.149.115.029.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G02.149.115.218
23072722,2013-01-15T00:00:00,DNA Methylation,G03.495.130.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G05.355.190
23072722,2013-01-15T00:00:00,Gene Expression Profiling,E05.393.332
23072722,2013-01-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23072722,2013-01-15T00:00:00,Histone Demethylases,D08.811.682.662.582.475
23072722,2013-01-15T00:00:00,Histones,D12.776.660.470
23072722,2013-01-15T00:00:00,Histones,D12.776.664.469
23072722,2013-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23072722,2013-01-15T00:00:00,Lysine,D12.125.068.555
23072722,2013-01-15T00:00:00,Lysine,D12.125.095.647
23072722,2013-01-15T00:00:00,Lysine,D12.125.142.497
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
23322627,2013-01-15T00:00:00,Age Factors,N05.715.350.075
23322627,2013-01-15T00:00:00,Age Factors,N06.850.490.250
23322627,2013-01-15T00:00:00,Aged,M01.060.116.100
23322627,2013-01-15T00:00:00,Biological Markers,D23.101
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.034.145
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.124.050.120
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.124.486.157
23322627,2013-01-15T00:00:00,Hearing Loss,C09.218.458.341
23322627,2013-01-15T00:00:00,Hearing Loss,C10.597.751.418.341
23322627,2013-01-15T00:00:00,Hearing Loss,C23.888.592.763.393.341
23322627,2013-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23322627,2013-01-15T00:00:00,Lipids,D10
23322627,2013-01-15T00:00:00,Middle Aged,M01.060.116.630
23322627,2013-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23322627,2013-01-15T00:00:00,Risk Factors,N05.715.350.200.700
23322627,2013-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23322627,2013-01-15T00:00:00,Risk Factors,N06.850.490.625.750
23322627,2013-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23324604,2013-01-16T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23324604,2013-01-16T00:00:00,Apoptosis,G04.299.139.160
23324604,2013-01-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23324604,2013-01-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23324604,2013-01-16T00:00:00,Cell Proliferation,G04.299.233.750
23324604,2013-01-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23324604,2013-01-16T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23324604,2013-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23324604,2013-01-16T00:00:00,Mouth Neoplasms,C04.588.443.591
23324604,2013-01-16T00:00:00,Mouth Neoplasms,C07.465.565
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
23324604,2013-01-16T00:00:00,RNA Stability,G02.111.780
23324604,2013-01-16T00:00:00,"RNA, Messenger",D13.444.735.544
23324604,2013-01-16T00:00:00,RNA-Binding Proteins,D12.776.157.725
23324604,2013-01-16T00:00:00,RNA-Binding Proteins,D12.776.664.962
23324604,2013-01-16T00:00:00,"Tumor Markers, Biological",D23.101.840
23324604,2013-01-16T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
23324604,2013-01-16T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
23324604,2013-01-16T00:00:00,bcl-Associated Death Protein,D12.644.360.075.718.100
23324604,2013-01-16T00:00:00,bcl-Associated Death Protein,D12.776.476.075.718.100
23324604,2013-01-16T00:00:00,bcl-Associated Death Protein,D12.776.744.049
23332093,2013-01-17T00:00:00,Adolescent,M01.060.057
23332093,2013-01-17T00:00:00,Adult,M01.060.116
23332093,2013-01-17T00:00:00,Aged,M01.060.116.100
23332093,2013-01-17T00:00:00,Case-Control Studies,E05.318.760.500.500
23332093,2013-01-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23332093,2013-01-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23332093,2013-01-17T00:00:00,Child,M01.060.406
23332093,2013-01-17T00:00:00,"Child, Preschool",M01.060.406.448
23332093,2013-01-17T00:00:00,Continuity of Patient Care,N04.590.233.727.210
23332093,2013-01-17T00:00:00,Graft Rejection,G12.425.901.545.328
23332093,2013-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23332093,2013-01-17T00:00:00,Infant,M01.060.703
23332093,2013-01-17T00:00:00,Medication Errors,E02.319.529
23332093,2013-01-17T00:00:00,Medication Errors,N02.421.450.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N02.421.668.438
23332093,2013-01-17T00:00:00,Medication Therapy Management,N03.219.521.576.343.575.500.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N03.219.521.576.343.840.938.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N04.590.661
23332093,2013-01-17T00:00:00,Middle Aged,M01.060.116.630
23332093,2013-01-17T00:00:00,Organ Transplantation,E04.936.450
23332093,2013-01-17T00:00:00,Patient Discharge,E02.760.400.610
23332093,2013-01-17T00:00:00,Patient Discharge,N02.421.585.400.610
23332093,2013-01-17T00:00:00,Pharmacists,M01.526.485.780
23332093,2013-01-17T00:00:00,Pharmacists,N02.360.780
23332093,2013-01-17T00:00:00,Risk Factors,E05.318.740.600.800.725
23332093,2013-01-17T00:00:00,Risk Factors,N05.715.350.200.700
23332093,2013-01-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23332093,2013-01-17T00:00:00,Risk Factors,N06.850.490.625.750
23332093,2013-01-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23332093,2013-01-17T00:00:00,Young Adult,M01.060.116.815
23337619,2013-01-18T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
23337619,2013-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23337619,2013-01-18T00:00:00,Neural Pathways,A08.612
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.228.662.600.400
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.574.812
23339888,2013-01-20T00:00:00,Adolescent,M01.060.057
23339888,2013-01-20T00:00:00,Adult,M01.060.116
23339888,2013-01-20T00:00:00,Aged,M01.060.116.100
23339888,2013-01-20T00:00:00,Child,M01.060.406
23339888,2013-01-20T00:00:00,"Child, Preschool",M01.060.406.448
23339888,2013-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23339888,2013-01-20T00:00:00,Infant,M01.060.703
23339888,2013-01-20T00:00:00,Middle Aged,M01.060.116.630
23339888,2013-01-20T00:00:00,Vaccination,E02.095.465.425.400.530.890
23339888,2013-01-20T00:00:00,Vaccination,E05.478.550.600.890
23339888,2013-01-20T00:00:00,Vaccination,N02.421.726.758.310.890
23339888,2013-01-20T00:00:00,Vaccination,N06.850.780.200.425.900
23339888,2013-01-20T00:00:00,Vaccination,N06.850.780.680.310.890
23339888,2013-01-20T00:00:00,Young Adult,M01.060.116.815
23347720,2013-01-21T00:00:00,Anaphylaxis,C20.543.480.099
23347720,2013-01-21T00:00:00,Animals,B01.050
23347720,2013-01-21T00:00:00,Ant Venoms,D20.888.065.055
23347720,2013-01-21T00:00:00,Ant Venoms,D23.946.833.065.055
23347720,2013-01-21T00:00:00,Ants,B01.050.500.131.617.479.205
23347720,2013-01-21T00:00:00,"Child, Preschool",M01.060.406.448
23347720,2013-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23347720,2013-01-21T00:00:00,Insect Bites and Stings,C21.613.127.441
23347720,2013-01-21T00:00:00,Rhabdomyolysis,C05.651.807
23347720,2013-01-21T00:00:00,Syndrome,C23.550.288.500
23349315,2013-01-24T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23349315,2013-01-24T00:00:00,Animals,B01.050
23349315,2013-01-24T00:00:00,Apoptosis,G04.299.139.160
23349315,2013-01-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23349315,2013-01-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23349315,2013-01-24T00:00:00,Cell Movement,G04.299.283
23349315,2013-01-24T00:00:00,Cell Movement,G07.700.560.500.180
23349315,2013-01-24T00:00:00,Cell Proliferation,G04.299.233.750
23349315,2013-01-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23349315,2013-01-24T00:00:00,Chick Embryo,A13.350.150
23349315,2013-01-24T00:00:00,Chick Embryo,A16.331.200
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A10.615.284.375
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A13.350.575
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A16.331.400
23349315,2013-01-24T00:00:00,Head and Neck Neoplasms,C04.588.443
23349315,2013-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23349315,2013-01-24T00:00:00,Interleukin-6,D12.644.276.374.465.506
23349315,2013-01-24T00:00:00,Interleukin-6,D12.776.467.374.465.506
23349315,2013-01-24T00:00:00,Interleukin-6,D23.529.374.465.506
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
23349315,2013-01-24T00:00:00,Neoplasm Invasiveness,C04.697.645
23349315,2013-01-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23349315,2013-01-24T00:00:00,Neoplasm Staging,E01.370.550
23349315,2013-01-24T00:00:00,RNA Stability,G02.111.780
23349315,2013-01-24T00:00:00,"RNA, Messenger",D13.444.735.544
23349315,2013-01-24T00:00:00,Tissue Array Analysis,E05.196.630.570.850
23349315,2013-01-24T00:00:00,Tissue Array Analysis,E05.588.570.850
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23359212,2013-01-24T00:00:00,Algorithms,G17.035
23359212,2013-01-24T00:00:00,Algorithms,L01.224.050
23359212,2013-01-24T00:00:00,Animals,B01.050
23359212,2013-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360767,2013-01-26T00:00:00,Aged,M01.060.116.100
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.695.175
23360767,2013-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360767,2013-01-26T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23411031,2013-01-27T00:00:00,Animals,B01.050
23411031,2013-01-27T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
23411031,2013-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23411031,2013-01-27T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23411031,2013-01-27T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23411031,2013-01-27T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23351552,2013-01-28T00:00:00,Arrestins,D12.776.306.090
23351552,2013-01-28T00:00:00,Arrestins,D12.776.543.090
23351552,2013-01-28T00:00:00,Cell Line,A11.251.210
23351552,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23351552,2013-01-28T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23351552,2013-01-28T00:00:00,"Microscopy, Fluorescence",E05.595.458
23351552,2013-01-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
23351552,2013-01-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
23356818,2013-01-28T00:00:00,African Continental Ancestry Group,M01.686.508.100
23356818,2013-01-28T00:00:00,Aged,M01.060.116.100
23356818,2013-01-28T00:00:00,Atrial Fibrillation,C14.280.067.198
23356818,2013-01-28T00:00:00,Atrial Fibrillation,C23.550.073.198
23356818,2013-01-28T00:00:00,"Cardiac Pacing, Artificial",E02.145
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.695.175
23356818,2013-01-28T00:00:00,Electric Countershock,E02.342.287
23356818,2013-01-28T00:00:00,Ethnic Groups,M01.686.754
23356818,2013-01-28T00:00:00,Ethnic Groups,N01.224.317
23356818,2013-01-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
23356818,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23356818,2013-01-28T00:00:00,Incidence,E05.318.308.985.525.375
23356818,2013-01-28T00:00:00,Incidence,L01.280.975.525.375
23356818,2013-01-28T00:00:00,Incidence,N01.224.935.597.500
23356818,2013-01-28T00:00:00,Incidence,N06.850.505.400.975.525.375
23356818,2013-01-28T00:00:00,Incidence,N06.850.520.308.985.525.375
23356818,2013-01-28T00:00:00,North America,Z01.107.567
23356818,2013-01-28T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23356818,2013-01-28T00:00:00,Risk Factors,E05.318.740.600.800.725
23356818,2013-01-28T00:00:00,Risk Factors,N05.715.350.200.700
23356818,2013-01-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23356818,2013-01-28T00:00:00,Risk Factors,N06.850.490.625.750
23356818,2013-01-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23356818,2013-01-28T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
23356818,2013-01-28T00:00:00,Time Factors,G01.910.857
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
23359698,2013-01-28T00:00:00,Ethnic Groups,M01.686.754
23359698,2013-01-28T00:00:00,Ethnic Groups,N01.224.317
23359698,2013-01-28T00:00:00,Gene Deletion,G05.355.600.800.320
23359698,2013-01-28T00:00:00,Gene Deletion,G05.365.590.762.320
23359698,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359698,2013-01-28T00:00:00,"Models, Genetic",E05.599.395.397
23359698,2013-01-28T00:00:00,Mutation,G05.365.590
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.075.437
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.350.530
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.500.530
23359698,2013-01-28T00:00:00,Phenotype,G05.695
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.244.453.915.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.170.915.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.783.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D12.776.422.220.453.915.760
23356584,2013-01-29T00:00:00,Adolescent,M01.060.057
23356584,2013-01-29T00:00:00,Adult,M01.060.116
23356584,2013-01-29T00:00:00,Age Factors,N05.715.350.075
23356584,2013-01-29T00:00:00,Age Factors,N06.850.490.250
23356584,2013-01-29T00:00:00,Biological Markers,D23.101
23356584,2013-01-29T00:00:00,Cell Proliferation,G04.299.233.750
23356584,2013-01-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23356584,2013-01-29T00:00:00,Child,M01.060.406
23356584,2013-01-29T00:00:00,"Child, Preschool",M01.060.406.448
23356584,2013-01-29T00:00:00,Fatty Liver,C06.552.241
23356584,2013-01-29T00:00:00,Gastric Bypass,E02.065.062.249
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.035.398.385
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.062.249
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.210.457.430
23356584,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23356584,2013-01-29T00:00:00,Liver,A03.620
23356584,2013-01-29T00:00:00,Liver Cirrhosis,C06.552.630
23356584,2013-01-29T00:00:00,Risk Factors,E05.318.740.600.800.725
23356584,2013-01-29T00:00:00,Risk Factors,N05.715.350.200.700
23356584,2013-01-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23356584,2013-01-29T00:00:00,Risk Factors,N06.850.490.625.750
23356584,2013-01-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23356584,2013-01-29T00:00:00,Stem Cells,A11.872
23356584,2013-01-29T00:00:00,Treatment Outcome,E01.789.800
23356584,2013-01-29T00:00:00,Treatment Outcome,N04.761.559.590.800
23356584,2013-01-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23360094,2013-01-29T00:00:00,Adolescent,M01.060.057
23360094,2013-01-29T00:00:00,Adult,M01.060.116
23360094,2013-01-29T00:00:00,Bladder Exstrophy,C12.706.132
23360094,2013-01-29T00:00:00,Bladder Exstrophy,C12.777.829.132
23360094,2013-01-29T00:00:00,Bladder Exstrophy,C13.351.875.132
23360094,2013-01-29T00:00:00,Bladder Exstrophy,C13.351.968.829.132
23360094,2013-01-29T00:00:00,Bladder Exstrophy,C16.131.939.132
23360094,2013-01-29T00:00:00,Child,M01.060.406
23360094,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360094,2013-01-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23360094,2013-01-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23360094,2013-01-29T00:00:00,Middle Aged,M01.060.116.630
23360094,2013-01-29T00:00:00,Young Adult,M01.060.116.815
23360332,2013-01-29T00:00:00,Diffusion of Innovation,L01.143.320
23360332,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",N02.360.630.490
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",N02.360.740.422
23360332,2013-01-29T00:00:00,Qualitative Research,H01.770.644.241.850
23360332,2013-01-29T00:00:00,Questionnaires,E05.318.308.750
23360332,2013-01-29T00:00:00,Questionnaires,L01.280.800
23360332,2013-01-29T00:00:00,Questionnaires,N05.715.360.300.695
23360332,2013-01-29T00:00:00,Questionnaires,N06.850.520.308.750
23360332,2013-01-29T00:00:00,South Carolina,Z01.107.567.875.075.662
23360332,2013-01-29T00:00:00,South Carolina,Z01.107.567.875.750.700
23360332,2013-01-29T00:00:00,Telemedicine,H02.403.840
23360332,2013-01-29T00:00:00,Telemedicine,L01.178.847.652
23360332,2013-01-29T00:00:00,Telemedicine,N04.590.374.800
23360446,2013-01-29T00:00:00,Animals,B01.050
23360446,2013-01-29T00:00:00,Central Nervous System Stimulants,D27.505.696.282
23360446,2013-01-29T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
23360446,2013-01-29T00:00:00,Cocaine,D02.145.074.722.388
23360446,2013-01-29T00:00:00,Cocaine,D03.132.889.354
23360446,2013-01-29T00:00:00,Cocaine,D03.605.869.388
23360446,2013-01-29T00:00:00,Cocaine,D04.075.080.875.099.722.388
23360446,2013-01-29T00:00:00,Dopamine,D02.092.211.215.311.342
23360446,2013-01-29T00:00:00,Dopamine,D02.092.311.342
23360446,2013-01-29T00:00:00,Gene Expression,G05.355.310
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.067.750
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.119.450
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.427.300
23360446,2013-01-29T00:00:00,Neurons,A08.663
23360446,2013-01-29T00:00:00,Neurons,A11.671
23360446,2013-01-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23360446,2013-01-29T00:00:00,Protein Transport,G03.495.166.700
23360446,2013-01-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23360446,2013-01-29T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23360446,2013-01-29T00:00:00,"Restraint, Physical",E02.085.700
23360446,2013-01-29T00:00:00,"Restraint, Physical",E05.472.760
23360446,2013-01-29T00:00:00,"Stress, Psychological",F01.145.126.990
23360446,2013-01-29T00:00:00,"Stress, Psychological",F02.830.900
23360755,2013-01-29T00:00:00,Animals,B01.050
23360755,2013-01-29T00:00:00,Apoptosis,G04.299.139.160
23360755,2013-01-29T00:00:00,Cell Aging,G04.299.119
23360755,2013-01-29T00:00:00,Cell Proliferation,G04.299.233.750
23360755,2013-01-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23360755,2013-01-29T00:00:00,Hematologic Diseases,C15.378
23360755,2013-01-29T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
23360755,2013-01-29T00:00:00,Hematopoietic Stem Cells,A11.148.378
23360755,2013-01-29T00:00:00,Hematopoietic Stem Cells,A11.872.378
23360755,2013-01-29T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
23360755,2013-01-29T00:00:00,Phenotype,G05.695
23360755,2013-01-29T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23360755,2013-01-29T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
23360755,2013-01-29T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
23360755,2013-01-29T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
23327468,2013-01-30T00:00:00,Cell Line,A11.251.210
23327468,2013-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23327468,2013-01-30T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
23327468,2013-01-30T00:00:00,Mass Spectrometry,E05.196.566
23327468,2013-01-30T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23327468,2013-01-30T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23327468,2013-01-30T00:00:00,Oxidative Stress,G03.495.710
23327468,2013-01-30T00:00:00,Oxidative Stress,G07.700.830.750
23327468,2013-01-30T00:00:00,Vitamin K,D02.455.426.559.847.638.721.374
23327468,2013-01-30T00:00:00,Vitamin K,D02.455.849.291.523.500
23327468,2013-01-30T00:00:00,Vitamin K,D04.615.638.721.374
23361338,2013-01-30T00:00:00,Adolescent,M01.060.057
23361338,2013-01-30T00:00:00,Adult,M01.060.116
23361338,2013-01-30T00:00:00,Breast Neoplasms,C04.588.180
23361338,2013-01-30T00:00:00,Breast Neoplasms,C17.800.090.500
23361338,2013-01-30T00:00:00,Dietary Supplements,J02.500.456
23361338,2013-01-30T00:00:00,Ethnic Groups,M01.686.754
23361338,2013-01-30T00:00:00,Ethnic Groups,N01.224.317
23361338,2013-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23361338,2013-01-30T00:00:00,Middle Aged,M01.060.116.630
23361338,2013-01-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23361338,2013-01-30T00:00:00,Risk Factors,N05.715.350.200.700
23361338,2013-01-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23361338,2013-01-30T00:00:00,Risk Factors,N06.850.490.625.750
23361338,2013-01-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23361338,2013-01-30T00:00:00,SEER Program,E05.318.308.970.725
23361338,2013-01-30T00:00:00,SEER Program,L01.280.950.725
23361338,2013-01-30T00:00:00,SEER Program,N04.452.859.819.725
23361338,2013-01-30T00:00:00,SEER Program,N05.715.360.300.715.700.725
23361338,2013-01-30T00:00:00,SEER Program,N06.850.520.308.970.725
23361338,2013-01-30T00:00:00,Survivors,M01.643.836
23361338,2013-01-30T00:00:00,Survivors,M01.860
23361338,2013-01-30T00:00:00,Vitamin D,D04.808.812.768
23361338,2013-01-30T00:00:00,Young Adult,M01.060.116.815
23361932,2013-01-30T00:00:00,Animals,B01.050
23361932,2013-01-30T00:00:00,Chondrocytes,A11.329.171
23361932,2013-01-30T00:00:00,"Disease Models, Animal",C22.232
23361932,2013-01-30T00:00:00,"Disease Models, Animal",E05.598.500
23361932,2013-01-30T00:00:00,"Disease Models, Animal",E05.599.395.080
23361932,2013-01-30T00:00:00,Disease Progression,C23.550.291.656
23361932,2013-01-30T00:00:00,Fibrosis,C23.550.355
23361932,2013-01-30T00:00:00,Hematoma,C23.550.414.838
23361932,2013-01-30T00:00:00,Hip Joint,A02.835.583.411
23361932,2013-01-30T00:00:00,"Muscle, Skeletal",A02.633.567
23361932,2013-01-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
23361932,2013-01-30T00:00:00,Rabbits,B01.050.150.900.649.521.700
23361932,2013-01-30T00:00:00,Time Factors,G01.910.857
23383213,2013-01-30T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
23383213,2013-01-30T00:00:00,Animals,B01.050
23383213,2013-01-30T00:00:00,Rivers,G01.311.750
23383213,2013-01-30T00:00:00,Rivers,G16.500.275.280.500
23383213,2013-01-30T00:00:00,Rivers,N06.230.232.500
23370205,2013-01-31T00:00:00,Algorithms,G17.035
23370205,2013-01-31T00:00:00,Algorithms,L01.224.050
23370205,2013-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23370205,2013-01-31T00:00:00,Stroke,C10.228.140.300.775
23370205,2013-01-31T00:00:00,Stroke,C14.907.253.855
23370205,2013-01-31T00:00:00,United States,Z01.107.567.875
22647828,2013-02-01T00:00:00,Adult,M01.060.116
22647828,2013-02-01T00:00:00,Aged,M01.060.116.100
22647828,2013-02-01T00:00:00,Artifacts,E05.047
22647828,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
22647828,2013-02-01T00:00:00,Clinical Competence,N04.761.210
22647828,2013-02-01T00:00:00,Deglutition,G10.261.326.215
22647828,2013-02-01T00:00:00,Deglutition Disorders,C06.405.117.119
22647828,2013-02-01T00:00:00,Deglutition Disorders,C09.775.174
22647828,2013-02-01T00:00:00,Esophagus,A03.556.875.500
22647828,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22647828,2013-02-01T00:00:00,Internship and Residency,I02.358.399.644
22647828,2013-02-01T00:00:00,Manometry,E05.559
22647828,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
22647828,2013-02-01T00:00:00,Pressure,G01.374.715
22878834,2013-02-01T00:00:00,Bronchoscopy,E01.370.386.105
22878834,2013-02-01T00:00:00,Bronchoscopy,E01.370.388.250.100
22878834,2013-02-01T00:00:00,Bronchoscopy,E04.800.250.100
22878834,2013-02-01T00:00:00,Bronchoscopy,E04.928.600.080
22878834,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
22878834,2013-02-01T00:00:00,Clinical Competence,N04.761.210
22878834,2013-02-01T00:00:00,Critical Care,E02.760.190
22878834,2013-02-01T00:00:00,Critical Care,N02.421.585.190
22878834,2013-02-01T00:00:00,Data Collection,E05.318.308
22878834,2013-02-01T00:00:00,Data Collection,L01.280
22878834,2013-02-01T00:00:00,Data Collection,N05.715.360.300
22878834,2013-02-01T00:00:00,Data Collection,N06.850.520.308
22878834,2013-02-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
22878834,2013-02-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
22878834,2013-02-01T00:00:00,Endosonography,E01.370.350.850.280
22878834,2013-02-01T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
22878834,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22878834,2013-02-01T00:00:00,Patient Simulation,I02.903.525
22878834,2013-02-01T00:00:00,United States,Z01.107.567.875
22902607,2013-02-01T00:00:00,Anesthesiology,H02.403.066
22902607,2013-02-01T00:00:00,Computer Simulation,L01.224.160
22902607,2013-02-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
22902607,2013-02-01T00:00:00,Educational Measurement,I02.399
22902607,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22902607,2013-02-01T00:00:00,Internal Medicine,H02.403.429
22902607,2013-02-01T00:00:00,"Intubation, Intratracheal",E05.497.578
22902607,2013-02-01T00:00:00,Masks,E07.700.500
22902607,2013-02-01T00:00:00,Masks,J01.637.708.500
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",N02.360.630.490
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",N02.360.740.422
22902607,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22902607,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23039284,2013-02-01T00:00:00,Animals,B01.050
23039284,2013-02-01T00:00:00,Autoimmunity,G12.450.192
23039284,2013-02-01T00:00:00,B-Lymphocytes,A11.063.438
23039284,2013-02-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.382.032.438
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
23039284,2013-02-01T00:00:00,Disease Progression,C23.550.291.656
23039284,2013-02-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23039284,2013-02-01T00:00:00,Flow Cytometry,E05.200.500.386.350
23039284,2013-02-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23039284,2013-02-01T00:00:00,Quinazolines,D03.438.786
23138547,2013-02-01T00:00:00,Adult,M01.060.116
23138547,2013-02-01T00:00:00,Brain,A08.186.211
23138547,2013-02-01T00:00:00,Brain Injuries,C10.228.140.199
23138547,2013-02-01T00:00:00,Brain Injuries,C10.900.300.087
23138547,2013-02-01T00:00:00,Brain Injuries,C21.866.260.118
23138547,2013-02-01T00:00:00,Brain Injuries,C21.866.915.300.200
23138547,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23138547,2013-02-01T00:00:00,Intracranial Pressure,G11.561.170.505
23138547,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23138547,2013-02-01T00:00:00,"Monitoring, Physiologic",E01.370.520
23138547,2013-02-01T00:00:00,Oxygen,D01.268.185.550
23138547,2013-02-01T00:00:00,Oxygen,D01.362.670
23138547,2013-02-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23138547,2013-02-01T00:00:00,Trauma Centers,N02.421.297.195.480
23138547,2013-02-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23138547,2013-02-01T00:00:00,Treatment Outcome,E01.789.800
23138547,2013-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23138547,2013-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23138547,2013-02-01T00:00:00,Young Adult,M01.060.116.815
23178069,2013-02-01T00:00:00,Breast Feeding,G07.610.220.500.500
23178069,2013-02-01T00:00:00,Breast Feeding,G07.610.593.185
23178069,2013-02-01T00:00:00,Breast Feeding,G07.700.620.185
23178069,2013-02-01T00:00:00,Diet,E05.272
23178069,2013-02-01T00:00:00,Diet,G07.610.240
23178069,2013-02-01T00:00:00,Dietary Proteins,D12.776.256
23178069,2013-02-01T00:00:00,Dietary Proteins,J02.500.428
23178069,2013-02-01T00:00:00,Dietary Supplements,J02.500.456
23178069,2013-02-01T00:00:00,Energy Intake,G07.610.240.340
23178069,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23178069,2013-02-01T00:00:00,Infant,M01.060.703
23178069,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23178069,2013-02-01T00:00:00,Lactation,G08.686.702.500
23178069,2013-02-01T00:00:00,Lactation,G08.686.785.420
23178069,2013-02-01T00:00:00,"Milk, Human",A12.200.467
23178069,2013-02-01T00:00:00,"Milk, Human",J02.200.700.500
23178069,2013-02-01T00:00:00,"Milk, Human",J02.500.350.525.500
23222499,2013-02-01T00:00:00,Adolescent,M01.060.057
23222499,2013-02-01T00:00:00,Adult,M01.060.116
23222499,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23222499,2013-02-01T00:00:00,African Americans,M01.686.754.100
23222499,2013-02-01T00:00:00,Aged,M01.060.116.100
23222499,2013-02-01T00:00:00,Delivery of Health Care,N04.590.374
23222499,2013-02-01T00:00:00,Delivery of Health Care,N05.300
23222499,2013-02-01T00:00:00,Demography,I01.240
23222499,2013-02-01T00:00:00,Demography,N01.224
23222499,2013-02-01T00:00:00,Demography,N06.850.505.400
23222499,2013-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23222499,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23222499,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23222499,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23222499,2013-02-01T00:00:00,Questionnaires,L01.280.800
23222499,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23222499,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23222499,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23222499,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23222499,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23222499,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23222499,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23222499,2013-02-01T00:00:00,United States,Z01.107.567.875
23241566,2013-02-01T00:00:00,Blood Pressure,E01.370.600.875.249
23241566,2013-02-01T00:00:00,Blood Pressure,G09.330.380.076
23241566,2013-02-01T00:00:00,Guidelines as Topic,N04.761.700.350
23241566,2013-02-01T00:00:00,Guidelines as Topic,N05.700.350
23241566,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23241566,2013-02-01T00:00:00,Hypertension,C14.907.489
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23241566,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23241566,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23241566,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23241566,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23241566,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23241566,2013-02-01T00:00:00,Stroke,C10.228.140.300.775
23241566,2013-02-01T00:00:00,Stroke,C14.907.253.855
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23254556,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23254556,2013-02-01T00:00:00,Neuronal Plasticity,G11.561.600.635
23254556,2013-02-01T00:00:00,Recovery of Function,G16.757
23254556,2013-02-01T00:00:00,Stroke,C10.228.140.300.775
23254556,2013-02-01T00:00:00,Stroke,C14.907.253.855
23254556,2013-02-01T00:00:00,Treatment Outcome,E01.789.800
23254556,2013-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23254556,2013-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23300312,2013-02-01T00:00:00,Animals,B01.050
23300312,2013-02-01T00:00:00,Antioxidants,D27.505.519.217
23300312,2013-02-01T00:00:00,Antioxidants,D27.505.696.706.125
23300312,2013-02-01T00:00:00,Antioxidants,D27.720.799.047
23300312,2013-02-01T00:00:00,Chickens,B01.050.150.900.248.350.150
23300312,2013-02-01T00:00:00,Chickens,B01.050.150.900.248.617.192
23303356,2013-02-01T00:00:00,Aged,M01.060.116.100
23303356,2013-02-01T00:00:00,Health Behavior,F01.145.488
23303356,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23303356,2013-02-01T00:00:00,Hypertension,C14.907.489
23303356,2013-02-01T00:00:00,Life Style,F01.829.458
23303356,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23329057,2013-02-01T00:00:00,Adenoidectomy,E04.580.068
23329057,2013-02-01T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
23329057,2013-02-01T00:00:00,Craniofacial Abnormalities,C05.660.207
23329057,2013-02-01T00:00:00,Craniofacial Abnormalities,C16.131.621.207
23329057,2013-02-01T00:00:00,Down Syndrome,C10.597.606.643.220
23329057,2013-02-01T00:00:00,Down Syndrome,C16.131.077.327
23329057,2013-02-01T00:00:00,Down Syndrome,C16.131.260.260
23329057,2013-02-01T00:00:00,Down Syndrome,C16.320.180.260
23329057,2013-02-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23329057,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23329057,2013-02-01T00:00:00,Infant,M01.060.703
23329057,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23329057,2013-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23329057,2013-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23329057,2013-02-01T00:00:00,Polysomnography,E01.370.520.625
23329057,2013-02-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
23329057,2013-02-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
23329057,2013-02-01T00:00:00,Tonsillectomy,E04.580.848
23329057,2013-02-01T00:00:00,Tracheostomy,E04.579.935
23329057,2013-02-01T00:00:00,Tracheostomy,E04.580.900
23329057,2013-02-01T00:00:00,Tracheostomy,E04.928.780
23331442,2013-02-01T00:00:00,Aged,M01.060.116.100
23331442,2013-02-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
23331442,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23331442,2013-02-01T00:00:00,Renin-Angiotensin System,G03.495.805
23331442,2013-02-01T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
23332327,2013-02-01T00:00:00,Adult,M01.060.116
23332327,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23332327,2013-02-01T00:00:00,African Americans,M01.686.754.100
23332327,2013-02-01T00:00:00,Aged,M01.060.116.100
23332327,2013-02-01T00:00:00,Community-Based Participatory Research,N05.425.104
23332327,2013-02-01T00:00:00,Diet,E05.272
23332327,2013-02-01T00:00:00,Diet,G07.610.240
23332327,2013-02-01T00:00:00,Health Behavior,F01.145.488
23332327,2013-02-01T00:00:00,Health Promotion,N02.370
23332327,2013-02-01T00:00:00,Health Promotion,N02.421.726.507
23332327,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23332327,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23332327,2013-02-01T00:00:00,Motor Activity,F01.145.632
23332327,2013-02-01T00:00:00,Motor Activity,G11.427.590.530.698
23332327,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23332327,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23336644,2013-02-01T00:00:00,Cutaneous Fistula,C17.800.135
23336644,2013-02-01T00:00:00,Cutaneous Fistula,C23.300.575.150
23336644,2013-02-01T00:00:00,"Diagnosis, Differential",E01.171
23336644,2013-02-01T00:00:00,"Diverticulitis, Colonic",C06.405.469.158.587.500
23336644,2013-02-01T00:00:00,"Hernia, Inguinal",C23.300.707.374.875
23336644,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336644,2013-02-01T00:00:00,Intestinal Fistula,C06.267.550
23336644,2013-02-01T00:00:00,Intestinal Fistula,C06.405.469.471
23336644,2013-02-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
23336644,2013-02-01T00:00:00,Intestinal Perforation,C06.405.469.557
23336644,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23336899,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
23336899,2013-02-01T00:00:00,Clinical Competence,N04.761.210
23336899,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336899,2013-02-01T00:00:00,Informed Consent,I01.880.604.473.650.718
23336899,2013-02-01T00:00:00,Informed Consent,I01.880.604.583.427
23336899,2013-02-01T00:00:00,Informed Consent,N03.706.437.650.312
23336899,2013-02-01T00:00:00,Informed Consent,N03.706.535.489
23336899,2013-02-01T00:00:00,"Specialties, Surgical",H02.403.810
23336901,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336901,2013-02-01T00:00:00,Tissue Donors,M01.898
23345347,2013-02-01T00:00:00,Breast Neoplasms,C04.588.180
23345347,2013-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
23345347,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23345347,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
23345347,2013-02-01T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
23345347,2013-02-01T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
23345347,2013-02-01T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
23345347,2013-02-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23345347,2013-02-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
23345347,2013-02-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
23354237,2013-02-01T00:00:00,Adult,M01.060.116
23354237,2013-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23354237,2013-02-01T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
23354237,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23354237,2013-02-01T00:00:00,Intensive Care Units,N02.278.388.493
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
23354237,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23354237,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23354237,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23354237,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23354237,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23360855,2013-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23360855,2013-02-01T00:00:00,Cross Infection,C01.539.248
23360855,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360855,2013-02-01T00:00:00,Infant,M01.060.703
23360855,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23360855,2013-02-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
23360855,2013-02-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23360855,2013-02-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23360855,2013-02-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23360855,2013-02-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23360855,2013-02-01T00:00:00,Program Evaluation,E05.337.820
23360855,2013-02-01T00:00:00,Program Evaluation,N04.761.685
23360855,2013-02-01T00:00:00,Program Evaluation,N05.715.360.650
23373750,2013-02-01T00:00:00,Animals,B01.050
23373750,2013-02-01T00:00:00,Bone Screws,E07.695.130
23373750,2013-02-01T00:00:00,Bone Screws,E07.858.442.660.115
23373750,2013-02-01T00:00:00,Bone Screws,E07.858.690.650.115
23373750,2013-02-01T00:00:00,Bone and Bones,A02.835.232
23373750,2013-02-01T00:00:00,Bone and Bones,A10.165.265
23373750,2013-02-01T00:00:00,Weight-Bearing,G01.374.676.965
23373750,2013-02-01T00:00:00,Weight-Bearing,G01.595.540.965
23375850,2013-02-01T00:00:00,Animals,B01.050
23375850,2013-02-01T00:00:00,Cardiovascular Diseases,C14
23375850,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23375850,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23375850,2013-02-01T00:00:00,Diabetic Angiopathies,C14.907.320
23375850,2013-02-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
23375850,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23375850,2013-02-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23375850,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23375850,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23375850,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23375850,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23375850,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23378075,2013-02-01T00:00:00,Adolescent,M01.060.057
23378075,2013-02-01T00:00:00,Adult,M01.060.116
23378075,2013-02-01T00:00:00,Family Practice,H02.403.280
23378075,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23378075,2013-02-01T00:00:00,Internship and Residency,I02.358.399.644
23378075,2013-02-01T00:00:00,Papillomavirus Infections,C02.256.650
23378075,2013-02-01T00:00:00,Papillomavirus Infections,C02.928.725
23378075,2013-02-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23378075,2013-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
23378075,2013-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
23378075,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23378075,2013-02-01T00:00:00,Questionnaires,L01.280.800
23378075,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23378075,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23378075,2013-02-01T00:00:00,Sex Factors,N05.715.350.675
23378075,2013-02-01T00:00:00,Sex Factors,N06.850.490.875
23378075,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23378075,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23378393,2013-02-01T00:00:00,Cadaver,C23.550.260.224
23378393,2013-02-01T00:00:00,Cleft Palate,C05.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C05.660.207.540.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.320.440.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.465.525.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.650.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.650.525.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.621.207.540.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.850.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.850.525.185
23378393,2013-02-01T00:00:00,Endosonography,E01.370.350.850.280
23378393,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23382526,2013-02-01T00:00:00,Crowns,E06.323.428.100
23382526,2013-02-01T00:00:00,Crowns,E06.323.528.250
23382526,2013-02-01T00:00:00,Crowns,E06.780.345.250
23382526,2013-02-01T00:00:00,Crowns,E06.780.345.737.100
23382526,2013-02-01T00:00:00,Crowns,E07.695.190.190.150
23382526,2013-02-01T00:00:00,Double-Blind Method,E05.318.780.300
23382526,2013-02-01T00:00:00,Double-Blind Method,E05.581.500.300
23382526,2013-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
23382526,2013-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
23382526,2013-02-01T00:00:00,"Education, Dental",I02.358.274
23382526,2013-02-01T00:00:00,Educational Measurement,I02.399
23382526,2013-02-01T00:00:00,Educational Technology,J01.897.280
23382526,2013-02-01T00:00:00,"Faculty, Dental",I02.463.273
23382526,2013-02-01T00:00:00,"Faculty, Dental",M01.526.339.273
23382526,2013-02-01T00:00:00,"Faculty, Dental",M01.526.485.360
23382526,2013-02-01T00:00:00,"Faculty, Dental",N02.360.360
23382526,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23382526,2013-02-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23382526,2013-02-01T00:00:00,Software,L01.224.900
23382526,2013-02-01T00:00:00,Tooth Preparation,E06.931
23382526,2013-02-01T00:00:00,User-Computer Interface,L01.224.900.910
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,E05.337.800.120
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,L01.453.270.120
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,N02.421.668.320.120
23386592,2013-02-01T00:00:00,Evidence-Based Medicine,H02.249.750
23386592,2013-02-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23386592,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23402449,2013-02-01T00:00:00,Cost of Illness,I01.137
23402449,2013-02-01T00:00:00,Cost of Illness,N03.219.151.165
23402449,2013-02-01T00:00:00,Depression,F01.145.126.350
23402449,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23402449,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23402449,2013-02-01T00:00:00,Health Care Costs,N03.219.151.400
23402449,2013-02-01T00:00:00,Health Care Costs,N05.300.375
23402449,2013-02-01T00:00:00,Health Expenditures,N03.219.151.450
23402449,2013-02-01T00:00:00,Health Expenditures,N05.300.385
23402449,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23402449,2013-02-01T00:00:00,Quality of Life,I01.800
23402449,2013-02-01T00:00:00,Quality of Life,K01.752.400.750
23404872,2013-02-01T00:00:00,Adult,M01.060.116
23404872,2013-02-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23404872,2013-02-01T00:00:00,Body Mass Index,E05.041.124.125
23404872,2013-02-01T00:00:00,Body Mass Index,G07.100.100.125
23404872,2013-02-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23404872,2013-02-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23404872,2013-02-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23404872,2013-02-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23404872,2013-02-01T00:00:00,Fetus,A16.378
23404872,2013-02-01T00:00:00,Folic Acid,D03.438.733.631.400
23404872,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23404872,2013-02-01T00:00:00,Infant,M01.060.703
23404872,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23404872,2013-02-01T00:00:00,Neural Tube Defects,C10.500.680
23404872,2013-02-01T00:00:00,Neural Tube Defects,C16.131.666.680
23404872,2013-02-01T00:00:00,Obesity,C18.654.726.500
23404872,2013-02-01T00:00:00,Obesity,C23.888.144.699.500
23404872,2013-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23404872,2013-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23404872,2013-02-01T00:00:00,Pregnancy,G08.686.785.760.769
23404872,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23404872,2013-02-01T00:00:00,Questionnaires,L01.280.800
23404872,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23404872,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23404872,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23404872,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23404872,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23404872,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23404872,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23404872,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23404872,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23513557,2013-02-01T00:00:00,Aged,M01.060.116.100
23513557,2013-02-01T00:00:00,"Diagnosis, Differential",E01.171
23513557,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C04.557.337.428.565.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C04.557.337.428.580.125
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C15.604.515.560.550.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C15.604.515.560.575.125
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C20.683.515.528.565.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C20.683.515.528.582.125
23513557,2013-02-01T00:00:00,Skin Neoplasms,C04.588.805
23513557,2013-02-01T00:00:00,Skin Neoplasms,C17.800.882
23539894,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23539894,2013-02-01T00:00:00,African Americans,M01.686.754.100
23539894,2013-02-01T00:00:00,Aged,M01.060.116.100
23539894,2013-02-01T00:00:00,Attitude to Health,F01.100.150
23539894,2013-02-01T00:00:00,Attitude to Health,N05.300.150
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23539894,2013-02-01T00:00:00,Cultural Diversity,I01.076.201.450.350
23539894,2013-02-01T00:00:00,Cultural Diversity,I01.880.143.450
23539894,2013-02-01T00:00:00,Hispanic Americans,M01.686.754.441
23539894,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23539894,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23539894,2013-02-01T00:00:00,Qualitative Research,H01.770.644.241.850
23539894,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23539894,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23546427,2013-02-01T00:00:00,Child,M01.060.406
23546427,2013-02-01T00:00:00,"Embolization, Therapeutic",E02.520.360
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.035.410.295
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.100.376.410.295
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.928.220.370.295
23546427,2013-02-01T00:00:00,Hemoptysis,C08.381.348
23546427,2013-02-01T00:00:00,Hemoptysis,C23.550.414.896
23546427,2013-02-01T00:00:00,Hemoptysis,C23.888.852.430
23546427,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23546427,2013-02-01T00:00:00,Postoperative Complications,C23.550.767
23380591,2013-02-03T00:00:00,Algorithms,G17.035
23380591,2013-02-03T00:00:00,Algorithms,L01.224.050
23380591,2013-02-03T00:00:00,Binding Sites,G02.111.570.120
23380591,2013-02-03T00:00:00,Internet,L01.224.230.110.500
23380591,2013-02-03T00:00:00,Proteins,D12.776
23380591,2013-02-03T00:00:00,Software,L01.224.900
23380591,2013-02-03T00:00:00,Static Electricity,G01.201.249.820
23379292,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23379292,2013-02-04T00:00:00,Middle Aged,M01.060.116.630
23391444,2013-02-04T00:00:00,Animals,B01.050
23391444,2013-02-04T00:00:00,"Carcinoma, Lewis Lung",C04.557.470.200.280
23391444,2013-02-04T00:00:00,"Carcinoma, Lewis Lung",C04.619.230
23391444,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391444,2013-02-04T00:00:00,"Hyperthermia, Induced",E02.565
23391444,2013-02-04T00:00:00,"Hyperthermia, Induced",E02.779.496
23391444,2013-02-04T00:00:00,Lipids,D10
23391444,2013-02-04T00:00:00,Liposomes,D25.479.517
23391444,2013-02-04T00:00:00,Liposomes,D26.255.260.517
23391444,2013-02-04T00:00:00,Liposomes,D27.720.280.260.517
23391444,2013-02-04T00:00:00,Liposomes,J01.637.051.479.517
23391444,2013-02-04T00:00:00,Liposomes,J01.637.087.500.517
23391444,2013-02-04T00:00:00,Nanoparticles,J01.637.512.600
23391444,2013-02-04T00:00:00,Skin Neoplasms,C04.588.805
23391444,2013-02-04T00:00:00,Skin Neoplasms,C17.800.882
23501140,2013-02-04T00:00:00,Adolescent,M01.060.057
23501140,2013-02-04T00:00:00,Adult,M01.060.116
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
23501140,2013-02-04T00:00:00,Child,M01.060.406
23501140,2013-02-04T00:00:00,Dental Clinics,N02.278.192.250
23501140,2013-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23501140,2013-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23501140,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23501140,2013-02-04T00:00:00,Internet,L01.224.230.110.500
23501140,2013-02-04T00:00:00,Middle Aged,M01.060.116.630
23501140,2013-02-04T00:00:00,Patient Education as Topic,I02.233.332.500
23501140,2013-02-04T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23501140,2013-02-04T00:00:00,Patient Education as Topic,N02.421.726.407.680
23501140,2013-02-04T00:00:00,Pilot Projects,E05.318.760.750
23501140,2013-02-04T00:00:00,Pilot Projects,E05.337.737
23501140,2013-02-04T00:00:00,Pilot Projects,N05.715.360.775.625
23501140,2013-02-04T00:00:00,Pilot Projects,N06.850.520.450.720
23501140,2013-02-04T00:00:00,Refuse Disposal,N06.850.780.200.800.800.700
23501140,2013-02-04T00:00:00,Refuse Disposal,N06.850.860.510.900.600
23501140,2013-02-04T00:00:00,Young Adult,M01.060.116.815
23380680,2013-02-05T00:00:00,Adult,M01.060.116
23380680,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23380680,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23380680,2013-02-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23380680,2013-02-05T00:00:00,Risk Factors,N05.715.350.200.700
23380680,2013-02-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23380680,2013-02-05T00:00:00,Risk Factors,N06.850.490.625.750
23380680,2013-02-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C10.228.854.770
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C10.900.850
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C21.866.819
23380680,2013-02-05T00:00:00,United States,Z01.107.567.875
23381105,2013-02-05T00:00:00,Adult,M01.060.116
23381105,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23381105,2013-02-05T00:00:00,"Hypertension, Portal",C06.552.494
23381105,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,D05.750.395.616
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,D25.720.395.616
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
23381105,2013-02-05T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
23381105,2013-02-05T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
23381105,2013-02-05T00:00:00,Reoperation,E04.690
23381105,2013-02-05T00:00:00,Stents,E07.695.750
23381105,2013-02-05T00:00:00,Treatment Outcome,E01.789.800
23381105,2013-02-05T00:00:00,Treatment Outcome,N04.761.559.590.800
23381105,2013-02-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23386625,2013-02-05T00:00:00,Aged,M01.060.116.100
23386625,2013-02-05T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23386625,2013-02-05T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23386625,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23386625,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
23386625,2013-02-05T00:00:00,SEER Program,E05.318.308.970.725
23386625,2013-02-05T00:00:00,SEER Program,L01.280.950.725
23386625,2013-02-05T00:00:00,SEER Program,N04.452.859.819.725
23386625,2013-02-05T00:00:00,SEER Program,N05.715.360.300.715.700.725
23386625,2013-02-05T00:00:00,SEER Program,N06.850.520.308.970.725
23386625,2013-02-05T00:00:00,United States,Z01.107.567.875
23391523,2013-02-05T00:00:00,Adolescent,M01.060.057
23391523,2013-02-05T00:00:00,Adult,M01.060.116
23391523,2013-02-05T00:00:00,Aged,M01.060.116.100
23391523,2013-02-05T00:00:00,Cause of Death,E05.318.308.985.550.250
23391523,2013-02-05T00:00:00,Cause of Death,L01.280.975.550.250
23391523,2013-02-05T00:00:00,Cause of Death,N01.224.935.698.100
23391523,2013-02-05T00:00:00,Cause of Death,N06.850.505.400.975.550.250
23391523,2013-02-05T00:00:00,Cause of Death,N06.850.520.308.985.550.250
23391523,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391523,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23391523,2013-02-05T00:00:00,Patient Discharge,E02.760.400.610
23391523,2013-02-05T00:00:00,Patient Discharge,N02.421.585.400.610
23391523,2013-02-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23391523,2013-02-05T00:00:00,Risk Factors,N05.715.350.200.700
23391523,2013-02-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23391523,2013-02-05T00:00:00,Risk Factors,N06.850.490.625.750
23391523,2013-02-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23391523,2013-02-05T00:00:00,South Carolina,Z01.107.567.875.075.662
23391523,2013-02-05T00:00:00,South Carolina,Z01.107.567.875.750.700
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C10.228.854.770
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C10.900.850
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C21.866.819
23391592,2013-02-05T00:00:00,Adolescent,M01.060.057
23391592,2013-02-05T00:00:00,Adult,M01.060.116
23391592,2013-02-05T00:00:00,Aged,M01.060.116.100
23391592,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391592,2013-02-05T00:00:00,Kidney Transplantation,E02.870.500
23391592,2013-02-05T00:00:00,Kidney Transplantation,E04.936.450.485
23391592,2013-02-05T00:00:00,Kidney Transplantation,E04.950.774.400
23391592,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23391592,2013-02-05T00:00:00,Perioperative Care,E02.760.722
23391592,2013-02-05T00:00:00,Perioperative Care,E04.604
23391592,2013-02-05T00:00:00,Perioperative Care,N02.421.585.722
23391592,2013-02-05T00:00:00,Young Adult,M01.060.116.815
23383719,2013-02-06T00:00:00,Adolescent,M01.060.057
23383719,2013-02-06T00:00:00,Adult,M01.060.116
23383719,2013-02-06T00:00:00,Aged,M01.060.116.100
23383719,2013-02-06T00:00:00,Cardiovascular Diseases,C14
23383719,2013-02-06T00:00:00,Diabetes Complications,C19.246.099
23383719,2013-02-06T00:00:00,Diabetes Mellitus,C18.452.394.750
23383719,2013-02-06T00:00:00,Diabetes Mellitus,C19.246
23383719,2013-02-06T00:00:00,Graft Rejection,G12.425.901.545.328
23383719,2013-02-06T00:00:00,Graft Survival,G12.425.901.545.340
23383719,2013-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23383719,2013-02-06T00:00:00,Kidney Transplantation,E02.870.500
23383719,2013-02-06T00:00:00,Kidney Transplantation,E04.936.450.485
23383719,2013-02-06T00:00:00,Kidney Transplantation,E04.950.774.400
23383719,2013-02-06T00:00:00,Middle Aged,M01.060.116.630
23383719,2013-02-06T00:00:00,Risk Factors,E05.318.740.600.800.725
23383719,2013-02-06T00:00:00,Risk Factors,N05.715.350.200.700
23383719,2013-02-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23383719,2013-02-06T00:00:00,Risk Factors,N06.850.490.625.750
23383719,2013-02-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23383719,2013-02-06T00:00:00,Treatment Outcome,E01.789.800
23383719,2013-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23383719,2013-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23383719,2013-02-06T00:00:00,Young Adult,M01.060.116.815
23385198,2013-02-06T00:00:00,Animals,B01.050
23385198,2013-02-06T00:00:00,Antibodies,D12.776.124.486.485.114
23385198,2013-02-06T00:00:00,Antibodies,D12.776.124.790.651.114
23385198,2013-02-06T00:00:00,Antibodies,D12.776.377.715.548.114
23385198,2013-02-06T00:00:00,Antioxidants,D27.505.519.217
23385198,2013-02-06T00:00:00,Antioxidants,D27.505.696.706.125
23385198,2013-02-06T00:00:00,Antioxidants,D27.720.799.047
23385198,2013-02-06T00:00:00,Apoptosis,G04.299.139.160
23385198,2013-02-06T00:00:00,Biological Markers,D23.101
23385198,2013-02-06T00:00:00,Brain Infarction,C10.228.140.300.150.477
23385198,2013-02-06T00:00:00,Brain Infarction,C10.228.140.300.775.200
23385198,2013-02-06T00:00:00,Brain Infarction,C14.907.253.092.477
23385198,2013-02-06T00:00:00,Brain Infarction,C14.907.253.855.200
23385198,2013-02-06T00:00:00,Drug Delivery Systems,E02.319.300
23385198,2013-02-06T00:00:00,Hippocampus,A08.186.211.464.405
23385198,2013-02-06T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
23385198,2013-02-06T00:00:00,Nanoparticles,J01.637.512.600
23385198,2013-02-06T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23385198,2013-02-06T00:00:00,Reperfusion Injury,C14.907.725
23385198,2013-02-06T00:00:00,Reperfusion Injury,C23.550.767.877
23385198,2013-02-06T00:00:00,Stroke,C10.228.140.300.775
23385198,2013-02-06T00:00:00,Stroke,C14.907.253.855
23385198,2013-02-06T00:00:00,Superoxide Dismutase,D08.811.682.881
23390923,2013-02-07T00:00:00,Adult,M01.060.116
23390923,2013-02-07T00:00:00,Aged,M01.060.116.100
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23390923,2013-02-07T00:00:00,Combined Modality Therapy,E02.186
23390923,2013-02-07T00:00:00,Disability Evaluation,E01.370.400
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23390923,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23390923,2013-02-07T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23390923,2013-02-07T00:00:00,Middle Aged,M01.060.116.630
23390923,2013-02-07T00:00:00,Stroke,C10.228.140.300.775
23390923,2013-02-07T00:00:00,Stroke,C14.907.253.855
23390923,2013-02-07T00:00:00,Thrombectomy,E04.100.814.842
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D23.119.970
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23390923,2013-02-07T00:00:00,Treatment Outcome,E01.789.800
23390923,2013-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23390923,2013-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23390923,2013-02-07T00:00:00,Young Adult,M01.060.116.815
23393065,2013-02-07T00:00:00,Acclimatization,G07.700.062.133
23393065,2013-02-07T00:00:00,Acclimatization,G16.100.057.500.133
23393065,2013-02-07T00:00:00,Adult,M01.060.116
23393065,2013-02-07T00:00:00,Dexamethasone,D04.808.745.432.769.344
23393065,2013-02-07T00:00:00,Dexamethasone,D04.808.908.238
23393065,2013-02-07T00:00:00,Down-Regulation,G02.111.087.225
23393065,2013-02-07T00:00:00,Down-Regulation,G02.149.115.225
23393065,2013-02-07T00:00:00,Down-Regulation,G05.355.315.200
23393065,2013-02-07T00:00:00,Down-Regulation,G07.690.812.230
23393065,2013-02-07T00:00:00,Down-Regulation,G07.700.680.230
23393065,2013-02-07T00:00:00,Glucocorticoids,D06.472.040.543
23393065,2013-02-07T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23393065,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23393065,2013-02-07T00:00:00,Treatment Outcome,E01.789.800
23393065,2013-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23393065,2013-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23409016,2013-02-07T00:00:00,Apoptosis,G04.299.139.160
23409016,2013-02-07T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23409016,2013-02-07T00:00:00,Flow Cytometry,E05.200.500.386.350
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
23409016,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23409016,2013-02-07T00:00:00,MicroRNAs,D13.150.650.319
23409016,2013-02-07T00:00:00,MicroRNAs,D13.444.735.150.319
23409016,2013-02-07T00:00:00,MicroRNAs,D13.444.735.790.099
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.186.500
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.319.685
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.774.722
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23409016,2013-02-07T00:00:00,Signal Transduction,G02.111.087.800
23409016,2013-02-07T00:00:00,Signal Transduction,G02.149.115.800
23409016,2013-02-07T00:00:00,Signal Transduction,G04.299.880
23409071,2013-02-07T00:00:00,Algorithms,G17.035
23409071,2013-02-07T00:00:00,Algorithms,L01.224.050
23409071,2013-02-07T00:00:00,Gene Expression,G05.355.310
23409071,2013-02-07T00:00:00,Gene Expression Profiling,E05.393.332
23409071,2013-02-07T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23409071,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23409071,2013-02-07T00:00:00,"Models, Theoretical",E05.599
23409071,2013-02-07T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
23409071,2013-02-07T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23394477,2013-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23394477,2013-02-08T00:00:00,Stroke,C10.228.140.300.775
23394477,2013-02-08T00:00:00,Stroke,C14.907.253.855
23394477,2013-02-08T00:00:00,Thrombectomy,E04.100.814.842
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D23.119.970
23481720,2013-02-11T00:00:00,Computer Simulation,L01.224.160
23481720,2013-02-11T00:00:00,Equipment Failure Analysis,E05.325.192
23481720,2013-02-11T00:00:00,Fiber Optic Technology,H01.671.617.249
23481720,2013-02-11T00:00:00,Hot Temperature,G01.906.595.543
23481720,2013-02-11T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
23481720,2013-02-11T00:00:00,Hot Temperature,G16.500.750.775.710.380
23481720,2013-02-11T00:00:00,Hot Temperature,N06.230.300.100.725.232
23481720,2013-02-11T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
23481720,2013-02-11T00:00:00,Light,G01.201.875.770.578
23481720,2013-02-11T00:00:00,Light,G01.590.540
23481720,2013-02-11T00:00:00,"Models, Theoretical",E05.599
23481720,2013-02-11T00:00:00,Nonlinear Dynamics,E05.599.850
23481720,2013-02-11T00:00:00,Nonlinear Dynamics,H01.548.675
23481720,2013-02-11T00:00:00,"Scattering, Radiation",E05.196.822
23481720,2013-02-11T00:00:00,"Scattering, Radiation",G01.595.861
23400317,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23400317,2013-02-12T00:00:00,Telemedicine,H02.403.840
23400317,2013-02-12T00:00:00,Telemedicine,L01.178.847.652
23400317,2013-02-12T00:00:00,Telemedicine,N04.590.374.800
23410586,2013-02-12T00:00:00,Adult,M01.060.116
23410586,2013-02-12T00:00:00,Breast Neoplasms,C04.588.180
23410586,2013-02-12T00:00:00,Breast Neoplasms,C17.800.090.500
23410586,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23410586,2013-02-12T00:00:00,Incidence,E05.318.308.985.525.375
23410586,2013-02-12T00:00:00,Incidence,L01.280.975.525.375
23410586,2013-02-12T00:00:00,Incidence,N01.224.935.597.500
23410586,2013-02-12T00:00:00,Incidence,N06.850.505.400.975.525.375
23410586,2013-02-12T00:00:00,Incidence,N06.850.520.308.985.525.375
23410586,2013-02-12T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23410586,2013-02-12T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23410586,2013-02-12T00:00:00,Neoplasms,C04
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C04.588.322.455
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C19.344.410
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C19.391.630.705
23410586,2013-02-12T00:00:00,United States,Z01.107.567.875
23415554,2013-02-12T00:00:00,Adolescent,M01.060.057
23415554,2013-02-12T00:00:00,Adult,M01.060.116
23415554,2013-02-12T00:00:00,Aged,M01.060.116.100
23415554,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415554,2013-02-12T00:00:00,Intensive Care Units,N02.278.388.493
23415554,2013-02-12T00:00:00,Middle Aged,M01.060.116.630
23415554,2013-02-12T00:00:00,"Surgical Procedures, Operative",E04
23415554,2013-02-12T00:00:00,Trauma Centers,N02.278.354.422.336.500
23415554,2013-02-12T00:00:00,Trauma Centers,N02.421.297.195.480
23415554,2013-02-12T00:00:00,Trauma Centers,N04.452.442.422.336.400
23415554,2013-02-12T00:00:00,Young Adult,M01.060.116.815
23408511,2013-02-13T00:00:00,Binding Sites,G02.111.570.120
23408511,2013-02-13T00:00:00,Computational Biology,H01.158.273.180
23408511,2013-02-13T00:00:00,Creatine,D02.078.370.280
23408511,2013-02-13T00:00:00,Creatine,D12.125.373
23408511,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23408511,2013-02-13T00:00:00,"Mutation, Missense",G05.365.590.650
23408671,2013-02-13T00:00:00,Anticoagulants,D27.505.954.502.119
23408671,2013-02-13T00:00:00,Cardiopulmonary Bypass,E04.292.413
23408671,2013-02-13T00:00:00,Drug Resistance,G07.690.320
23408671,2013-02-13T00:00:00,Heparin,D09.698.373.400
23408671,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23418583,2013-02-13T00:00:00,Animals,B01.050
23418583,2013-02-13T00:00:00,"Animals, Newborn",B01.050.050.282
23418583,2013-02-13T00:00:00,Cell Membrane,A11.284.149
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.233.348
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23418583,2013-02-13T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23418583,2013-02-13T00:00:00,"Microscopy, Confocal",E05.595.395
23418583,2013-02-13T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23418583,2013-02-13T00:00:00,"Microscopy, Fluorescence",E05.595.458
23418583,2013-02-13T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23418583,2013-02-13T00:00:00,Mitochondria,A11.284.835.626
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A11.620.500
23418583,2013-02-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
23418589,2013-02-13T00:00:00,Animals,B01.050
23418589,2013-02-13T00:00:00,"Disease Models, Animal",C22.232
23418589,2013-02-13T00:00:00,"Disease Models, Animal",E05.598.500
23418589,2013-02-13T00:00:00,"Disease Models, Animal",E05.599.395.080
23418589,2013-02-13T00:00:00,Gene Expression,G05.355.310
23418589,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23418589,2013-02-13T00:00:00,Mutation,G05.365.590
23418589,2013-02-13T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
23418589,2013-02-13T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
23418589,2013-02-13T00:00:00,Neurons,A08.663
23418589,2013-02-13T00:00:00,Neurons,A11.671
23418589,2013-02-13T00:00:00,Superoxide Dismutase,D08.811.682.881
23418589,2013-02-13T00:00:00,Time Factors,G01.910.857
23415658,2013-02-14T00:00:00,Adult,M01.060.116
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.034.145
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.124.050.120
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.124.486.157
23415658,2013-02-14T00:00:00,Child,M01.060.406
23415658,2013-02-14T00:00:00,Child Abuse,I01.198.240.856.350.250
23415658,2013-02-14T00:00:00,Child Abuse,I01.880.735.900.350.250
23415658,2013-02-14T00:00:00,Child Abuse,I01.880.787.293.292
23415658,2013-02-14T00:00:00,Cytokines,D12.644.276.374
23415658,2013-02-14T00:00:00,Cytokines,D12.776.467.374
23415658,2013-02-14T00:00:00,Cytokines,D23.529.374
23415658,2013-02-14T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23415658,2013-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415658,2013-02-14T00:00:00,Life Change Events,F01.829.458.410
23415658,2013-02-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23415658,2013-02-14T00:00:00,"Stress, Psychological",F01.145.126.990
23415658,2013-02-14T00:00:00,"Stress, Psychological",F02.830.900
23415658,2013-02-14T00:00:00,Young Adult,M01.060.116.815
23410875,2013-02-15T00:00:00,Animals,B01.050
23410875,2013-02-15T00:00:00,Myocardial Infarction,C14.280.647.500
23410875,2013-02-15T00:00:00,Myocardial Infarction,C14.907.585.500
23410875,2013-02-15T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23498287,2013-02-15T00:00:00,"History, 20th Century",K01.400.504.968
23498287,2013-02-15T00:00:00,United States,Z01.107.567.875
23417570,2013-02-16T00:00:00,Animals,B01.050
23417570,2013-02-16T00:00:00,Estrogens,D27.505.696.399.472.277
23417570,2013-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23417570,2013-02-16T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
23417570,2013-02-16T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
23417570,2013-02-16T00:00:00,Myocardium,A02.633.580
23417570,2013-02-16T00:00:00,Myocardium,A07.541.704
23417570,2013-02-16T00:00:00,Myocardium,A10.690.552.750
23417570,2013-02-16T00:00:00,Sex Characteristics,G08.686.815
23417570,2013-02-16T00:00:00,Ventricular Remodeling,C23.300.985
23417570,2013-02-16T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23422879,2013-02-17T00:00:00,Animals,B01.050
23422879,2013-02-17T00:00:00,DNA Damage,C21.111
23422879,2013-02-17T00:00:00,DNA Damage,G05.355.180
23422879,2013-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422879,2013-02-17T00:00:00,Neurodegenerative Diseases,C10.574
23422879,2013-02-17T00:00:00,Oxidative Stress,G03.495.710
23422879,2013-02-17T00:00:00,Oxidative Stress,G07.700.830.750
23441136,2013-02-18T00:00:00,African Americans,M01.686.508.100.100
23441136,2013-02-18T00:00:00,African Americans,M01.686.754.100
23441136,2013-02-18T00:00:00,Alleles,G05.360.340.024.340.030
23441136,2013-02-18T00:00:00,Apoptosis,G04.299.139.160
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
23441136,2013-02-18T00:00:00,DNA-Binding Proteins,D12.776.260
23441136,2013-02-18T00:00:00,European Continental Ancestry Group,M01.686.508.400
23441136,2013-02-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23441136,2013-02-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
23441136,2013-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23441136,2013-02-18T00:00:00,Inflammation,C23.550.470
23441136,2013-02-18T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23441136,2013-02-18T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23441136,2013-02-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23422753,2013-02-19T00:00:00,Adolescent,M01.060.057
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
23422753,2013-02-19T00:00:00,Child,M01.060.406
23422753,2013-02-19T00:00:00,"Child, Preschool",M01.060.406.448
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23422753,2013-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422753,2013-02-19T00:00:00,Membrane Proteins,D12.776.543
23422753,2013-02-19T00:00:00,Mutation,G05.365.590
23422753,2013-02-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23422753,2013-02-19T00:00:00,Risk Factors,E05.318.740.600.800.725
23422753,2013-02-19T00:00:00,Risk Factors,N05.715.350.200.700
23422753,2013-02-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23422753,2013-02-19T00:00:00,Risk Factors,N06.850.490.625.750
23422753,2013-02-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23422753,2013-02-19T00:00:00,Stroke,C10.228.140.300.775
23422753,2013-02-19T00:00:00,Stroke,C14.907.253.855
23161644,2013-02-20T00:00:00,Computer Simulation,L01.224.160
23161644,2013-02-20T00:00:00,Electromagnetic Fields,G01.201.260
23161644,2013-02-20T00:00:00,Electromagnetic Fields,G01.201.875.240
23161644,2013-02-20T00:00:00,Electrophoresis,E05.196.401
23161644,2013-02-20T00:00:00,Electrophoresis,E05.301.300
23161644,2013-02-20T00:00:00,Electrophoresis,G02.149.767.570
23161644,2013-02-20T00:00:00,Electrophoresis,G02.842.750.570
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.233.348
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23161644,2013-02-20T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23161644,2013-02-20T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23425628,2013-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425628,2013-02-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
23425628,2013-02-20T00:00:00,Lung Neoplasms,C08.381.540
23425628,2013-02-20T00:00:00,Lung Neoplasms,C08.785.520
23425628,2013-02-20T00:00:00,Smoking,F01.145.466.753
23425165,2013-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425165,2013-02-21T00:00:00,Lung Neoplasms,C04.588.894.797.520
23425165,2013-02-21T00:00:00,Lung Neoplasms,C08.381.540
23425165,2013-02-21T00:00:00,Lung Neoplasms,C08.785.520
23425165,2013-02-21T00:00:00,Mass Screening,E01.370.500
23425165,2013-02-21T00:00:00,Mass Screening,E05.318.308.250.580
23425165,2013-02-21T00:00:00,Mass Screening,N02.421.143.827.233.443
23425165,2013-02-21T00:00:00,Mass Screening,N02.421.726.233.443
23425165,2013-02-21T00:00:00,Mass Screening,N05.715.360.300.375.500
23425165,2013-02-21T00:00:00,Mass Screening,N06.850.520.308.250.580
23425165,2013-02-21T00:00:00,Mass Screening,N06.850.780.500
23425165,2013-02-21T00:00:00,Patient Selection,E05.581.500.653
23425165,2013-02-21T00:00:00,Patient Selection,N04.590.731
23425165,2013-02-21T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23425165,2013-02-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23425165,2013-02-21T00:00:00,Risk Assessment,N04.452.871.715
23425165,2013-02-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23425165,2013-02-21T00:00:00,Risk Assessment,N06.850.505.715
23425165,2013-02-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23425165,2013-02-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23425165,2013-02-21T00:00:00,Risk Factors,N05.715.350.200.700
23425165,2013-02-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23425165,2013-02-21T00:00:00,Risk Factors,N06.850.490.625.750
23425165,2013-02-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23425165,2013-02-21T00:00:00,Smoking,F01.145.466.753
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23434577,2013-02-21T00:00:00,Occupational Exposure,N06.850.460.350.600
23434577,2013-02-21T00:00:00,Oxidative Stress,G03.495.710
23434577,2013-02-21T00:00:00,Oxidative Stress,G07.700.830.750
23438514,2013-02-21T00:00:00,Animals,B01.050
23438514,2013-02-21T00:00:00,Cell Differentiation,G04.299.151
23438514,2013-02-21T00:00:00,Cell Survival,G04.299.316
23438514,2013-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
23438514,2013-02-21T00:00:00,Lipid Metabolism,G03.495.520
23438514,2013-02-21T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23438514,2013-02-21T00:00:00,"Microscopy, Fluorescence",E05.595.458
23438514,2013-02-21T00:00:00,Oligodendroglia,A08.637.600
23438514,2013-02-21T00:00:00,Oligodendroglia,A11.650.600
23438514,2013-02-21T00:00:00,Psychosine,D02.033.100.700.700
23438514,2013-02-21T00:00:00,Psychosine,D02.092.063.700.700
23438514,2013-02-21T00:00:00,Psychosine,D09.400.410.420.806
23438514,2013-02-21T00:00:00,Psychosine,D10.390.470.806
23438514,2013-02-21T00:00:00,Psychosine,D10.570.877.360.806
23438514,2013-02-21T00:00:00,RNA Interference,G05.355.315.203.374.790
23438514,2013-02-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
23394144,2013-02-22T00:00:00,Animals,B01.050
23394144,2013-02-22T00:00:00,Cell Proliferation,G04.299.233.750
23394144,2013-02-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23394144,2013-02-22T00:00:00,Endothelial Cells,A11.436.275
23394144,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
23394144,2013-02-22T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
23394144,2013-02-22T00:00:00,"Receptors, Peptide",D12.776.543.750.750
23432971,2013-02-22T00:00:00,Animals,B01.050
23432971,2013-02-22T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
23432971,2013-02-22T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
23432971,2013-02-22T00:00:00,Anticarcinogenic Agents,D27.720.799.018
23432971,2013-02-22T00:00:00,Antineoplastic Agents,D27.505.954.248
23432971,2013-02-22T00:00:00,Biological Transport,G03.495.166
23432971,2013-02-22T00:00:00,Enzyme Inhibitors,D27.505.519.389
23432971,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23432971,2013-02-22T00:00:00,Neoplasms,C04
23432971,2013-02-22T00:00:00,Polyamines,D02.092.782
23413239,2013-02-25T00:00:00,Carbon,D01.268.150
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.233.348
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23439434,2013-02-25T00:00:00,Aged,M01.060.116.100
23439434,2013-02-25T00:00:00,Cell Line,A11.251.210
23439434,2013-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23439434,2013-02-25T00:00:00,Middle Aged,M01.060.116.630
23439434,2013-02-25T00:00:00,Osteitis Deformans,C05.116.692
23439434,2013-02-25T00:00:00,RANK Ligand,D12.644.276.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.644.276.972.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.776.467.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.776.467.972.562
23439434,2013-02-25T00:00:00,RANK Ligand,D23.529.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D23.529.972.562
23439434,2013-02-25T00:00:00,Signal Transduction,G02.111.087.800
23439434,2013-02-25T00:00:00,Signal Transduction,G02.149.115.800
23439434,2013-02-25T00:00:00,Signal Transduction,G04.299.880
23443134,2013-02-26T00:00:00,Acetylgalactosamine,D09.067.342.356.050
23443134,2013-02-26T00:00:00,Amino Acid Sequence,G02.111.570.060
23443134,2013-02-26T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23443134,2013-02-26T00:00:00,Animals,B01.050
23443134,2013-02-26T00:00:00,Glycoproteins,D09.400.430
23443134,2013-02-26T00:00:00,Glycoproteins,D12.776.395
23443134,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23443134,2013-02-26T00:00:00,Molecular Sequence Data,L01.453.245.667
23443134,2013-02-26T00:00:00,Osteoblasts,A11.329.629
23443134,2013-02-26T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23443134,2013-02-26T00:00:00,Osteogenesis,G11.427.590.560.100.729
23443134,2013-02-26T00:00:00,Peptide Fragments,D12.644.541
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
23443134,2013-02-26T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
23443736,2013-02-26T00:00:00,Adolescent,M01.060.057
23443736,2013-02-26T00:00:00,Adult,M01.060.116
23443736,2013-02-26T00:00:00,Animals,B01.050
23443736,2013-02-26T00:00:00,Complement System Proteins,D12.776.124.486.274
23443736,2013-02-26T00:00:00,Cytokines,D12.644.276.374
23443736,2013-02-26T00:00:00,Cytokines,D12.776.467.374
23443736,2013-02-26T00:00:00,Cytokines,D23.529.374
23443736,2013-02-26T00:00:00,Heart,A07.541
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.100.376.475
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.928.220.390
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.936.450.475
23443736,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23443736,2013-02-26T00:00:00,Middle Aged,M01.060.116.630
23443736,2013-02-26T00:00:00,"Models, Animal",E05.598
23443736,2013-02-26T00:00:00,Myocardium,A02.633.580
23443736,2013-02-26T00:00:00,Myocardium,A07.541.704
23443736,2013-02-26T00:00:00,Myocardium,A10.690.552.750
23443736,2013-02-26T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23443736,2013-02-26T00:00:00,Reperfusion Injury,C14.907.725
23443736,2013-02-26T00:00:00,Reperfusion Injury,C23.550.767.877
23443736,2013-02-26T00:00:00,Tissue Donors,M01.898
23443736,2013-02-26T00:00:00,Young Adult,M01.060.116.815
23468913,2013-02-26T00:00:00,Animals,B01.050
23468913,2013-02-26T00:00:00,Binding Sites,G02.111.570.120
23468913,2013-02-26T00:00:00,Cell Line,A11.251.210
23468913,2013-02-26T00:00:00,Endocardium,A07.541.207
23468913,2013-02-26T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
23468913,2013-02-26T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23468913,2013-02-26T00:00:00,Heart,A07.541
23468913,2013-02-26T00:00:00,Molecular Sequence Data,L01.453.245.667
23468913,2013-02-26T00:00:00,Myocardium,A02.633.580
23468913,2013-02-26T00:00:00,Myocardium,A07.541.704
23468913,2013-02-26T00:00:00,Myocardium,A10.690.552.750
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G02.111.087.847
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G02.149.115.847
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G05.355.310.700
23485770,2013-02-26T00:00:00,Adenocarcinoma,C04.557.470.200.025
23485770,2013-02-26T00:00:00,Adult,M01.060.116
23485770,2013-02-26T00:00:00,Aged,M01.060.116.100
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
23485770,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23485770,2013-02-26T00:00:00,Middle Aged,M01.060.116.630
23485770,2013-02-26T00:00:00,Neoplasm Staging,E01.370.550
23485770,2013-02-26T00:00:00,Questionnaires,E05.318.308.750
23485770,2013-02-26T00:00:00,Questionnaires,L01.280.800
23485770,2013-02-26T00:00:00,Questionnaires,N05.715.360.300.695
23485770,2013-02-26T00:00:00,Questionnaires,N06.850.520.308.750
23485770,2013-02-26T00:00:00,Risk Factors,E05.318.740.600.800.725
23485770,2013-02-26T00:00:00,Risk Factors,N05.715.350.200.700
23485770,2013-02-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23485770,2013-02-26T00:00:00,Risk Factors,N06.850.490.625.750
23485770,2013-02-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23511065,2013-02-27T00:00:00,Adult,M01.060.116
23511065,2013-02-27T00:00:00,Age Factors,N05.715.350.075
23511065,2013-02-27T00:00:00,Age Factors,N06.850.490.250
23511065,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23511065,2013-02-27T00:00:00,Middle Aged,M01.060.116.630
23511065,2013-02-27T00:00:00,Patient Selection,E05.581.500.653
23511065,2013-02-27T00:00:00,Patient Selection,N04.590.731
23511065,2013-02-27T00:00:00,Questionnaires,E05.318.308.750
23511065,2013-02-27T00:00:00,Questionnaires,L01.280.800
23511065,2013-02-27T00:00:00,Questionnaires,N05.715.360.300.695
23511065,2013-02-27T00:00:00,Questionnaires,N06.850.520.308.750
23511065,2013-02-27T00:00:00,Self Efficacy,F01.752.747.792.700
23511065,2013-02-27T00:00:00,Smoking,F01.145.466.753
23511065,2013-02-27T00:00:00,Smoking Cessation,F01.145.940.700
23511065,2013-02-27T00:00:00,Social Support,I01.880.656.600
23511065,2013-02-27T00:00:00,Time Factors,G01.910.857
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23517721,2013-02-27T00:00:00,Antineoplastic Agents,D27.505.954.248
23517721,2013-02-27T00:00:00,Arachidonate 5-Lipoxygenase,D08.811.682.690.416.444.050.055
23517721,2013-02-27T00:00:00,Arachidonate 5-Lipoxygenase,D12.776.556.579.374.450.025.020
23517721,2013-02-27T00:00:00,Cell Proliferation,G04.299.233.750
23517721,2013-02-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23517721,2013-02-27T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
23517721,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23517721,2013-02-27T00:00:00,Hyaluronic Acid,D09.698.373.475
23517721,2013-02-27T00:00:00,"Models, Molecular",E05.599.595
23517721,2013-02-27T00:00:00,Molecular Structure,G02.111.570
23517721,2013-02-27T00:00:00,Molecular Structure,G02.575
23517721,2013-02-27T00:00:00,Molecular Structure,G02.842.575
23517721,2013-02-27T00:00:00,Signal Transduction,G02.111.087.800
23517721,2013-02-27T00:00:00,Signal Transduction,G02.149.115.800
23517721,2013-02-27T00:00:00,Signal Transduction,G04.299.880
23730981,2013-02-27T00:00:00,Blood Pressure,E01.370.600.875.249
23730981,2013-02-27T00:00:00,Blood Pressure,G09.330.380.076
23730981,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23453434,2013-02-28T00:00:00,Adolescent,M01.060.057
23453434,2013-02-28T00:00:00,Adult,M01.060.116
23453434,2013-02-28T00:00:00,Environmental Pollutants,D27.888.284
23453434,2013-02-28T00:00:00,Fetal Blood,A12.207.152.200
23453434,2013-02-28T00:00:00,Fetal Blood,A15.145.300
23453434,2013-02-28T00:00:00,Fetal Blood,A16.378.200
23453434,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23453434,2013-02-28T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
23453434,2013-02-28T00:00:00,Middle Aged,M01.060.116.630
23453434,2013-02-28T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23453434,2013-02-28T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23453434,2013-02-28T00:00:00,Pregnancy,G08.686.785.760.769
23453434,2013-02-28T00:00:00,Questionnaires,E05.318.308.750
23453434,2013-02-28T00:00:00,Questionnaires,L01.280.800
23453434,2013-02-28T00:00:00,Questionnaires,N05.715.360.300.695
23453434,2013-02-28T00:00:00,Questionnaires,N06.850.520.308.750
23453434,2013-02-28T00:00:00,Young Adult,M01.060.116.815
23453771,2013-02-28T00:00:00,"Child, Preschool",M01.060.406.448
23453771,2013-02-28T00:00:00,Disease Progression,C23.550.291.656
23453771,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C04.588.149.721.656
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C04.588.364.659
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C05.116.231.754.659
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C11.319.457
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C11.675.659
23453771,2013-02-28T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
23453771,2013-02-28T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
23453771,2013-02-28T00:00:00,Time Factors,G01.910.857
23468611,2013-02-28T00:00:00,Amino Acid Sequence,G02.111.570.060
23468611,2013-02-28T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23468611,2013-02-28T00:00:00,Animals,B01.050
23468611,2013-02-28T00:00:00,Computer Simulation,L01.224.160
23468611,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468611,2013-02-28T00:00:00,Hydrogen Bonding,G02.149.767.620
23468611,2013-02-28T00:00:00,Hydrogen Bonding,G02.842.750.620
23468611,2013-02-28T00:00:00,"Models, Molecular",E05.599.595
23468611,2013-02-28T00:00:00,Molecular Sequence Data,L01.453.245.667
23468611,2013-02-28T00:00:00,Protein Conformation,G02.111.570.790.709
23468611,2013-02-28T00:00:00,Protein Stability,G02.111.700
23468611,2013-02-28T00:00:00,Static Electricity,G01.201.249.820
23468661,2013-02-28T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23468661,2013-02-28T00:00:00,African Americans,M01.686.508.100.100
23468661,2013-02-28T00:00:00,African Americans,M01.686.754.100
23468661,2013-02-28T00:00:00,Alleles,G05.360.340.024.340.030
23468661,2013-02-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
23468661,2013-02-28T00:00:00,Gene Expression Regulation,G05.355.315
23468661,2013-02-28T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23468661,2013-02-28T00:00:00,Genetic Predisposition to Disease,G05.380.355
23468661,2013-02-28T00:00:00,Hispanic Americans,M01.686.754.441
23468661,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468661,2013-02-28T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23468661,2013-02-28T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23468661,2013-02-28T00:00:00,MicroRNAs,D13.150.650.319
23468661,2013-02-28T00:00:00,MicroRNAs,D13.444.735.150.319
23468661,2013-02-28T00:00:00,MicroRNAs,D13.444.735.790.099
23468661,2013-02-28T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23597335,2013-02-28T00:00:00,Aged,M01.060.116.100
23597335,2013-02-28T00:00:00,Caregivers,M01.085
23597335,2013-02-28T00:00:00,Caregivers,M01.526.485.200
23597335,2013-02-28T00:00:00,Caregivers,N02.360.200
23597335,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597335,2013-02-28T00:00:00,Middle Aged,M01.060.116.630
23597335,2013-02-28T00:00:00,Psychophysiologic Disorders,C23.888.592.700
23597335,2013-02-28T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23597335,2013-02-28T00:00:00,Questionnaires,E05.318.308.750
23597335,2013-02-28T00:00:00,Questionnaires,L01.280.800
23597335,2013-02-28T00:00:00,Questionnaires,N05.715.360.300.695
23597335,2013-02-28T00:00:00,Questionnaires,N06.850.520.308.750
23597335,2013-02-28T00:00:00,Risk Factors,E05.318.740.600.800.725
23597335,2013-02-28T00:00:00,Risk Factors,N05.715.350.200.700
23597335,2013-02-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23597335,2013-02-28T00:00:00,Risk Factors,N06.850.490.625.750
23597335,2013-02-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23597335,2013-02-28T00:00:00,Social Perception,F02.463.593.752
23597335,2013-02-28T00:00:00,"Stress, Psychological",F01.145.126.990
23597335,2013-02-28T00:00:00,"Stress, Psychological",F02.830.900
23192532,2013-03-01T00:00:00,Computer Simulation,L01.224.160
23192532,2013-03-01T00:00:00,Electromagnetic Fields,G01.201.260
23192532,2013-03-01T00:00:00,Electromagnetic Fields,G01.201.875.240
23192532,2013-03-01T00:00:00,Electrophoresis,E05.196.401
23192532,2013-03-01T00:00:00,Electrophoresis,E05.301.300
23192532,2013-03-01T00:00:00,Electrophoresis,G02.149.767.570
23192532,2013-03-01T00:00:00,Electrophoresis,G02.842.750.570
23192532,2013-03-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23192532,2013-03-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23192532,2013-03-01T00:00:00,"Models, Theoretical",E05.599
23258773,2013-03-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23258773,2013-03-01T00:00:00,Environmental Monitoring,N06.850.780.375
23258773,2013-03-01T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23258773,2013-03-01T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23258773,2013-03-01T00:00:00,Rivers,G01.311.750
23258773,2013-03-01T00:00:00,Rivers,G16.500.275.280.500
23258773,2013-03-01T00:00:00,Rivers,N06.230.232.500
23258773,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23258773,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23258773,2013-03-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23338772,2013-03-01T00:00:00,"Diagnosis, Differential",E01.171
23338772,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359110,2013-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
23359110,2013-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
23359110,2013-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
23359110,2013-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
23359110,2013-03-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G02.111.087.218
23359110,2013-03-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G02.149.115.218
23359110,2013-03-01T00:00:00,DNA Methylation,G03.495.130.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G05.355.190
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23359110,2013-03-01T00:00:00,Histones,D12.776.660.470
23359110,2013-03-01T00:00:00,Histones,D12.776.664.469
23359110,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359110,2013-03-01T00:00:00,MicroRNAs,D13.150.650.319
23359110,2013-03-01T00:00:00,MicroRNAs,D13.444.735.150.319
23359110,2013-03-01T00:00:00,MicroRNAs,D13.444.735.790.099
23359110,2013-03-01T00:00:00,Substance-Related Disorders,C21.739
23359110,2013-03-01T00:00:00,Substance-Related Disorders,F03.900
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G02.111.087.847
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G02.149.115.847
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G05.355.310.700
23379433,2013-03-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
23379433,2013-03-01T00:00:00,Alleles,G05.360.340.024.340.030
23379433,2013-03-01T00:00:00,Breast Neoplasms,C04.588.180
23379433,2013-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
23379433,2013-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23379433,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23379433,2013-03-01T00:00:00,"Immunity, Humoral",G12.450.050.420
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
23379433,2013-03-01T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23379433,2013-03-01T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23379433,2013-03-01T00:00:00,"Receptors, IgG",D23.101.100.110.695
23391867,2013-03-01T00:00:00,Fiber Optic Technology,H01.671.617.249
23391867,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415116,2013-03-01T00:00:00,Adolescent,M01.060.057
23415116,2013-03-01T00:00:00,Adult,M01.060.116
23415116,2013-03-01T00:00:00,Drug Delivery Systems,E02.319.300
23415116,2013-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23415116,2013-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23415116,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415116,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23415116,2013-03-01T00:00:00,Nicotine,D03.132.760.570
23415116,2013-03-01T00:00:00,Nicotine,D03.383.725.518
23415116,2013-03-01T00:00:00,Smoking,F01.145.466.753
23415116,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23422526,2013-03-01T00:00:00,Adolescent,M01.060.057
23422526,2013-03-01T00:00:00,Adult,M01.060.116
23422526,2013-03-01T00:00:00,Aged,M01.060.116.100
23422526,2013-03-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
23422526,2013-03-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
23422526,2013-03-01T00:00:00,Electroencephalography,E01.370.376.300
23422526,2013-03-01T00:00:00,Electroencephalography,E01.370.405.245
23422526,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422526,2013-03-01T00:00:00,Length of Stay,E02.760.400.480
23422526,2013-03-01T00:00:00,Length of Stay,N02.421.585.400.480
23422526,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23422526,2013-03-01T00:00:00,Seizures,C10.228.140.490.631
23422526,2013-03-01T00:00:00,Seizures,C10.597.742
23422526,2013-03-01T00:00:00,Seizures,C23.888.592.742
23422526,2013-03-01T00:00:00,Treatment Outcome,E01.789.800
23422526,2013-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23422526,2013-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23422526,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23425740,2013-03-01T00:00:00,Adult,M01.060.116
23425740,2013-03-01T00:00:00,"Hospitals, Community",N02.278.421.306
23425740,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425740,2013-03-01T00:00:00,Incidence,E05.318.308.985.525.375
23425740,2013-03-01T00:00:00,Incidence,L01.280.975.525.375
23425740,2013-03-01T00:00:00,Incidence,N01.224.935.597.500
23425740,2013-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23425740,2013-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23425740,2013-03-01T00:00:00,Radiation Dosage,E05.799.513
23425740,2013-03-01T00:00:00,Radiation Dosage,G01.201.875.740
23425740,2013-03-01T00:00:00,Radiation Dosage,N06.850.810.250
23425740,2013-03-01T00:00:00,Radiation Injuries,C21.866.733
23425740,2013-03-01T00:00:00,Radiation Injuries,N06.850.810.300.360
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23425740,2013-03-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23425740,2013-03-01T00:00:00,Trauma Centers,N02.421.297.195.480
23425740,2013-03-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23425740,2013-03-01T00:00:00,United States,Z01.107.567.875
23425740,2013-03-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23425740,2013-03-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23425740,2013-03-01T00:00:00,Wounds and Injuries,C21.866
23426240,2013-03-01T00:00:00,Child Abuse,I01.198.240.856.350.250
23426240,2013-03-01T00:00:00,Child Abuse,I01.880.735.900.350.250
23426240,2013-03-01T00:00:00,Child Abuse,I01.880.787.293.292
23426240,2013-03-01T00:00:00,"Child, Preschool",M01.060.406.448
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C10.900.300
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C21.866.260
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C21.866.915.300
23426240,2013-03-01T00:00:00,"Diagnosis, Differential",E01.171
23426240,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23426240,2013-03-01T00:00:00,Incidence,E05.318.308.985.525.375
23426240,2013-03-01T00:00:00,Incidence,L01.280.975.525.375
23426240,2013-03-01T00:00:00,Incidence,N01.224.935.597.500
23426240,2013-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23426240,2013-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23426240,2013-03-01T00:00:00,Infant,M01.060.703
23426240,2013-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
23426240,2013-03-01T00:00:00,Poisson Distribution,E05.318.740.994.750
23426240,2013-03-01T00:00:00,Poisson Distribution,G17.820.750
23426240,2013-03-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
23426240,2013-03-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
23426240,2013-03-01T00:00:00,Population Surveillance,E05.318.308.250.700
23426240,2013-03-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
23426240,2013-03-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
23426240,2013-03-01T00:00:00,Population Surveillance,N06.850.780.675
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C11.290.807
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C11.768.710
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C23.550.414.756.775
23426240,2013-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23426240,2013-03-01T00:00:00,Risk Factors,N05.715.350.200.700
23426240,2013-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23426240,2013-03-01T00:00:00,Risk Factors,N06.850.490.625.750
23426240,2013-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23426240,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23426240,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23434251,2013-03-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
23434251,2013-03-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
23434251,2013-03-01T00:00:00,Decision Making,F02.463.785.373
23434251,2013-03-01T00:00:00,Delivery of Health Care,N04.590.374
23434251,2013-03-01T00:00:00,Delivery of Health Care,N05.300
23434251,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23434251,2013-03-01T00:00:00,"Specialties, Surgical",H02.403.810
23434251,2013-03-01T00:00:00,United States,Z01.107.567.875
23438517,2013-03-01T00:00:00,Career Choice,F02.463.785.373.346.400
23438517,2013-03-01T00:00:00,Hepacivirus,B04.450.410
23438517,2013-03-01T00:00:00,Hepacivirus,B04.820.250.475
23438517,2013-03-01T00:00:00,Hepacivirus,B04.909.777.310.475
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
23438517,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438517,2013-03-01T00:00:00,Internship and Residency,I02.358.399.644
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
23438527,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438527,2013-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23438527,2013-03-01T00:00:00,Lung Neoplasms,C08.381.540
23438527,2013-03-01T00:00:00,Lung Neoplasms,C08.785.520
23438527,2013-03-01T00:00:00,Neoplasm Staging,E01.370.550
23438527,2013-03-01T00:00:00,Pneumonectomy,E04.928.600.600
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
23448818,2013-03-01T00:00:00,Adult,M01.060.116
23448818,2013-03-01T00:00:00,Ambulatory Care,E02.760.106
23448818,2013-03-01T00:00:00,Ambulatory Care,N02.421.585.106
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D20.215.401.203
23448818,2013-03-01T00:00:00,Graft Rejection,G12.425.901.545.328
23448818,2013-03-01T00:00:00,Health Care Costs,N03.219.151.400
23448818,2013-03-01T00:00:00,Health Care Costs,N05.300.375
23448818,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23448818,2013-03-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23448818,2013-03-01T00:00:00,Kidney Transplantation,E02.870.500
23448818,2013-03-01T00:00:00,Kidney Transplantation,E04.936.450.485
23448818,2013-03-01T00:00:00,Kidney Transplantation,E04.950.774.400
23448818,2013-03-01T00:00:00,Length of Stay,E02.760.400.480
23448818,2013-03-01T00:00:00,Length of Stay,N02.421.585.400.480
23448818,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23448818,2013-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23448818,2013-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23448818,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23448818,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23448818,2013-03-01T00:00:00,Time Factors,G01.910.857
23449699,2013-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
23449699,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23449699,2013-03-01T00:00:00,Hyperprolactinemia,C10.228.140.617.738.250.450
23449699,2013-03-01T00:00:00,Hyperprolactinemia,C19.700.355.600
23449699,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23449699,2013-03-01T00:00:00,Prolactin,D06.472.699.322.576.773
23449699,2013-03-01T00:00:00,Prolactin,D06.472.699.631.525.525
23449699,2013-03-01T00:00:00,Prolactin,D12.644.548.691.525.525
23449699,2013-03-01T00:00:00,Risperidone,D03.383.742.698.685
23452479,2013-03-01T00:00:00,Computer-Assisted Instruction,I02.903.573.208
23452479,2013-03-01T00:00:00,Curriculum,I02.158
23452479,2013-03-01T00:00:00,Educational Measurement,I02.399
23452479,2013-03-01T00:00:00,Health Physics,H01.671.368
23452479,2013-03-01T00:00:00,Health Physics,H02.229.333
23452479,2013-03-01T00:00:00,Internship and Residency,I02.358.399.644
23452479,2013-03-01T00:00:00,Program Evaluation,E05.337.820
23452479,2013-03-01T00:00:00,Program Evaluation,N04.761.685
23452479,2013-03-01T00:00:00,Program Evaluation,N05.715.360.650
23452479,2013-03-01T00:00:00,Radiology,H02.403.740
23452479,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23452479,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23455498,2013-03-01T00:00:00,Animals,B01.050
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
23455498,2013-03-01T00:00:00,Embryo Loss,C13.703.039.711
23455498,2013-03-01T00:00:00,Embryo Loss,C23.550.260.440
23455498,2013-03-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
23455498,2013-03-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
23455498,2013-03-01T00:00:00,Interleukin-10,D23.529.374.465.510
23455498,2013-03-01T00:00:00,Macrophages,A11.329.372
23455498,2013-03-01T00:00:00,Macrophages,A11.627.482
23455498,2013-03-01T00:00:00,Macrophages,A11.733.397
23455498,2013-03-01T00:00:00,Macrophages,A15.382.680.397
23455498,2013-03-01T00:00:00,Macrophages,A15.382.812.522
23455498,2013-03-01T00:00:00,NK Cell Lectin-Like Receptor Subfamily K,D12.776.543.750.705.895.800.910
23455498,2013-03-01T00:00:00,NK Cell Lectin-Like Receptor Subfamily K,D23.050.301.264.035.582
23455498,2013-03-01T00:00:00,NK Cell Lectin-Like Receptor Subfamily K,D23.101.100.110.582
23455498,2013-03-01T00:00:00,Poly I-C,D13.695.578.550.560.600
23455498,2013-03-01T00:00:00,Poly I-C,D13.695.578.550.650.600
23455498,2013-03-01T00:00:00,Pregnancy,G08.686.785.760.769
23455498,2013-03-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23455498,2013-03-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23455498,2013-03-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
23455498,2013-03-01T00:00:00,Uterus,A05.360.319.679
23457180,2013-03-01T00:00:00,Acetylcysteine,D02.886.030.230.259
23457180,2013-03-01T00:00:00,Acetylcysteine,D12.125.166.230.259
23457180,2013-03-01T00:00:00,Age of Onset,N05.715.350.075.100
23457180,2013-03-01T00:00:00,Age of Onset,N06.850.490.250.100
23457180,2013-03-01T00:00:00,Animals,B01.050
23457180,2013-03-01T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
23457180,2013-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23457180,2013-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
23457180,2013-03-01T00:00:00,Cocaine,D02.145.074.722.388
23457180,2013-03-01T00:00:00,Cocaine,D03.132.889.354
23457180,2013-03-01T00:00:00,Cocaine,D03.605.869.388
23457180,2013-03-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
23457180,2013-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
23457180,2013-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
23457180,2013-03-01T00:00:00,"Disease Models, Animal",C22.232
23457180,2013-03-01T00:00:00,"Disease Models, Animal",E05.598.500
23457180,2013-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23457180,2013-03-01T00:00:00,Disease Progression,C23.550.291.656
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23457180,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23457180,2013-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
23457180,2013-03-01T00:00:00,"Stress, Psychological",F02.830.900
23458289,2013-03-01T00:00:00,Animals,B01.050
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A10.615.284.375
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A13.350.575
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A16.331.400
23458289,2013-03-01T00:00:00,Progesterone,D04.808.745.745.654.829
23458289,2013-03-01T00:00:00,Progesterone,D06.472.334.734.623
23458289,2013-03-01T00:00:00,Progesterone,D06.472.334.851.687.750
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.826.750.150
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
23458289,2013-03-01T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
23458289,2013-03-01T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
23458289,2013-03-01T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
23458289,2013-03-01T00:00:00,Steroids,D04.808
23458289,2013-03-01T00:00:00,Turtles,B01.050.150.900.833.848
23460146,2013-03-01T00:00:00,Communication,F01.145.209
23460146,2013-03-01T00:00:00,Communication,L01.143
23460146,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460146,2013-03-01T00:00:00,Lung Diseases,C08.381
23460146,2013-03-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23460146,2013-03-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23460177,2013-03-01T00:00:00,Aircraft,J01.937.285.100
23460177,2013-03-01T00:00:00,Anoxia,C23.888.852.079
23460177,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460177,2013-03-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23460177,2013-03-01T00:00:00,Occupational Exposure,N06.850.460.350.600
23460177,2013-03-01T00:00:00,Travel,I03.883
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C18.452.076.176.390
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C18.452.394.750.535
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C19.246.099.812
23466141,2013-03-01T00:00:00,Emergency Medicine,H02.403.250
23466141,2013-03-01T00:00:00,Fluid Therapy,E02.319.360
23466141,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23466141,2013-03-01T00:00:00,Hypercalcemia,C18.452.174.451
23466141,2013-03-01T00:00:00,Hypercalcemia,C18.452.950.340
23466141,2013-03-01T00:00:00,Hyperparathyroidism,C19.642.355
23466141,2013-03-01T00:00:00,Insulin,D06.472.699.587.740.625
23466141,2013-03-01T00:00:00,Insulin,D12.644.548.586.740.625
23466141,2013-03-01T00:00:00,North America,Z01.107.567
23466141,2013-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23466141,2013-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23466141,2013-03-01T00:00:00,Pregnancy,G08.686.785.760.769
23466141,2013-03-01T00:00:00,Pregnancy Complications,C13.703
23466141,2013-03-01T00:00:00,Thyroid Crisis,C19.874.397.685.905
23466141,2013-03-01T00:00:00,Thyroid Crisis,C19.874.902.905
23486380,2013-03-01T00:00:00,Actins,D05.750.078.730.250
23486380,2013-03-01T00:00:00,Actins,D12.776.210.500.100
23486380,2013-03-01T00:00:00,Actins,D12.776.220.525.255
23486380,2013-03-01T00:00:00,Adsorption,G02.149.047
23486380,2013-03-01T00:00:00,Adsorption,G02.149.767.029
23486380,2013-03-01T00:00:00,Adsorption,G02.842.750.029
23486380,2013-03-01T00:00:00,Alloys,D01.552.033
23486380,2013-03-01T00:00:00,Alloys,D25.058
23486380,2013-03-01T00:00:00,Alloys,J01.637.051.058
23486380,2013-03-01T00:00:00,Animals,B01.050
23486380,2013-03-01T00:00:00,Endothelial Cells,A11.436.275
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.124.050.250
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.124.125.500
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.811.300
23486380,2013-03-01T00:00:00,Fibrinogen,D23.119.490
23486380,2013-03-01T00:00:00,Graphite,D01.268.150.300
23486380,2013-03-01T00:00:00,Graphite,D01.578.300
23486380,2013-03-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23486380,2013-03-01T00:00:00,"Microscopy, Confocal",E05.595.395
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
23486380,2013-03-01T00:00:00,Prostheses and Implants,E07.695
23486380,2013-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.034.841
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.124.050.700
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.124.727
23486380,2013-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
23486380,2013-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
23486380,2013-03-01T00:00:00,Stents,E07.695.750
23527652,2013-03-01T00:00:00,Adult,M01.060.116
23527652,2013-03-01T00:00:00,Brain Mapping,E01.370.350.086
23527652,2013-03-01T00:00:00,Brain Mapping,E01.370.376.149
23527652,2013-03-01T00:00:00,Brain Mapping,E05.132
23527652,2013-03-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23527652,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23527652,2013-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23527652,2013-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23527652,2013-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23527652,2013-03-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
23527652,2013-03-01T00:00:00,"Models, Neurological",E05.599.395.642
23527652,2013-03-01T00:00:00,"Models, Theoretical",E05.599
23527652,2013-03-01T00:00:00,Oxygen,D01.268.185.550
23527652,2013-03-01T00:00:00,Oxygen,D01.362.670
23527652,2013-03-01T00:00:00,Photic Stimulation,E05.723.729
23527652,2013-03-01T00:00:00,Reaction Time,F02.830.650
23527652,2013-03-01T00:00:00,Reaction Time,F04.669.817
23527652,2013-03-01T00:00:00,Reaction Time,G11.561.677
23527652,2013-03-01T00:00:00,Verbal Learning,F02.463.425.952
23527652,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23528021,2013-03-01T00:00:00,Asthma,C08.127.108
23528021,2013-03-01T00:00:00,Asthma,C08.381.495.108
23528021,2013-03-01T00:00:00,Asthma,C08.674.095
23528021,2013-03-01T00:00:00,Asthma,C20.543.480.680.095
23528021,2013-03-01T00:00:00,Bronchiectasis,C08.127.384
23528021,2013-03-01T00:00:00,Cough,C08.618.248
23528021,2013-03-01T00:00:00,Cough,C23.888.852.293
23528021,2013-03-01T00:00:00,Disease Progression,C23.550.291.656
23528021,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23528021,2013-03-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23528021,2013-03-01T00:00:00,alpha 1-Antitrypsin Deficiency,C17.300.050
23551410,2013-03-01T00:00:00,Adult,M01.060.116
23551410,2013-03-01T00:00:00,Age Factors,N05.715.350.075
23551410,2013-03-01T00:00:00,Age Factors,N06.850.490.250
23551410,2013-03-01T00:00:00,Aged,M01.060.116.100
23551410,2013-03-01T00:00:00,Alleles,G05.360.340.024.340.030
23551410,2013-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23551410,2013-03-01T00:00:00,Body Mass Index,E05.041.124.125
23551410,2013-03-01T00:00:00,Body Mass Index,G07.100.100.125
23551410,2013-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23551410,2013-03-01T00:00:00,Cardiovascular Diseases,C14
23551410,2013-03-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23551410,2013-03-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23551410,2013-03-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23551410,2013-03-01T00:00:00,Executive Function,F02.463.217
23551410,2013-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23551410,2013-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23551410,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23551410,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23551410,2013-03-01T00:00:00,Neuropsychological Tests,F04.711.513
23551410,2013-03-01T00:00:00,Obesity,C18.654.726.500
23551410,2013-03-01T00:00:00,Obesity,C23.888.144.699.500
23551410,2013-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23551410,2013-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23551410,2013-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23551410,2013-03-01T00:00:00,Proteins,D12.776
23551410,2013-03-01T00:00:00,Psychomotor Performance,F02.808
23551410,2013-03-01T00:00:00,Psychomotor Performance,G11.427.700
23551410,2013-03-01T00:00:00,Psychomotor Performance,G11.561.623
23571057,2013-03-01T00:00:00,Critical Care,E02.760.190
23571057,2013-03-01T00:00:00,Critical Care,N02.421.585.190
23571057,2013-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
23571057,2013-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23571057,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571057,2013-03-01T00:00:00,Intensive Care Units,N02.278.388.493
23571057,2013-03-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23599957,2013-03-01T00:00:00,Animals,B01.050
23599957,2013-03-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23599957,2013-03-01T00:00:00,Environmental Monitoring,N06.850.780.375
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23460709,2013-03-04T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23460709,2013-03-04T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23460709,2013-03-04T00:00:00,Cisplatin,D01.210.375
23460709,2013-03-04T00:00:00,Cisplatin,D01.625.125
23460709,2013-03-04T00:00:00,Cisplatin,D01.710.100
23460709,2013-03-04T00:00:00,Exanthema,C17.800.257
23460709,2013-03-04T00:00:00,Head and Neck Neoplasms,C04.588.443
23460709,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
23460709,2013-03-04T00:00:00,Pain,C10.597.617
23460709,2013-03-04T00:00:00,Pain,C23.888.592.612
23460709,2013-03-04T00:00:00,Pain,C23.888.646
23460709,2013-03-04T00:00:00,Pain,F02.830.816.444
23460709,2013-03-04T00:00:00,Pain,G11.561.600.810.444
23460709,2013-03-04T00:00:00,Quinazolines,D03.438.786
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
23460709,2013-03-04T00:00:00,Remission Induction,E02.860
23460709,2013-03-04T00:00:00,Treatment Outcome,E01.789.800
23460709,2013-03-04T00:00:00,Treatment Outcome,N04.761.559.590.800
23460709,2013-03-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23510830,2013-03-04T00:00:00,Animals,B01.050
23510830,2013-03-04T00:00:00,Blood Glucose,D09.546.359.448.500
23510830,2013-03-04T00:00:00,Carrier Proteins,D12.776.157
23510830,2013-03-04T00:00:00,Cholesterol,D04.808.247.222.284
23510830,2013-03-04T00:00:00,Cholesterol,D04.808.247.808.197
23510830,2013-03-04T00:00:00,Cholesterol,D10.570.938.208
23510830,2013-03-04T00:00:00,Cholesterol,D10.851.208
23510830,2013-03-04T00:00:00,"Disease Models, Animal",C22.232
23510830,2013-03-04T00:00:00,"Disease Models, Animal",E05.598.500
23510830,2013-03-04T00:00:00,"Disease Models, Animal",E05.599.395.080
23510830,2013-03-04T00:00:00,Fatty Liver,C06.552.241
23510830,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23510830,2013-03-04T00:00:00,Inflammation,C23.550.470
23510830,2013-03-04T00:00:00,Insulin,D06.472.699.587.740.625
23510830,2013-03-04T00:00:00,Insulin,D12.644.548.586.740.625
23510830,2013-03-04T00:00:00,Liver,A03.620
23510830,2013-03-04T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23510830,2013-03-04T00:00:00,Metabolic Syndrome X,C18.452.625
23510830,2013-03-04T00:00:00,"Muscle, Skeletal",A02.633.567
23510830,2013-03-04T00:00:00,"Muscle, Skeletal",A10.690.552.500
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23460266,2013-03-05T00:00:00,Adult,M01.060.116
23460266,2013-03-05T00:00:00,Cocaine-Related Disorders,C21.739.300
23460266,2013-03-05T00:00:00,Cocaine-Related Disorders,F03.900.300
23460266,2013-03-05T00:00:00,Cues,F02.463.425.234
23460266,2013-03-05T00:00:00,Double-Blind Method,E05.318.780.300
23460266,2013-03-05T00:00:00,Double-Blind Method,E05.581.500.300
23460266,2013-03-05T00:00:00,Double-Blind Method,N05.715.360.780.320
23460266,2013-03-05T00:00:00,Double-Blind Method,N06.850.520.445.300
23460266,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460266,2013-03-05T00:00:00,Time Factors,G01.910.857
23462656,2013-03-05T00:00:00,Adolescent,M01.060.057
23462656,2013-03-05T00:00:00,Adult,M01.060.116
23462656,2013-03-05T00:00:00,Aged,M01.060.116.100
23462656,2013-03-05T00:00:00,Deglutition Disorders,C06.405.117.119
23462656,2013-03-05T00:00:00,Deglutition Disorders,C09.775.174
23462656,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462656,2013-03-05T00:00:00,Middle Aged,M01.060.116.630
23462656,2013-03-05T00:00:00,Quality of Life,I01.800
23462656,2013-03-05T00:00:00,Quality of Life,K01.752.400.750
23462656,2013-03-05T00:00:00,Questionnaires,E05.318.308.750
23462656,2013-03-05T00:00:00,Questionnaires,L01.280.800
23462656,2013-03-05T00:00:00,Questionnaires,N05.715.360.300.695
23462656,2013-03-05T00:00:00,Questionnaires,N06.850.520.308.750
23462656,2013-03-05T00:00:00,Sialadenitis,C07.465.815.793
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C04.588.322.894
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C04.588.443.915
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C19.344.894
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C19.874.788
23462656,2013-03-05T00:00:00,Young Adult,M01.060.116.815
23463546,2013-03-05T00:00:00,"Models, Chemical",E05.599.495
23463546,2013-03-05T00:00:00,Molecular Weight,G02.842.580
23463546,2013-03-05T00:00:00,Polymers,D05.750
23463546,2013-03-05T00:00:00,Polymers,D25.720
23463546,2013-03-05T00:00:00,Polymers,J01.637.051.720
23463546,2013-03-05T00:00:00,Proteins,D12.776
23465380,2013-03-05T00:00:00,Calcinosis,C18.452.174.130
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.370.050.200
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.370.380.200
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
23465380,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23465380,2013-03-05T00:00:00,Middle Aged,M01.060.116.630
23465380,2013-03-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
23465380,2013-03-05T00:00:00,Risk Assessment,N04.452.871.715
23465380,2013-03-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23465380,2013-03-05T00:00:00,Risk Assessment,N06.850.505.715
23465380,2013-03-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23465380,2013-03-05T00:00:00,South Carolina,Z01.107.567.875.075.662
23465380,2013-03-05T00:00:00,South Carolina,Z01.107.567.875.750.700
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,E05.318.760.535
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,E05.337.250
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23462880,2013-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C10.228.854.770
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C10.900.850
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C21.866.819
23462880,2013-03-06T00:00:00,United States,Z01.107.567.875
23468226,2013-03-06T00:00:00,Adult,M01.060.116
23468226,2013-03-06T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23468226,2013-03-06T00:00:00,Factor VIIa,D08.811.277.656.300.760.300
23468226,2013-03-06T00:00:00,Factor VIIa,D08.811.277.656.959.350.300
23468226,2013-03-06T00:00:00,Factor VIIa,D12.776.124.125.325.300
23468226,2013-03-06T00:00:00,Factor VIIa,D23.119.325.300
23468226,2013-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468226,2013-03-06T00:00:00,Length of Stay,E02.760.400.480
23468226,2013-03-06T00:00:00,Length of Stay,N02.421.585.400.480
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.210.650
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.936.450.490
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.936.580.490
23468226,2013-03-06T00:00:00,Preoperative Care,E02.760.795
23468226,2013-03-06T00:00:00,Preoperative Care,E04.641
23468226,2013-03-06T00:00:00,Preoperative Care,N02.421.585.795
23468226,2013-03-06T00:00:00,Recombinant Proteins,D12.776.828
23468226,2013-03-06T00:00:00,Treatment Outcome,E01.789.800
23468226,2013-03-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23468226,2013-03-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23473317,2013-03-06T00:00:00,Animals,B01.050
23473317,2013-03-06T00:00:00,Cocaine,D02.145.074.722.388
23473317,2013-03-06T00:00:00,Cocaine,D03.132.889.354
23473317,2013-03-06T00:00:00,Cocaine,D03.605.869.388
23473317,2013-03-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
23473317,2013-03-06T00:00:00,Cocaine-Related Disorders,C21.739.300
23473317,2013-03-06T00:00:00,Cocaine-Related Disorders,F03.900.300
23473317,2013-03-06T00:00:00,"Conditioning, Operant",F02.463.425.179.509
23473317,2013-03-06T00:00:00,Cues,F02.463.425.234
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.067.750
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.119.450
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.427.300
23473317,2013-03-06T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23473317,2013-03-06T00:00:00,"Microscopy, Confocal",E05.595.395
23473317,2013-03-06T00:00:00,Motivation,F01.658
23473317,2013-03-06T00:00:00,Motivation,F01.752.543.500.750
23473317,2013-03-06T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23473317,2013-03-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23473317,2013-03-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23473317,2013-03-06T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23473317,2013-03-06T00:00:00,Self Administration,E02.319.890
23473317,2013-03-06T00:00:00,Self Administration,E02.900.890
23473317,2013-03-06T00:00:00,Synaptic Transmission,G02.111.087.800.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G02.149.115.800.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G04.299.880.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G07.265.337.900
23473317,2013-03-06T00:00:00,Synaptic Transmission,G07.700.240.900
23473317,2013-03-06T00:00:00,Synaptic Transmission,G11.561.600.835
23473812,2013-03-06T00:00:00,Animals,B01.050
23473812,2013-03-06T00:00:00,"Animals, Newborn",B01.050.050.282
23473812,2013-03-06T00:00:00,Calcium,D01.268.552.100
23473812,2013-03-06T00:00:00,Calcium,D01.552.539.288
23473812,2013-03-06T00:00:00,Calcium,D23.119.100
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.157.530.400.150
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.543.550.425.150
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.543.585.400.150
23473812,2013-03-06T00:00:00,Carrier Proteins,D12.776.157
23473812,2013-03-06T00:00:00,Electric Stimulation,E05.723.402
23473812,2013-03-06T00:00:00,Gene Expression Regulation,G05.355.315
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.067.750
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.119.450
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.427.300
23473812,2013-03-06T00:00:00,Mutation,G05.365.590
23473812,2013-03-06T00:00:00,Neurons,A08.663
23473812,2013-03-06T00:00:00,Neurons,A11.671
23473812,2013-03-06T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23473812,2013-03-06T00:00:00,Probability,E05.318.740.600
23473812,2013-03-06T00:00:00,Probability,G17.680
23473812,2013-03-06T00:00:00,Probability,N05.715.360.750.625
23473812,2013-03-06T00:00:00,Probability,N06.850.520.830.600
23473812,2013-03-06T00:00:00,Pyridinium Compounds,D03.383.725.762
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D01.625.075
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D02.092.877
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D02.675.276
23473812,2013-03-06T00:00:00,Synapses,A08.850
23473812,2013-03-06T00:00:00,Synapses,A11.284.149.165.420.780
23473812,2013-03-06T00:00:00,Synaptosomes,A11.284.835.859
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23471966,2013-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23471966,2013-03-07T00:00:00,Liver Neoplasms,C04.588.274.623
23471966,2013-03-07T00:00:00,Liver Neoplasms,C06.301.623
23471966,2013-03-07T00:00:00,Liver Neoplasms,C06.552.697
23471966,2013-03-07T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23471966,2013-03-07T00:00:00,Mitochondria,A11.284.835.626
23471966,2013-03-07T00:00:00,Mitochondrial Proteins,D12.776.575
23471966,2013-03-07T00:00:00,Neoplasm Proteins,D12.776.624
23471966,2013-03-07T00:00:00,Piperazines,D03.383.606
23471966,2013-03-07T00:00:00,Tubulin,D05.750.078.734.800
23471966,2013-03-07T00:00:00,Tubulin,D12.776.220.600.800
23471966,2013-03-07T00:00:00,Tubulin,D12.776.641.920
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
23473840,2013-03-07T00:00:00,Aging,G07.700.320.124
23473840,2013-03-07T00:00:00,Animals,B01.050
23473840,2013-03-07T00:00:00,Brain,A08.186.211
23473840,2013-03-07T00:00:00,Brain Chemistry,G02.111.100
23473840,2013-03-07T00:00:00,Brain Chemistry,G03.200
23473840,2013-03-07T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
23473840,2013-03-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23473840,2013-03-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23525072,2013-03-07T00:00:00,Animals,B01.050
23525072,2013-03-07T00:00:00,Bone Marrow Transplantation,E04.936.580.040
23525072,2013-03-07T00:00:00,DNA,D13.444.308
23525072,2013-03-07T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23525072,2013-03-07T00:00:00,Flow Cytometry,E05.200.500.386.350
23525072,2013-03-07T00:00:00,Graft Survival,G12.425.901.545.340
23525072,2013-03-07T00:00:00,"Models, Animal",E05.598
23470564,2013-03-08T00:00:00,Animals,B01.050
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
23470564,2013-03-08T00:00:00,Apoptosis,G04.299.139.160
23470564,2013-03-08T00:00:00,Combined Modality Therapy,E02.186
23470564,2013-03-08T00:00:00,Deoxycytidine,D03.383.742.680.245.500
23470564,2013-03-08T00:00:00,Deoxycytidine,D13.570.230.329
23470564,2013-03-08T00:00:00,Deoxycytidine,D13.570.685.245.500
23470564,2013-03-08T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23470564,2013-03-08T00:00:00,Gene Transfer Techniques,E05.393.350
23470564,2013-03-08T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
23470564,2013-03-08T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
23470564,2013-03-08T00:00:00,Liver Neoplasms,C04.588.274.623
23470564,2013-03-08T00:00:00,Liver Neoplasms,C06.301.623
23470564,2013-03-08T00:00:00,Liver Neoplasms,C06.552.697
23470564,2013-03-08T00:00:00,Nanomedicine,H01.603.600
23470564,2013-03-08T00:00:00,Nanomedicine,J01.897.115.625
23470564,2013-03-08T00:00:00,Nanomedicine,J01.897.520.600.600
23470564,2013-03-08T00:00:00,Nanoparticles,J01.637.512.600
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C06.301.761
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C06.689.667
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C19.344.421
23470564,2013-03-08T00:00:00,"Receptors, Transferrin",D12.776.157.905.500
23470564,2013-03-08T00:00:00,"Receptors, Transferrin",D12.776.543.750.850
23381505,2013-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23381505,2013-03-11T00:00:00,Middle Aged,M01.060.116.630
23381505,2013-03-11T00:00:00,Nutrition Surveys,E05.318.308.250.600
23381505,2013-03-11T00:00:00,Nutrition Surveys,E05.318.308.585.550
23381505,2013-03-11T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23381505,2013-03-11T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23381505,2013-03-11T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23381505,2013-03-11T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23381505,2013-03-11T00:00:00,Population Dynamics,I01.240.600
23381505,2013-03-11T00:00:00,Population Dynamics,N01.224.625
23381505,2013-03-11T00:00:00,Population Dynamics,N06.850.505.400.700
23381505,2013-03-11T00:00:00,United States,Z01.107.567.875
23404122,2013-03-11T00:00:00,Animals,B01.050
23404122,2013-03-11T00:00:00,Astrocytes,A08.637.200
23404122,2013-03-11T00:00:00,Astrocytes,A11.650.200
23404122,2013-03-11T00:00:00,Cell Survival,G04.299.316
23404122,2013-03-11T00:00:00,Chronic Disease,C23.550.291.500
23404122,2013-03-11T00:00:00,"Disease Models, Animal",C22.232
23404122,2013-03-11T00:00:00,"Disease Models, Animal",E05.598.500
23404122,2013-03-11T00:00:00,"Disease Models, Animal",E05.599.395.080
23404122,2013-03-11T00:00:00,Intraocular Pressure,G14.440
23404122,2013-03-11T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23404122,2013-03-11T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23404122,2013-03-11T00:00:00,Ocular Hypertension,C11.525
23404122,2013-03-11T00:00:00,Piperazines,D03.383.606
23404122,2013-03-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23404122,2013-03-11T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.100.620.200
23404122,2013-03-11T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.720.600.610.200
23404122,2013-03-11T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.750.555.610.200
23404122,2013-03-11T00:00:00,Retina,A09.371.729
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23478382,2013-03-12T00:00:00,Adolescent,M01.060.057
23478382,2013-03-12T00:00:00,Adult,M01.060.116
23478382,2013-03-12T00:00:00,Age Factors,N05.715.350.075
23478382,2013-03-12T00:00:00,Age Factors,N06.850.490.250
23478382,2013-03-12T00:00:00,Aged,M01.060.116.100
23478382,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23478382,2013-03-12T00:00:00,Laparoscopy,E01.370.388.250.520
23478382,2013-03-12T00:00:00,Laparoscopy,E04.800.250.520
23478382,2013-03-12T00:00:00,Manometry,E05.559
23478382,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23478382,2013-03-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
23478382,2013-03-12T00:00:00,Risk Assessment,N04.452.871.715
23478382,2013-03-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23478382,2013-03-12T00:00:00,Risk Assessment,N06.850.505.715
23478382,2013-03-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23478382,2013-03-12T00:00:00,Sex Factors,N05.715.350.675
23478382,2013-03-12T00:00:00,Sex Factors,N06.850.490.875
23478382,2013-03-12T00:00:00,Treatment Outcome,E01.789.800
23478382,2013-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23478382,2013-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23478382,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23479544,2013-03-12T00:00:00,Adolescent,M01.060.057
23479544,2013-03-12T00:00:00,Adult,M01.060.116
23479544,2013-03-12T00:00:00,Aged,M01.060.116.100
23479544,2013-03-12T00:00:00,Auditory Perception,F02.463.593.071
23479544,2013-03-12T00:00:00,Hearing Loss,C09.218.458.341
23479544,2013-03-12T00:00:00,Hearing Loss,C10.597.751.418.341
23479544,2013-03-12T00:00:00,Hearing Loss,C23.888.592.763.393.341
23479544,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23479544,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23479544,2013-03-12T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
23479544,2013-03-12T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
23479544,2013-03-12T00:00:00,Noise,G01.595.907.567
23479544,2013-03-12T00:00:00,Noise,G16.500.275.600
23479544,2013-03-12T00:00:00,Noise,N06.230.400
23479544,2013-03-12T00:00:00,Noise,N06.850.460.610
23479544,2013-03-12T00:00:00,United States,Z01.107.567.875
23479544,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23482476,2013-03-12T00:00:00,Adolescent,M01.060.057
23482476,2013-03-12T00:00:00,Adult,M01.060.116
23482476,2013-03-12T00:00:00,Age Factors,N05.715.350.075
23482476,2013-03-12T00:00:00,Age Factors,N06.850.490.250
23482476,2013-03-12T00:00:00,Aged,M01.060.116.100
23482476,2013-03-12T00:00:00,Child,M01.060.406
23482476,2013-03-12T00:00:00,Combined Modality Therapy,E02.186
23482476,2013-03-12T00:00:00,Head and Neck Neoplasms,C04.588.443
23482476,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23482476,2013-03-12T00:00:00,Incidence,E05.318.308.985.525.375
23482476,2013-03-12T00:00:00,Incidence,L01.280.975.525.375
23482476,2013-03-12T00:00:00,Incidence,N01.224.935.597.500
23482476,2013-03-12T00:00:00,Incidence,N06.850.505.400.975.525.375
23482476,2013-03-12T00:00:00,Incidence,N06.850.520.308.985.525.375
23482476,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23482476,2013-03-12T00:00:00,Neoplasm Staging,E01.370.550
23482476,2013-03-12T00:00:00,Plasmacytoma,C04.557.595.600
23482476,2013-03-12T00:00:00,Plasmacytoma,C20.683.515.880
23482476,2013-03-12T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
23482476,2013-03-12T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
23482476,2013-03-12T00:00:00,SEER Program,E05.318.308.970.725
23482476,2013-03-12T00:00:00,SEER Program,L01.280.950.725
23482476,2013-03-12T00:00:00,SEER Program,N04.452.859.819.725
23482476,2013-03-12T00:00:00,SEER Program,N05.715.360.300.715.700.725
23482476,2013-03-12T00:00:00,SEER Program,N06.850.520.308.970.725
23482476,2013-03-12T00:00:00,Sex Factors,N05.715.350.675
23482476,2013-03-12T00:00:00,Sex Factors,N06.850.490.875
23482476,2013-03-12T00:00:00,Time Factors,G01.910.857
23482476,2013-03-12T00:00:00,Treatment Outcome,E01.789.800
23482476,2013-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23482476,2013-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23482476,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23497257,2013-03-12T00:00:00,Adult,M01.060.116
23497257,2013-03-12T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
23497257,2013-03-12T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
23497257,2013-03-12T00:00:00,HIV Infections,C02.782.815.616.400
23497257,2013-03-12T00:00:00,HIV Infections,C02.800.801.400
23497257,2013-03-12T00:00:00,HIV Infections,C20.673.480
23497257,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497257,2013-03-12T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23497257,2013-03-12T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23497257,2013-03-12T00:00:00,Questionnaires,E05.318.308.750
23497257,2013-03-12T00:00:00,Questionnaires,L01.280.800
23497257,2013-03-12T00:00:00,Questionnaires,N05.715.360.300.695
23497257,2013-03-12T00:00:00,Questionnaires,N06.850.520.308.750
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23497462,2013-03-12T00:00:00,Attitude of Health Personnel,F01.100.050
23497462,2013-03-12T00:00:00,Attitude of Health Personnel,N05.300.100
23497462,2013-03-12T00:00:00,Career Choice,F02.463.785.373.346.400
23497462,2013-03-12T00:00:00,Diffusion of Innovation,L01.143.320
23497462,2013-03-12T00:00:00,Forecasting,I01.320
23497462,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497462,2013-03-12T00:00:00,Motivation,F01.658
23497462,2013-03-12T00:00:00,Motivation,F01.752.543.500.750
23493397,2013-03-14T00:00:00,Animals,B01.050
23493397,2013-03-14T00:00:00,Cell Line,A11.251.210
23493397,2013-03-14T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
23493397,2013-03-14T00:00:00,Homeodomain Proteins,D12.776.260.400
23493397,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
23493397,2013-03-14T00:00:00,Oxidative Stress,G03.495.710
23493397,2013-03-14T00:00:00,Oxidative Stress,G07.700.830.750
23493397,2013-03-14T00:00:00,Phospholipids,D10.570.755
23493397,2013-03-14T00:00:00,Phospholipids,D10.695
23493397,2013-03-14T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23493397,2013-03-14T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23516612,2013-03-14T00:00:00,Animals,B01.050
23516612,2013-03-14T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23516612,2013-03-14T00:00:00,Mitochondria,A11.284.835.626
23516612,2013-03-14T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23516612,2013-03-14T00:00:00,Zebrafish Proteins,D12.776.325.500
23500034,2013-03-15T00:00:00,Drainage,E02.309
23500034,2013-03-15T00:00:00,Drainage,E04.237
23500034,2013-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23500034,2013-03-15T00:00:00,"Monitoring, Physiologic",E01.370.520
23500034,2013-03-15T00:00:00,Pain Measurement,E01.370.376.550.600
23500034,2013-03-15T00:00:00,"Pain, Postoperative",C23.550.767.700
23500034,2013-03-15T00:00:00,"Pain, Postoperative",C23.888.646.530
23500034,2013-03-15T00:00:00,Prostatectomy,E04.950.774.860.625
23500034,2013-03-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
23500034,2013-03-15T00:00:00,Risk Assessment,N04.452.871.715
23500034,2013-03-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23500034,2013-03-15T00:00:00,Risk Assessment,N06.850.505.715
23500034,2013-03-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23500034,2013-03-15T00:00:00,Robotics,H01.671.293.643
23500034,2013-03-15T00:00:00,Robotics,J01.897.104.834
23500034,2013-03-15T00:00:00,Robotics,L01.224.065.630
23500034,2013-03-15T00:00:00,Treatment Outcome,E01.789.800
23500034,2013-03-15T00:00:00,Treatment Outcome,N04.761.559.590.800
23500034,2013-03-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23497456,2013-03-16T00:00:00,Animals,B01.050
23497456,2013-03-16T00:00:00,Antineoplastic Agents,D27.505.954.248
23497456,2013-03-16T00:00:00,Apoptosis,G04.299.139.160
23497456,2013-03-16T00:00:00,Cell Proliferation,G04.299.233.750
23497456,2013-03-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23497456,2013-03-16T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23497456,2013-03-16T00:00:00,Flow Cytometry,E05.200.500.386.350
23497456,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497456,2013-03-16T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23497456,2013-03-16T00:00:00,MicroRNAs,D13.150.650.319
23497456,2013-03-16T00:00:00,MicroRNAs,D13.444.735.150.319
23497456,2013-03-16T00:00:00,MicroRNAs,D13.444.735.790.099
23497456,2013-03-16T00:00:00,"RNA, Messenger",D13.444.735.544
23510946,2013-03-16T00:00:00,Adult,M01.060.116
23510946,2013-03-16T00:00:00,"Diagnosis, Differential",E01.171
23510946,2013-03-16T00:00:00,Esophageal Perforation,C06.405.117.468
23510946,2013-03-16T00:00:00,Esophageal Perforation,C21.866.348
23510946,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23510946,2013-03-16T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
23510946,2013-03-16T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
23510946,2013-03-16T00:00:00,"Tuberculosis, Gastrointestinal",C01.252.410.040.552.846.628
23510946,2013-03-16T00:00:00,"Tuberculosis, Gastrointestinal",C06.405.874
23518262,2013-03-16T00:00:00,Aged,M01.060.116.100
23518262,2013-03-16T00:00:00,Electroconvulsive Therapy,F04.570.200.583
23518262,2013-03-16T00:00:00,Electroconvulsive Therapy,F04.669.224.300
23518262,2013-03-16T00:00:00,Electrodes,E07.305.250
23518262,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23518262,2013-03-16T00:00:00,Middle Aged,M01.060.116.630
23518262,2013-03-16T00:00:00,Neuropsychological Tests,F04.711.513
23518262,2013-03-16T00:00:00,Seizures,C10.228.140.490.631
23518262,2013-03-16T00:00:00,Seizures,C10.597.742
23518262,2013-03-16T00:00:00,Seizures,C23.888.592.742
23518262,2013-03-16T00:00:00,Treatment Outcome,E01.789.800
23518262,2013-03-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23518262,2013-03-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23508045,2013-03-18T00:00:00,Adenoviridae,B04.280.030
23508045,2013-03-18T00:00:00,Adenoviridae,B04.909.204.097
23508045,2013-03-18T00:00:00,Animals,B01.050
23508045,2013-03-18T00:00:00,Apoptosis,G04.299.139.160
23508045,2013-03-18T00:00:00,Blood Pressure,E01.370.600.875.249
23508045,2013-03-18T00:00:00,Blood Pressure,G09.330.380.076
23508045,2013-03-18T00:00:00,Endothelial Cells,A11.436.275
23508045,2013-03-18T00:00:00,Fetal Blood,A12.207.152.200
23508045,2013-03-18T00:00:00,Fetal Blood,A15.145.300
23508045,2013-03-18T00:00:00,Fetal Blood,A16.378.200
23508045,2013-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
23508045,2013-03-18T00:00:00,Myocardial Infarction,C14.280.647.500
23508045,2013-03-18T00:00:00,Myocardial Infarction,C14.907.585.500
23508045,2013-03-18T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23508045,2013-03-18T00:00:00,Oxidative Stress,G03.495.710
23508045,2013-03-18T00:00:00,Oxidative Stress,G07.700.830.750
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23508045,2013-03-18T00:00:00,Stem Cells,A11.872
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D23.101.840.870
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
23509163,2013-03-18T00:00:00,Adolescent,M01.060.057
23509163,2013-03-18T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23509163,2013-03-18T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23509163,2013-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23509163,2013-03-18T00:00:00,Interviews as Topic,E05.318.308.420
23509163,2013-03-18T00:00:00,Interviews as Topic,L01.280.520
23509163,2013-03-18T00:00:00,Interviews as Topic,N05.715.360.300.400
23509163,2013-03-18T00:00:00,Interviews as Topic,N06.850.520.308.420
23509163,2013-03-18T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23509163,2013-03-18T00:00:00,Parents,F01.829.263.500.320
23509163,2013-03-18T00:00:00,Parents,I01.880.225.500.340
23509163,2013-03-18T00:00:00,Parents,M01.620
23509163,2013-03-18T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23509163,2013-03-18T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23509163,2013-03-18T00:00:00,Physician-Patient Relations,N05.300.660.625
23509163,2013-03-18T00:00:00,United States,Z01.107.567.875
23509163,2013-03-18T00:00:00,Vaccination,E02.095.465.425.400.530.890
23509163,2013-03-18T00:00:00,Vaccination,E05.478.550.600.890
23509163,2013-03-18T00:00:00,Vaccination,N02.421.726.758.310.890
23509163,2013-03-18T00:00:00,Vaccination,N06.850.780.200.425.900
23509163,2013-03-18T00:00:00,Vaccination,N06.850.780.680.310.890
23515265,2013-03-20T00:00:00,Blood Pressure,E01.370.600.875.249
23515265,2013-03-20T00:00:00,Blood Pressure,G09.330.380.076
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.695.175
23515265,2013-03-20T00:00:00,Disease Progression,C23.550.291.656
23515265,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23515265,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23515265,2013-03-20T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23515265,2013-03-20T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23515265,2013-03-20T00:00:00,Ventricular Pressure,G09.330.190.962.950
23515265,2013-03-20T00:00:00,Ventricular Pressure,G09.330.380.937
23515277,2013-03-20T00:00:00,Activities of Daily Living,E02.831.067
23515277,2013-03-20T00:00:00,Activities of Daily Living,I03.050
23515277,2013-03-20T00:00:00,Activities of Daily Living,N02.421.784.110
23515277,2013-03-20T00:00:00,Adult,M01.060.116
23515277,2013-03-20T00:00:00,Aged,M01.060.116.100
23515277,2013-03-20T00:00:00,Cardiac Output,E01.370.370.380.150
23515277,2013-03-20T00:00:00,Cardiac Output,G09.330.380.124
23515277,2013-03-20T00:00:00,Diastole,G09.330.190.541.295
23515277,2013-03-20T00:00:00,Diastole,G11.427.590.540.554.250
23515277,2013-03-20T00:00:00,Diastole,G11.427.590.540.570.295
23515277,2013-03-20T00:00:00,Exercise,G11.427.590.237
23515277,2013-03-20T00:00:00,Exercise,I03.350
23515277,2013-03-20T00:00:00,Heart Failure,C14.280.434
23515277,2013-03-20T00:00:00,Hemodynamics,G09.330.190.400
23515277,2013-03-20T00:00:00,Hemodynamics,G09.330.380
23515277,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23515277,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23515277,2013-03-20T00:00:00,Stroke Volume,E01.370.370.380.150.700
23515277,2013-03-20T00:00:00,Stroke Volume,G09.330.380.124.882
23518004,2013-03-21T00:00:00,African Americans,M01.686.508.100.100
23518004,2013-03-21T00:00:00,African Americans,M01.686.754.100
23518004,2013-03-21T00:00:00,Aged,M01.060.116.100
23518004,2013-03-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23518004,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23518004,2013-03-21T00:00:00,Middle Aged,M01.060.116.630
23518004,2013-03-21T00:00:00,Population Surveillance,E05.318.308.250.700
23518004,2013-03-21T00:00:00,Population Surveillance,N05.715.360.300.375.625
23518004,2013-03-21T00:00:00,Population Surveillance,N06.850.520.308.250.700
23518004,2013-03-21T00:00:00,Population Surveillance,N06.850.780.675
23518004,2013-03-21T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23518004,2013-03-21T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23518004,2013-03-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23518004,2013-03-21T00:00:00,Risk Factors,N05.715.350.200.700
23518004,2013-03-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23518004,2013-03-21T00:00:00,Risk Factors,N06.850.490.625.750
23518004,2013-03-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23518004,2013-03-21T00:00:00,Stroke,C10.228.140.300.775
23518004,2013-03-21T00:00:00,Stroke,C14.907.253.855
23518004,2013-03-21T00:00:00,Time Factors,G01.910.857
23519469,2013-03-21T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
23519469,2013-03-21T00:00:00,Apoptosis,G04.299.139.160
23519469,2013-03-21T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23519469,2013-03-21T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23519469,2013-03-21T00:00:00,Ceramides,D02.065.313
23519469,2013-03-21T00:00:00,Ceramides,D09.400.410.420.525.200
23519469,2013-03-21T00:00:00,Ceramides,D10.390.470.675.200
23519469,2013-03-21T00:00:00,Ceramides,D10.570.877.360.612.200
23519469,2013-03-21T00:00:00,Folic Acid,D03.438.733.631.400
23519469,2013-03-21T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23519469,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23519469,2013-03-21T00:00:00,Membrane Proteins,D12.776.543
23519469,2013-03-21T00:00:00,"Mutation, Missense",G05.365.590.650
23519469,2013-03-21T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
23519469,2013-03-21T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
23519469,2013-03-21T00:00:00,"Stress, Physiological",G07.700.830
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
23519612,2013-03-21T00:00:00,Alternative Splicing,G02.111.087.750.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G02.149.115.750.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G03.495.839.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G05.355.315.700.700.100
23519612,2013-03-21T00:00:00,Animals,B01.050
23519612,2013-03-21T00:00:00,Cell Line,A11.251.210
23519612,2013-03-21T00:00:00,Cell Movement,G04.299.283
23519612,2013-03-21T00:00:00,Cell Movement,G07.700.560.500.180
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.377.715.390
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.395.550.350
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.543.550.350
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.860.300.450
23519612,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23519612,2013-03-21T00:00:00,Mutation,G05.365.590
23519612,2013-03-21T00:00:00,Phosphorylation,G02.111.087.677
23519612,2013-03-21T00:00:00,Phosphorylation,G02.149.115.677
23519612,2013-03-21T00:00:00,Phosphorylation,G02.149.465.700
23519612,2013-03-21T00:00:00,Phosphorylation,G02.607.750.700
23519612,2013-03-21T00:00:00,Phosphorylation,G03.495.790
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
23519612,2013-03-21T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23519612,2013-03-21T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
23519612,2013-03-21T00:00:00,"RNA, Messenger",D13.444.735.544
23519612,2013-03-21T00:00:00,RNA-Binding Proteins,D12.776.157.725
23519612,2013-03-21T00:00:00,RNA-Binding Proteins,D12.776.664.962
23523039,2013-03-21T00:00:00,Aortic Valve,A07.541.510.110
23523039,2013-03-21T00:00:00,Certification,N03.706.110.120
23523039,2013-03-21T00:00:00,Certification,N05.700.200.190
23523039,2013-03-21T00:00:00,Health Services Accessibility,N04.590.374.350
23523039,2013-03-21T00:00:00,Health Services Accessibility,N05.300.430
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis,E07.695.310
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
23523039,2013-03-21T00:00:00,Hospitals,N02.278.421
23523039,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23523039,2013-03-21T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23523039,2013-03-21T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23555291,2013-03-21T00:00:00,African Americans,M01.686.508.100.100
23555291,2013-03-21T00:00:00,African Americans,M01.686.754.100
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D10.532.432.400
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
23555291,2013-03-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.318.416.249
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.318.780.392
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.385.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.522.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23555291,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23555291,2013-03-21T00:00:00,"Lipoproteins, HDL",D10.532.432
23555291,2013-03-21T00:00:00,"Lipoproteins, HDL",D12.776.521.479
23555291,2013-03-21T00:00:00,"Lipoproteins, LDL",D10.532.515
23555291,2013-03-21T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23529144,2013-03-22T00:00:00,Adult,M01.060.116
23529144,2013-03-22T00:00:00,Aged,M01.060.116.100
23529144,2013-03-22T00:00:00,Disability Evaluation,E01.370.400
23529144,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529144,2013-03-22T00:00:00,Middle Aged,M01.060.116.630
23529144,2013-03-22T00:00:00,Motor Activity,F01.145.632
23529144,2013-03-22T00:00:00,Motor Activity,G11.427.590.530.698
23529144,2013-03-22T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23529144,2013-03-22T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23529144,2013-03-22T00:00:00,Paresis,C10.597.636
23529144,2013-03-22T00:00:00,Paresis,C23.888.592.643
23529144,2013-03-22T00:00:00,Recovery of Function,G16.757
23529144,2013-03-22T00:00:00,Stroke,C10.228.140.300.775
23529144,2013-03-22T00:00:00,Stroke,C14.907.253.855
23529144,2013-03-22T00:00:00,Upper Extremity,A01.378.800
23533664,2013-03-22T00:00:00,Cell Aging,G04.299.119
23533664,2013-03-22T00:00:00,DNA Damage,C21.111
23533664,2013-03-22T00:00:00,DNA Damage,G05.355.180
23533664,2013-03-22T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23533664,2013-03-22T00:00:00,Flow Cytometry,E05.200.500.386.350
23533664,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23533664,2013-03-22T00:00:00,Lung Neoplasms,C04.588.894.797.520
23533664,2013-03-22T00:00:00,Lung Neoplasms,C08.381.540
23533664,2013-03-22T00:00:00,Lung Neoplasms,C08.785.520
23533664,2013-03-22T00:00:00,Reactive Oxygen Species,D01.339.431
23533664,2013-03-22T00:00:00,Reactive Oxygen Species,D01.650.775
23533664,2013-03-22T00:00:00,Stilbenes,D02.455.426.559.389.150.700
23533674,2013-03-22T00:00:00,DNA Methylation,G02.111.087.029.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G02.111.087.218
23533674,2013-03-22T00:00:00,DNA Methylation,G02.149.115.029.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G02.149.115.218
23533674,2013-03-22T00:00:00,DNA Methylation,G03.495.130.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G05.355.190
23533674,2013-03-22T00:00:00,Histones,D12.776.660.470
23533674,2013-03-22T00:00:00,Histones,D12.776.664.469
23533674,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C04.588.322.455
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C19.344.410
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C19.391.630.705
23533674,2013-03-22T00:00:00,RGS Proteins,D12.644.360.325.150.750
23533674,2013-03-22T00:00:00,RGS Proteins,D12.776.402.150.750
23533674,2013-03-22T00:00:00,RGS Proteins,D12.776.476.325.150.750
23522556,2013-03-24T00:00:00,Community Mental Health Services,F04.408.307
23522556,2013-03-24T00:00:00,Community Mental Health Services,N02.421.143.183
23522556,2013-03-24T00:00:00,Community Mental Health Services,N02.421.461.232
23522556,2013-03-24T00:00:00,Delivery of Health Care,N04.590.374
23522556,2013-03-24T00:00:00,Delivery of Health Care,N05.300
23522556,2013-03-24T00:00:00,Diffusion of Innovation,L01.143.320
23522556,2013-03-24T00:00:00,Health Policy,I01.880.604.825.608.400
23522556,2013-03-24T00:00:00,Health Policy,N03.706.825.608.428
23522556,2013-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23530041,2013-03-25T00:00:00,Animals,B01.050
23530041,2013-03-25T00:00:00,Cell Line,A11.251.210
23530041,2013-03-25T00:00:00,Cell Survival,G04.299.316
23530041,2013-03-25T00:00:00,Gene Expression,G05.355.310
23530041,2013-03-25T00:00:00,Heart Ventricles,A07.541.560
23530041,2013-03-25T00:00:00,Lipid Metabolism,G03.495.520
23530041,2013-03-25T00:00:00,"Muscle, Skeletal",A02.633.567
23530041,2013-03-25T00:00:00,"Muscle, Skeletal",A10.690.552.500
23530041,2013-03-25T00:00:00,Myocardium,A02.633.580
23530041,2013-03-25T00:00:00,Myocardium,A07.541.704
23530041,2013-03-25T00:00:00,Myocardium,A10.690.552.750
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A11.620.500
23530041,2013-03-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23530041,2013-03-25T00:00:00,Sphingolipids,D10.570.877
23530041,2013-03-25T00:00:00,Sphingolipids,D10.808
23530041,2013-03-25T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
23530212,2013-03-25T00:00:00,Animals,B01.050
23530212,2013-03-25T00:00:00,Anoxia,C23.888.852.079
23530212,2013-03-25T00:00:00,Complement C3,D12.776.124.050.140
23530212,2013-03-25T00:00:00,Complement C3,D12.776.124.486.274.250
23530212,2013-03-25T00:00:00,Fibrosis,C23.550.355
23530212,2013-03-25T00:00:00,Graft Rejection,G12.425.901.545.328
23530212,2013-03-25T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23530212,2013-03-25T00:00:00,Microcirculation,G09.330.190.163.645
23530212,2013-03-25T00:00:00,Oxygen,D01.268.185.550
23530212,2013-03-25T00:00:00,Oxygen,D01.362.670
23530212,2013-03-25T00:00:00,Perfusion,E05.680
23530212,2013-03-25T00:00:00,Thrombin,D08.811.277.656.300.760.855
23530212,2013-03-25T00:00:00,Thrombin,D08.811.277.656.959.350.855
23530212,2013-03-25T00:00:00,Thrombin,D12.776.124.125.890
23530212,2013-03-25T00:00:00,Thrombin,D23.119.960
23541069,2013-03-26T00:00:00,"Adaptation, Psychological",F01.058
23541069,2013-03-26T00:00:00,Adolescent,M01.060.057
23541069,2013-03-26T00:00:00,Child,M01.060.406
23541069,2013-03-26T00:00:00,Cognitive Therapy,F04.754.137.428
23541069,2013-03-26T00:00:00,Depression,F01.145.126.350
23541069,2013-03-26T00:00:00,Disability Evaluation,E01.370.400
23541069,2013-03-26T00:00:00,Fibromyalgia,C05.651.324
23541069,2013-03-26T00:00:00,Fibromyalgia,C05.799.321
23541069,2013-03-26T00:00:00,Fibromyalgia,C10.668.491.425
23541069,2013-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23541069,2013-03-26T00:00:00,Pain Measurement,E01.370.376.550.600
23541069,2013-03-26T00:00:00,Psychiatric Status Rating Scales,F04.586
23541069,2013-03-26T00:00:00,Questionnaires,E05.318.308.750
23541069,2013-03-26T00:00:00,Questionnaires,L01.280.800
23541069,2013-03-26T00:00:00,Questionnaires,N05.715.360.300.695
23541069,2013-03-26T00:00:00,Questionnaires,N06.850.520.308.750
23541069,2013-03-26T00:00:00,Treatment Outcome,E01.789.800
23541069,2013-03-26T00:00:00,Treatment Outcome,N04.761.559.590.800
23541069,2013-03-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23537390,2013-03-28T00:00:00,Animals,B01.050
23537390,2013-03-28T00:00:00,Cell Cycle Proteins,D12.776.167
23537390,2013-03-28T00:00:00,Cilia,A11.284.180.165
23537390,2013-03-28T00:00:00,Fishes,B01.050.150.900.493
23537390,2013-03-28T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23537390,2013-03-28T00:00:00,Mutation,G05.365.590
23537390,2013-03-28T00:00:00,Phylogeny,G05.697
23537390,2013-03-28T00:00:00,Phylogeny,G16.100.275.605
23537390,2013-03-28T00:00:00,Phylogeny,L01.100.697
23537390,2013-03-28T00:00:00,Signal Transduction,G02.111.087.800
23537390,2013-03-28T00:00:00,Signal Transduction,G02.149.115.800
23537390,2013-03-28T00:00:00,Signal Transduction,G04.299.880
23537390,2013-03-28T00:00:00,Skull,A02.835.232.781
23541868,2013-03-28T00:00:00,Adult,M01.060.116
23541868,2013-03-28T00:00:00,Aged,M01.060.116.100
23541868,2013-03-28T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23541868,2013-03-28T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23541868,2013-03-28T00:00:00,Blood Transfusion,E02.095.135
23541868,2013-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23541868,2013-03-28T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23541868,2013-03-28T00:00:00,Middle Aged,M01.060.116.630
23624105,2013-03-30T00:00:00,Adult,M01.060.116
23624105,2013-03-30T00:00:00,Agriculture,J01.040
23624105,2013-03-30T00:00:00,Attitude to Health,F01.100.150
23624105,2013-03-30T00:00:00,Attitude to Health,N05.300.150
23624105,2013-03-30T00:00:00,Cellular Phone,L01.178.847.698.300
23624105,2013-03-30T00:00:00,Chronic Disease,C23.550.291.500
23624105,2013-03-30T00:00:00,Hispanic Americans,M01.686.754.441
23624105,2013-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23624105,2013-03-30T00:00:00,South Carolina,Z01.107.567.875.075.662
23624105,2013-03-30T00:00:00,South Carolina,Z01.107.567.875.750.700
23624105,2013-03-30T00:00:00,Telemedicine,H02.403.840
23624105,2013-03-30T00:00:00,Telemedicine,L01.178.847.652
23624105,2013-03-30T00:00:00,Telemedicine,N04.590.374.800
23624105,2013-03-30T00:00:00,Young Adult,M01.060.116.815
23097329,2013-04-01T00:00:00,Animals,B01.050
23097329,2013-04-01T00:00:00,Brain,A08.186.211
23097329,2013-04-01T00:00:00,Cell Differentiation,G04.299.151
23097329,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.140.079.545
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.140.380.278
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.662.262.249.750
23097329,2013-04-01T00:00:00,Huntington Disease,C10.574.500.497
23097329,2013-04-01T00:00:00,Huntington Disease,C16.320.400.430
23097329,2013-04-01T00:00:00,Huntington Disease,F03.087.250.400
23097329,2013-04-01T00:00:00,Huntington Disease,F03.087.400.390
23097329,2013-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23146924,2013-04-01T00:00:00,Adult,M01.060.116
23146924,2013-04-01T00:00:00,Aged,M01.060.116.100
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23146924,2013-04-01T00:00:00,"Diagnosis, Differential",E01.171
23146924,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C12.758.820.750
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C12.777.419.473
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
23146924,2013-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23146924,2013-04-01T00:00:00,Lung Neoplasms,C08.381.540
23146924,2013-04-01T00:00:00,Lung Neoplasms,C08.785.520
23146924,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C06.301.761
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C06.689.667
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C19.344.421
23146924,2013-04-01T00:00:00,Skin Neoplasms,C04.588.805
23146924,2013-04-01T00:00:00,Skin Neoplasms,C17.800.882
23299051,2013-04-01T00:00:00,Clinical Competence,I02.399.630.210
23299051,2013-04-01T00:00:00,Clinical Competence,N04.761.210
23299051,2013-04-01T00:00:00,Computer Simulation,L01.224.160
23299051,2013-04-01T00:00:00,Conscious Sedation,E03.250
23299051,2013-04-01T00:00:00,"Education, Medical",I02.358.399
23299051,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425984,2013-04-01T00:00:00,Academic Medical Centers,N02.278.020
23425984,2013-04-01T00:00:00,Biostatistics,E05.318.740.237
23425984,2013-04-01T00:00:00,Health Services Research,N03.349.380
23425984,2013-04-01T00:00:00,Health Services Research,N05.425
23425984,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425984,2013-04-01T00:00:00,Professional Competence,I02.399.630
23425984,2013-04-01T00:00:00,Professional Role,F01.829.316.616.625
23434896,2013-04-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23434896,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23434896,2013-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23434896,2013-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23470779,2013-04-01T00:00:00,Adolescent,M01.060.057
23470779,2013-04-01T00:00:00,Adult,M01.060.116
23470779,2013-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
23470779,2013-04-01T00:00:00,Blood Pressure,G09.330.380.076
23470779,2013-04-01T00:00:00,Child,M01.060.406
23470779,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23470779,2013-04-01T00:00:00,"Models, Genetic",E05.599.395.397
23470779,2013-04-01T00:00:00,Sex Factors,N05.715.350.675
23470779,2013-04-01T00:00:00,Sex Factors,N06.850.490.875
23470779,2013-04-01T00:00:00,Young Adult,M01.060.116.815
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
23474970,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23474970,2013-04-01T00:00:00,Liver Cirrhosis,C06.552.630
23474970,2013-04-01T00:00:00,Mental Disorders,F03
23474970,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23474970,2013-04-01T00:00:00,Sepsis,C01.539.757
23474970,2013-04-01T00:00:00,Sepsis,C23.550.470.790.500
23487599,2013-04-01T00:00:00,African Americans,M01.686.508.100.100
23487599,2013-04-01T00:00:00,African Americans,M01.686.754.100
23487599,2013-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
23487599,2013-04-01T00:00:00,Blood Pressure,G09.330.380.076
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.247.222.159
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.247.808.146
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.812.768.196
23487599,2013-04-01T00:00:00,Cholecalciferol,D10.570.938.146
23487599,2013-04-01T00:00:00,Dietary Supplements,J02.500.456
23487599,2013-04-01T00:00:00,Double-Blind Method,E05.318.780.300
23487599,2013-04-01T00:00:00,Double-Blind Method,E05.581.500.300
23487599,2013-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
23487599,2013-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
23487599,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23487599,2013-04-01T00:00:00,Hypertension,C14.907.489
23487599,2013-04-01T00:00:00,Treatment Outcome,E01.789.800
23487599,2013-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23487599,2013-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23521451,2013-04-01T00:00:00,Contrast Media,D27.720.259
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.370.050.200
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.370.380.200
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23521451,2013-04-01T00:00:00,Disease Progression,C23.550.291.656
23521451,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23521451,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23521451,2013-04-01T00:00:00,Regression Analysis,E05.318.740.750
23521451,2013-04-01T00:00:00,Regression Analysis,N05.715.360.750.695
23521451,2013-04-01T00:00:00,Regression Analysis,N06.850.520.830.750
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23522158,2013-04-01T00:00:00,Angioplasty,E02.148.050
23522158,2013-04-01T00:00:00,Angioplasty,E04.100.814.050
23522158,2013-04-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23522158,2013-04-01T00:00:00,Brain Ischemia,C14.907.253.092
23522158,2013-04-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
23522158,2013-04-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
23522158,2013-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
23522158,2013-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
23522158,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522158,2013-04-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
23522158,2013-04-01T00:00:00,Perfusion,E05.680
23522158,2013-04-01T00:00:00,Stents,E07.695.750
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.100.376.475
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.928.220.390
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.936.450.475
23522226,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522226,2013-04-01T00:00:00,Tissue Donors,M01.898
23522226,2013-04-01T00:00:00,Tissue and Organ Procurement,N02.421.911
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C04.557.665.560.260
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C04.700.305
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C16.320.700.305
23522414,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522414,2013-04-01T00:00:00,Skin Neoplasms,C04.588.805
23522414,2013-04-01T00:00:00,Skin Neoplasms,C17.800.882
23529880,2013-04-01T00:00:00,Adult,M01.060.116
23529880,2013-04-01T00:00:00,Aged,M01.060.116.100
23529880,2013-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23529880,2013-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23529880,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529880,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23529880,2013-04-01T00:00:00,Mouth Neoplasms,C04.588.443.591
23529880,2013-04-01T00:00:00,Mouth Neoplasms,C07.465.565
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
23529880,2013-04-01T00:00:00,SEER Program,E05.318.308.970.725
23529880,2013-04-01T00:00:00,SEER Program,L01.280.950.725
23529880,2013-04-01T00:00:00,SEER Program,N04.452.859.819.725
23529880,2013-04-01T00:00:00,SEER Program,N05.715.360.300.715.700.725
23529880,2013-04-01T00:00:00,SEER Program,N06.850.520.308.970.725
23529880,2013-04-01T00:00:00,United States,Z01.107.567.875
23529880,2013-04-01T00:00:00,Young Adult,M01.060.116.815
23531954,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531954,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531954,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531954,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23531954,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23531957,2013-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23531957,2013-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
23531957,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531957,2013-04-01T00:00:00,Oral Health,N01.400.535
23531957,2013-04-01T00:00:00,Periodontal Diseases,C07.465.714
23531958,2013-04-01T00:00:00,Glucocorticoids,D06.472.040.543
23531958,2013-04-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23531958,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531958,2013-04-01T00:00:00,Hyperglycemia,C18.452.394.952
23531958,2013-04-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23531958,2013-04-01T00:00:00,Incidence,E05.318.308.985.525.375
23531958,2013-04-01T00:00:00,Incidence,L01.280.975.525.375
23531958,2013-04-01T00:00:00,Incidence,N01.224.935.597.500
23531958,2013-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23531958,2013-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23531960,2013-04-01T00:00:00,Anti-Obesity Agents,D27.505.954.427.140
23531960,2013-04-01T00:00:00,Benzazepines,D03.438.079
23531960,2013-04-01T00:00:00,Fructose,D09.546.359.250
23531960,2013-04-01T00:00:00,Fructose,D09.546.465.354
23531960,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531960,2013-04-01T00:00:00,Obesity,C18.654.726.500
23531960,2013-04-01T00:00:00,Obesity,C23.888.144.699.500
23531960,2013-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23531960,2013-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23531960,2013-04-01T00:00:00,Phentermine,D02.092.471.683.152.766
23531961,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531961,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531961,2013-04-01T00:00:00,Exercise,G11.427.590.237
23531961,2013-04-01T00:00:00,Exercise,I03.350
23531961,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531961,2013-04-01T00:00:00,Hypertension,C14.907.489
23531961,2013-04-01T00:00:00,Telemedicine,H02.403.840
23531961,2013-04-01T00:00:00,Telemedicine,L01.178.847.652
23531961,2013-04-01T00:00:00,Telemedicine,N04.590.374.800
23531961,2013-04-01T00:00:00,Weight Loss,C23.888.144.243.963
23531961,2013-04-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23531962,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531962,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531962,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531962,2013-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23531962,2013-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23531962,2013-04-01T00:00:00,Primary Health Care,N04.590.233.727
23531962,2013-04-01T00:00:00,Regional Medical Programs,N03.349.650.400
23531962,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23531962,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23558419,2013-04-01T00:00:00,Adult,M01.060.116
23558419,2013-04-01T00:00:00,Aged,M01.060.116.100
23558419,2013-04-01T00:00:00,Colonic Polyps,C23.300.825.411.235
23558419,2013-04-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
23558419,2013-04-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
23558419,2013-04-01T00:00:00,Colonoscopy,E04.210.240.250.160
23558419,2013-04-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
23558419,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23558419,2013-04-01T00:00:00,Mental Recall,F02.463.425.540.641
23558419,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23558419,2013-04-01T00:00:00,Pilot Projects,E05.318.760.750
23558419,2013-04-01T00:00:00,Pilot Projects,E05.337.737
23558419,2013-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
23558419,2013-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
23558419,2013-04-01T00:00:00,Poisson Distribution,E05.318.740.994.750
23558419,2013-04-01T00:00:00,Poisson Distribution,G17.820.750
23558419,2013-04-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
23558419,2013-04-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
23558419,2013-04-01T00:00:00,Questionnaires,E05.318.308.750
23558419,2013-04-01T00:00:00,Questionnaires,L01.280.800
23558419,2013-04-01T00:00:00,Questionnaires,N05.715.360.300.695
23558419,2013-04-01T00:00:00,Questionnaires,N06.850.520.308.750
23558419,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23558419,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23575132,2013-04-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
23575132,2013-04-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
23575132,2013-04-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
23575132,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23575132,2013-04-01T00:00:00,Infant,M01.060.703
23575132,2013-04-01T00:00:00,Infant Food,J02.500.525.500
23575132,2013-04-01T00:00:00,Meat Products,J02.500.600.500
23575132,2013-04-01T00:00:00,Temperature,G01.906.595
23575132,2013-04-01T00:00:00,Temperature,G16.500.275.063.725.710
23575132,2013-04-01T00:00:00,Temperature,G16.500.750.775.710
23575132,2013-04-01T00:00:00,Temperature,N06.230.150.450
23575132,2013-04-01T00:00:00,Temperature,N06.230.300.100.725.710
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D08.811.520.650.200.040
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D23.946.123.946.040
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D23.946.896.980.040
23581466,2013-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
23581466,2013-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23581466,2013-04-01T00:00:00,Animals,B01.050
23581466,2013-04-01T00:00:00,Calcium,D01.268.552.100
23581466,2013-04-01T00:00:00,Calcium,D01.552.539.288
23581466,2013-04-01T00:00:00,Calcium,D23.119.100
23581466,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23581466,2013-04-01T00:00:00,"Models, Molecular",E05.599.595
23581466,2013-04-01T00:00:00,Peptides,D12.644
23581466,2013-04-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23691683,2013-04-01T00:00:00,General Surgery,H02.403.810.300
23691683,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23691683,2013-04-01T00:00:00,Leadership,F01.752.609
23691683,2013-04-01T00:00:00,United States,Z01.107.567.875
23562653,2013-04-03T00:00:00,Animals,B01.050
23562653,2013-04-03T00:00:00,Apoptosis,G04.299.139.160
23562653,2013-04-03T00:00:00,Cell Proliferation,G04.299.233.750
23562653,2013-04-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23562653,2013-04-03T00:00:00,Cell Survival,G04.299.316
23562653,2013-04-03T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23562653,2013-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23562653,2013-04-03T00:00:00,MicroRNAs,D13.150.650.319
23562653,2013-04-03T00:00:00,MicroRNAs,D13.444.735.150.319
23562653,2013-04-03T00:00:00,MicroRNAs,D13.444.735.790.099
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23562653,2013-04-03T00:00:00,Plasmids,G05.360.600
23562653,2013-04-03T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
23562653,2013-04-03T00:00:00,Telomerase,D12.776.157.725.500.921
23562653,2013-04-03T00:00:00,Telomerase,D12.776.664.962.500.921
23559082,2013-04-04T00:00:00,Adult,M01.060.116
23559082,2013-04-04T00:00:00,Calcium,D01.268.552.100
23559082,2013-04-04T00:00:00,Calcium,D01.552.539.288
23559082,2013-04-04T00:00:00,Calcium,D23.119.100
23559082,2013-04-04T00:00:00,Dietary Supplements,J02.500.456
23559082,2013-04-04T00:00:00,Double-Blind Method,E05.318.780.300
23559082,2013-04-04T00:00:00,Double-Blind Method,E05.581.500.300
23559082,2013-04-04T00:00:00,Double-Blind Method,N05.715.360.780.320
23559082,2013-04-04T00:00:00,Double-Blind Method,N06.850.520.445.300
23559082,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23559082,2013-04-04T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23559082,2013-04-04T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23559082,2013-04-04T00:00:00,Parathyroid Hormone,D06.472.699.590
23559082,2013-04-04T00:00:00,Parathyroid Hormone,D12.644.548.587
23559082,2013-04-04T00:00:00,Pregnancy,G08.686.785.760.769
23559082,2013-04-04T00:00:00,Vitamin D,D04.808.812.768
23559082,2013-04-04T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23608249,2013-04-04T00:00:00,Aged,M01.060.116.100
23608249,2013-04-04T00:00:00,Biological Markers,D23.101
23608249,2013-04-04T00:00:00,Blood Glucose,D09.546.359.448.500
23608249,2013-04-04T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23608249,2013-04-04T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23608249,2013-04-04T00:00:00,Diabetic Angiopathies,C14.907.320
23608249,2013-04-04T00:00:00,Diabetic Angiopathies,C19.246.099.500
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
23608249,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608249,2013-04-04T00:00:00,Hypoglycemic Agents,D27.505.696.422
23608249,2013-04-04T00:00:00,Incidence,E05.318.308.985.525.375
23608249,2013-04-04T00:00:00,Incidence,L01.280.975.525.375
23608249,2013-04-04T00:00:00,Incidence,N01.224.935.597.500
23608249,2013-04-04T00:00:00,Incidence,N06.850.505.400.975.525.375
23608249,2013-04-04T00:00:00,Incidence,N06.850.520.308.985.525.375
23608249,2013-04-04T00:00:00,Middle Aged,M01.060.116.630
23608249,2013-04-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
23608249,2013-04-04T00:00:00,Risk Assessment,N04.452.871.715
23608249,2013-04-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23608249,2013-04-04T00:00:00,Risk Assessment,N06.850.505.715
23608249,2013-04-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23608249,2013-04-04T00:00:00,Risk Factors,E05.318.740.600.800.725
23608249,2013-04-04T00:00:00,Risk Factors,N05.715.350.200.700
23608249,2013-04-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23608249,2013-04-04T00:00:00,Risk Factors,N06.850.490.625.750
23608249,2013-04-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23608249,2013-04-04T00:00:00,Time Factors,G01.910.857
23608249,2013-04-04T00:00:00,United States,Z01.107.567.875
23608249,2013-04-04T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23608249,2013-04-04T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23608249,2013-04-04T00:00:00,Vitamin D,D04.808.812.768
23608249,2013-04-04T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23557538,2013-04-05T00:00:00,Adult,M01.060.116
23557538,2013-04-05T00:00:00,African Americans,M01.686.508.100.100
23557538,2013-04-05T00:00:00,African Americans,M01.686.754.100
23557538,2013-04-05T00:00:00,Aged,M01.060.116.100
23557538,2013-04-05T00:00:00,Chronic Periodontitis,C07.465.714.533.324
23557538,2013-04-05T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23557538,2013-04-05T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23557538,2013-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23557538,2013-04-05T00:00:00,Hypertension,C14.907.489
23557538,2013-04-05T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23557538,2013-04-05T00:00:00,Metabolic Syndrome X,C18.452.625
23557538,2013-04-05T00:00:00,Middle Aged,M01.060.116.630
23557538,2013-04-05T00:00:00,Obesity,C18.654.726.500
23557538,2013-04-05T00:00:00,Obesity,C23.888.144.699.500
23557538,2013-04-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23557538,2013-04-05T00:00:00,Obesity,G07.100.100.160.120.699.500
23557538,2013-04-05T00:00:00,Regression Analysis,E05.318.740.750
23557538,2013-04-05T00:00:00,Regression Analysis,N05.715.360.750.695
23557538,2013-04-05T00:00:00,Regression Analysis,N06.850.520.830.750
23557538,2013-04-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23557538,2013-04-05T00:00:00,Risk Factors,N05.715.350.200.700
23557538,2013-04-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23557538,2013-04-05T00:00:00,Risk Factors,N06.850.490.625.750
23557538,2013-04-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23557538,2013-04-05T00:00:00,United States,Z01.107.567.875
23566636,2013-04-06T00:00:00,Adult,M01.060.116
23566636,2013-04-06T00:00:00,Aged,M01.060.116.100
23566636,2013-04-06T00:00:00,Brain Ischemia,C10.228.140.300.150
23566636,2013-04-06T00:00:00,Brain Ischemia,C14.907.253.092
23566636,2013-04-06T00:00:00,Double-Blind Method,E05.318.780.300
23566636,2013-04-06T00:00:00,Double-Blind Method,E05.581.500.300
23566636,2013-04-06T00:00:00,Double-Blind Method,N05.715.360.780.320
23566636,2013-04-06T00:00:00,Double-Blind Method,N06.850.520.445.300
23566636,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23566636,2013-04-06T00:00:00,Middle Aged,M01.060.116.630
23566636,2013-04-06T00:00:00,Stroke,C10.228.140.300.775
23566636,2013-04-06T00:00:00,Stroke,C14.907.253.855
23566636,2013-04-06T00:00:00,Treatment Outcome,E01.789.800
23566636,2013-04-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23566636,2013-04-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23566636,2013-04-06T00:00:00,Vitamin B Complex,D27.505.696.377.605.600.708
23570694,2013-04-09T00:00:00,Biomedical Research,H01.770.644.145
23570694,2013-04-09T00:00:00,Evidence-Based Medicine,H02.249.750
23570694,2013-04-09T00:00:00,Evidence-Based Medicine,H02.403.200.400
23570694,2013-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23570694,2013-04-09T00:00:00,Medical Oncology,H02.403.429.515
23570694,2013-04-09T00:00:00,Neoplasms,C04
23570694,2013-04-09T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23570694,2013-04-09T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23570694,2013-04-09T00:00:00,Risk Assessment,E05.318.740.600.800.715
23570694,2013-04-09T00:00:00,Risk Assessment,N04.452.871.715
23570694,2013-04-09T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23570694,2013-04-09T00:00:00,Risk Assessment,N06.850.505.715
23570694,2013-04-09T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23570694,2013-04-09T00:00:00,Smoking,F01.145.466.753
23570694,2013-04-09T00:00:00,Smoking Cessation,F01.145.940.700
23570694,2013-04-09T00:00:00,United States,Z01.107.567.875
23572575,2013-04-09T00:00:00,Animals,B01.050
23572575,2013-04-09T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23572575,2013-04-09T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23572575,2013-04-09T00:00:00,Fibroblasts,A11.329.228
23572575,2013-04-09T00:00:00,Fibroblasts,A11.872.228
23572575,2013-04-09T00:00:00,Gastrointestinal Tract,A03.556
23572575,2013-04-09T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
23572575,2013-04-09T00:00:00,Homeostasis,G07.700.360
23572575,2013-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23572575,2013-04-09T00:00:00,Membrane Glycoproteins,D12.776.395.550
23572575,2013-04-09T00:00:00,Membrane Glycoproteins,D12.776.543.550
23572575,2013-04-09T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
23572575,2013-04-09T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
23572575,2013-04-09T00:00:00,Molecular Chaperones,D12.776.580
23572575,2013-04-09T00:00:00,Plasmids,G05.360.600
23576578,2013-04-10T00:00:00,Angiotensin II,D06.472.699.094.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.400.070.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.456.073.041
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.548.058.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.776.641.650.070.078
23576578,2013-04-10T00:00:00,Angiotensin II,D23.469.050.050.050
23576578,2013-04-10T00:00:00,Animals,B01.050
23576578,2013-04-10T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23576578,2013-04-10T00:00:00,Arrestins,D12.776.306.090
23576578,2013-04-10T00:00:00,Arrestins,D12.776.543.090
23576578,2013-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
23576578,2013-04-10T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.260.600
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.660.600
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.930.600
23576578,2013-04-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23576578,2013-04-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
23578931,2013-04-11T00:00:00,Animals,B01.050
23578931,2013-04-11T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23578931,2013-04-11T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23578931,2013-04-11T00:00:00,Cell Movement,G04.299.283
23578931,2013-04-11T00:00:00,Cell Movement,G07.700.560.500.180
23578931,2013-04-11T00:00:00,Endothelial Cells,A11.436.275
23578931,2013-04-11T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23578931,2013-04-11T00:00:00,Heart Valves,A07.541.510
23578931,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23578931,2013-04-11T00:00:00,MicroRNAs,D13.150.650.319
23578931,2013-04-11T00:00:00,MicroRNAs,D13.444.735.150.319
23578931,2013-04-11T00:00:00,MicroRNAs,D13.444.735.790.099
23578931,2013-04-11T00:00:00,RNA-Binding Proteins,D12.776.157.725
23578931,2013-04-11T00:00:00,RNA-Binding Proteins,D12.776.664.962
23578931,2013-04-11T00:00:00,Time Factors,G01.910.857
23578931,2013-04-11T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23578931,2013-04-11T00:00:00,Zebrafish Proteins,D12.776.325.500
23582638,2013-04-11T00:00:00,Adenoviridae,B04.280.030
23582638,2013-04-11T00:00:00,Adenoviridae,B04.909.204.097
23582638,2013-04-11T00:00:00,Adult,M01.060.116
23582638,2013-04-11T00:00:00,Drug Carriers,D26.255.260
23582638,2013-04-11T00:00:00,Drug Carriers,D27.720.280.260
23582638,2013-04-11T00:00:00,Drug Carriers,E02.319.300.380
23582638,2013-04-11T00:00:00,"Genes, Immunoglobulin",G05.360.340.024.340.335
23582638,2013-04-11T00:00:00,"Genes, Immunoglobulin",G12.500.299
23582638,2013-04-11T00:00:00,Genetic Vectors,G05.360.337
23582638,2013-04-11T00:00:00,HIV Infections,C02.782.815.616.400
23582638,2013-04-11T00:00:00,HIV Infections,C02.800.801.400
23582638,2013-04-11T00:00:00,HIV Infections,C20.673.480
23582638,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23582638,2013-04-11T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23582638,2013-04-11T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23582638,2013-04-11T00:00:00,"Receptors, IgG",D23.101.100.110.695
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D12.776.828.868
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D20.215.894.865
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D23.050.865
23583651,2013-04-11T00:00:00,"Adaptation, Physiological",G07.700.062
23583651,2013-04-11T00:00:00,"Adaptation, Physiological",G16.100.057.500
23583651,2013-04-11T00:00:00,Animals,B01.050
23583651,2013-04-11T00:00:00,Anoxia,C23.888.852.079
23583651,2013-04-11T00:00:00,Case-Control Studies,E05.318.760.500.500
23583651,2013-04-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23583651,2013-04-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23583651,2013-04-11T00:00:00,Chronic Disease,C23.550.291.500
23583651,2013-04-11T00:00:00,Disease Progression,C23.550.291.656
23583651,2013-04-11T00:00:00,Down-Regulation,G02.111.087.225
23583651,2013-04-11T00:00:00,Down-Regulation,G02.149.115.225
23583651,2013-04-11T00:00:00,Down-Regulation,G05.355.315.200
23583651,2013-04-11T00:00:00,Down-Regulation,G07.690.812.230
23583651,2013-04-11T00:00:00,Down-Regulation,G07.700.680.230
23583651,2013-04-11T00:00:00,Endothelial Cells,A11.436.275
23583651,2013-04-11T00:00:00,"Endothelium, Vascular",A07.231.330
23583651,2013-04-11T00:00:00,"Endothelium, Vascular",A10.272.491.355
23583651,2013-04-11T00:00:00,Gene Expression Regulation,G05.355.315
23583651,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23583651,2013-04-11T00:00:00,"Hypertension, Pulmonary",C08.381.423
23583651,2013-04-11T00:00:00,Lung,A04.411
23583651,2013-04-11T00:00:00,"RNA, Messenger",D13.444.735.544
23583651,2013-04-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23583651,2013-04-11T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23583651,2013-04-11T00:00:00,"Scleroderma, Systemic",C17.300.799
23583651,2013-04-11T00:00:00,"Scleroderma, Systemic",C17.800.784
23587964,2013-04-12T00:00:00,Biotechnology,H01.158.550
23587964,2013-04-12T00:00:00,Biotechnology,J01.897.120
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.200.200
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.362.150
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.650.550.200
23587964,2013-04-12T00:00:00,Methane,D02.455.326.146.571
23583978,2013-04-14T00:00:00,African Americans,M01.686.508.100.100
23583978,2013-04-14T00:00:00,African Americans,M01.686.754.100
23583978,2013-04-14T00:00:00,Body Mass Index,E01.370.600.115.100.125
23583978,2013-04-14T00:00:00,Body Mass Index,E05.041.124.125
23583978,2013-04-14T00:00:00,Body Mass Index,G07.100.100.125
23583978,2013-04-14T00:00:00,Body Mass Index,N06.850.505.200.100.175
23583978,2013-04-14T00:00:00,Case-Control Studies,E05.318.760.500.500
23583978,2013-04-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23583978,2013-04-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23583978,2013-04-14T00:00:00,Genetic Loci,G05.360.340.024.380
23583978,2013-04-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23583978,2013-04-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.318.416.249
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.318.780.392
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.385.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.522.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23583978,2013-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23583978,2013-04-14T00:00:00,Linkage Disequilibrium,G05.540.500
23583978,2013-04-14T00:00:00,Obesity,C18.654.726.500
23583978,2013-04-14T00:00:00,Obesity,C23.888.144.699.500
23583978,2013-04-14T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23583978,2013-04-14T00:00:00,Obesity,G07.100.100.160.120.699.500
23583978,2013-04-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23669539,2013-04-15T00:00:00,Animals,B01.050
23669539,2013-04-15T00:00:00,"Immunity, Innate",G12.450.575
23669539,2013-04-15T00:00:00,"Models, Statistical",E05.318.740.500
23669539,2013-04-15T00:00:00,"Models, Statistical",E05.599.835
23669539,2013-04-15T00:00:00,"Models, Statistical",N05.715.360.750.530
23669539,2013-04-15T00:00:00,"Models, Statistical",N06.850.520.830.500
23669539,2013-04-15T00:00:00,Phylogeny,G05.697
23669539,2013-04-15T00:00:00,Phylogeny,G16.100.275.605
23669539,2013-04-15T00:00:00,Phylogeny,L01.100.697
23669539,2013-04-15T00:00:00,Regression Analysis,E05.318.740.750
23669539,2013-04-15T00:00:00,Regression Analysis,N05.715.360.750.695
23669539,2013-04-15T00:00:00,Regression Analysis,N06.850.520.830.750
23591789,2013-04-16T00:00:00,Adolescent,M01.060.057
23591789,2013-04-16T00:00:00,Adult,M01.060.116
23591789,2013-04-16T00:00:00,Aminoglycosides,D09.408.051
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23591789,2013-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23591789,2013-04-16T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23591789,2013-04-16T00:00:00,Middle Aged,M01.060.116.630
23597371,2013-04-18T00:00:00,Biomedical Research,H01.770.644.145
23597371,2013-04-18T00:00:00,Cardiovascular Diseases,C14
23597371,2013-04-18T00:00:00,Evidence-Based Medicine,H02.249.750
23597371,2013-04-18T00:00:00,Evidence-Based Medicine,H02.403.200.400
23597371,2013-04-18T00:00:00,Health Policy,I01.880.604.825.608.400
23597371,2013-04-18T00:00:00,Health Policy,N03.706.825.608.428
23597371,2013-04-18T00:00:00,Health Promotion,N02.370
23597371,2013-04-18T00:00:00,Health Promotion,N02.421.726.507
23597371,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597371,2013-04-18T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
23597371,2013-04-18T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
23597371,2013-04-18T00:00:00,Risk Factors,E05.318.740.600.800.725
23597371,2013-04-18T00:00:00,Risk Factors,N05.715.350.200.700
23597371,2013-04-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23597371,2013-04-18T00:00:00,Risk Factors,N06.850.490.625.750
23597371,2013-04-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23597371,2013-04-18T00:00:00,Rural Population,N01.600.725
23597371,2013-04-18T00:00:00,United States,Z01.107.567.875
23598275,2013-04-18T00:00:00,Hospitalization,E02.760.400
23598275,2013-04-18T00:00:00,Hospitalization,N02.421.585.400
23598275,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23598275,2013-04-18T00:00:00,Myocardial Infarction,C14.280.647.500
23598275,2013-04-18T00:00:00,Myocardial Infarction,C14.907.585.500
23598275,2013-04-18T00:00:00,Myocardial Reperfusion,E04.100.700.600
23598275,2013-04-18T00:00:00,Myocardial Reperfusion,E05.680.730.600
23598275,2013-04-18T00:00:00,Time Factors,G01.910.857
23601571,2013-04-22T00:00:00,Adolescent,M01.060.057
23601571,2013-04-22T00:00:00,Child,M01.060.406
23601571,2013-04-22T00:00:00,"Child, Preschool",M01.060.406.448
23601571,2013-04-22T00:00:00,Diet,E05.272
23601571,2013-04-22T00:00:00,Diet,G07.610.240
23601571,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23601571,2013-04-22T00:00:00,Life Style,F01.829.458
23601571,2013-04-22T00:00:00,Obesity,C18.654.726.500
23601571,2013-04-22T00:00:00,Obesity,C23.888.144.699.500
23601571,2013-04-22T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23601571,2013-04-22T00:00:00,Obesity,G07.100.100.160.120.699.500
23601571,2013-04-22T00:00:00,Risk Factors,E05.318.740.600.800.725
23601571,2013-04-22T00:00:00,Risk Factors,N05.715.350.200.700
23601571,2013-04-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23601571,2013-04-22T00:00:00,Risk Factors,N06.850.490.625.750
23601571,2013-04-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23601571,2013-04-22T00:00:00,Social Environment,I01.880.656
23608661,2013-04-22T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23608661,2013-04-22T00:00:00,Blood Pressure,E01.370.600.875.249
23608661,2013-04-22T00:00:00,Blood Pressure,G09.330.380.076
23608661,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608661,2013-04-22T00:00:00,Hypertension,C14.907.489
23608661,2013-04-22T00:00:00,Life Style,F01.829.458
23608661,2013-04-22T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23608661,2013-04-22T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23608661,2013-04-22T00:00:00,United States,Z01.107.567.875
23613330,2013-04-23T00:00:00,Adult,M01.060.116
23613330,2013-04-23T00:00:00,Aged,M01.060.116.100
23613330,2013-04-23T00:00:00,Ankle Joint,A02.835.583.378.062
23613330,2013-04-23T00:00:00,Bone Nails,E07.695.120
23613330,2013-04-23T00:00:00,Bone Nails,E07.858.442.660.100
23613330,2013-04-23T00:00:00,Bone Nails,E07.858.690.650.100
23613330,2013-04-23T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
23613330,2013-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23613330,2013-04-23T00:00:00,Joint Diseases,C05.550
23613330,2013-04-23T00:00:00,Middle Aged,M01.060.116.630
23613330,2013-04-23T00:00:00,Postoperative Complications,C23.550.767
23613330,2013-04-23T00:00:00,Quality of Life,I01.800
23613330,2013-04-23T00:00:00,Quality of Life,K01.752.400.750
23616168,2013-04-24T00:00:00,Adolescent,M01.060.057
23616168,2013-04-24T00:00:00,Adult,M01.060.116
23616168,2013-04-24T00:00:00,African Continental Ancestry Group,M01.686.508.100
23616168,2013-04-24T00:00:00,Age of Onset,N05.715.350.075.100
23616168,2013-04-24T00:00:00,Age of Onset,N06.850.490.250.100
23616168,2013-04-24T00:00:00,Aged,M01.060.116.100
23616168,2013-04-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
23616168,2013-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23616168,2013-04-24T00:00:00,Hypertension,C14.907.489
23616168,2013-04-24T00:00:00,Incidence,E05.318.308.985.525.375
23616168,2013-04-24T00:00:00,Incidence,L01.280.975.525.375
23616168,2013-04-24T00:00:00,Incidence,N01.224.935.597.500
23616168,2013-04-24T00:00:00,Incidence,N06.850.505.400.975.525.375
23616168,2013-04-24T00:00:00,Incidence,N06.850.520.308.985.525.375
23616168,2013-04-24T00:00:00,Life Style,F01.829.458
23616168,2013-04-24T00:00:00,Middle Aged,M01.060.116.630
23616168,2013-04-24T00:00:00,Motor Activity,F01.145.632
23616168,2013-04-24T00:00:00,Motor Activity,G11.427.590.530.698
23616168,2013-04-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23616168,2013-04-24T00:00:00,Risk Factors,N05.715.350.200.700
23616168,2013-04-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23616168,2013-04-24T00:00:00,Risk Factors,N06.850.490.625.750
23616168,2013-04-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23616168,2013-04-24T00:00:00,Stroke,C10.228.140.300.775
23616168,2013-04-24T00:00:00,Stroke,C14.907.253.855
23616168,2013-04-24T00:00:00,Young Adult,M01.060.116.815
23616555,2013-04-24T00:00:00,Animals,B01.050
23616555,2013-04-24T00:00:00,Avoidance Learning,F02.463.425.097
23616555,2013-04-24T00:00:00,Cocaine,D02.145.074.722.388
23616555,2013-04-24T00:00:00,Cocaine,D03.132.889.354
23616555,2013-04-24T00:00:00,Cocaine,D03.605.869.388
23616555,2013-04-24T00:00:00,Cocaine,D04.075.080.875.099.722.388
23616555,2013-04-24T00:00:00,"Conditioning, Operant",F02.463.425.179.509
23616555,2013-04-24T00:00:00,Dopamine,D02.092.211.215.311.342
23616555,2013-04-24T00:00:00,Dopamine,D02.092.311.342
23616555,2013-04-24T00:00:00,Habenula,A08.186.211.464.200.360
23616555,2013-04-24T00:00:00,Habenula,A08.186.211.730.317.200.360
23616555,2013-04-24T00:00:00,Mesencephalon,A08.186.211.132.659
23616555,2013-04-24T00:00:00,Mesencephalon,A08.186.211.653
23616555,2013-04-24T00:00:00,Neural Pathways,A08.612
23616555,2013-04-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23616555,2013-04-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23616602,2013-04-24T00:00:00,Adult,M01.060.116
23616602,2013-04-24T00:00:00,Cost of Illness,I01.137
23616602,2013-04-24T00:00:00,Cost of Illness,N03.219.151.165
23616602,2013-04-24T00:00:00,Forecasting,I01.320
23616602,2013-04-24T00:00:00,Heart Failure,C14.280.434
23616602,2013-04-24T00:00:00,Hospitalization,E02.760.400
23616602,2013-04-24T00:00:00,Hospitalization,N02.421.585.400
23616602,2013-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23616602,2013-04-24T00:00:00,Income,N01.824.417
23616602,2013-04-24T00:00:00,Patient Care Team,N04.590.715
23616602,2013-04-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23616602,2013-04-24T00:00:00,Risk Factors,N05.715.350.200.700
23616602,2013-04-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23616602,2013-04-24T00:00:00,Risk Factors,N06.850.490.625.750
23616602,2013-04-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23616602,2013-04-24T00:00:00,Terminal Care,E02.760.905
23616602,2013-04-24T00:00:00,Terminal Care,N02.421.585.905
23616602,2013-04-24T00:00:00,United States,Z01.107.567.875
23683959,2013-04-24T00:00:00,Plutonium,D01.268.033.700
23683959,2013-04-24T00:00:00,Plutonium,D01.268.271.100.700
23683959,2013-04-24T00:00:00,Plutonium,D01.268.556.700
23683959,2013-04-24T00:00:00,Plutonium,D01.552.020.734
23683959,2013-04-24T00:00:00,Plutonium,D01.552.544.700
23683959,2013-04-24T00:00:00,Quartz,D01.578.750.600
23683959,2013-04-24T00:00:00,Quartz,D01.650.550.825.600
23683959,2013-04-24T00:00:00,Quartz,D01.837.725.600
23683959,2013-04-24T00:00:00,Time Factors,G01.910.857
23620586,2013-04-25T00:00:00,Cell Cycle Proteins,D12.776.167
23620586,2013-04-25T00:00:00,Ceramides,D02.065.313
23620586,2013-04-25T00:00:00,Ceramides,D09.400.410.420.525.200
23620586,2013-04-25T00:00:00,Ceramides,D10.390.470.675.200
23620586,2013-04-25T00:00:00,Ceramides,D10.570.877.360.612.200
23620586,2013-04-25T00:00:00,Lipid Metabolism,G03.495.520
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D12.644.360.583
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D12.776.476.561
23620586,2013-04-25T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
23387998,2013-04-26T00:00:00,Micelles,D05.374
23387998,2013-04-26T00:00:00,Micelles,D26.255.560
23387998,2013-04-26T00:00:00,Micelles,D27.720.280.560
23387998,2013-04-26T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23387998,2013-04-26T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23387998,2013-04-26T00:00:00,Nanoparticles,J01.637.512.600
23387998,2013-04-26T00:00:00,Oxides,D01.248.497.158.685
23387998,2013-04-26T00:00:00,Oxides,D01.650.550
23387998,2013-04-26T00:00:00,Surface Properties,G02.842.850
23622112,2013-04-26T00:00:00,Fruit,A18.024.500
23622112,2013-04-26T00:00:00,Fruit,J02.500.562
23622112,2013-04-26T00:00:00,Insulin,D06.472.699.587.740.625
23622112,2013-04-26T00:00:00,Insulin,D12.644.548.586.740.625
23622112,2013-04-26T00:00:00,Nanotechnology,H01.603
23622112,2013-04-26T00:00:00,Nanotechnology,J01.897.520.600
23622112,2013-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
23622112,2013-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
23622112,2013-04-26T00:00:00,Water,D01.455.900
23622112,2013-04-26T00:00:00,Water,D01.650.550.925
23731521,2013-04-26T00:00:00,Adult,M01.060.116
23731521,2013-04-26T00:00:00,Civil Defense,I01.451.227
23731521,2013-04-26T00:00:00,Clinical Competence,I02.399.630.210
23731521,2013-04-26T00:00:00,Clinical Competence,N04.761.210
23731521,2013-04-26T00:00:00,Competency-Based Education,I02.158.210
23731521,2013-04-26T00:00:00,Computer Simulation,L01.224.160
23731521,2013-04-26T00:00:00,Disaster Planning,N06.230.100.035
23731521,2013-04-26T00:00:00,Health Personnel,M01.526.485
23731521,2013-04-26T00:00:00,Health Personnel,N02.360
23731521,2013-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23731521,2013-04-26T00:00:00,Middle Aged,M01.060.116.630
23731521,2013-04-26T00:00:00,"Models, Educational",E05.599.545
23731521,2013-04-26T00:00:00,"Models, Educational",I02.903.302
23731521,2013-04-26T00:00:00,Patient Care Team,N04.590.715
23731521,2013-04-26T00:00:00,Patient Simulation,I02.903.525
23731521,2013-04-26T00:00:00,South Carolina,Z01.107.567.875.075.662
23731521,2013-04-26T00:00:00,South Carolina,Z01.107.567.875.750.700
23731521,2013-04-26T00:00:00,United States,Z01.107.567.875
23411743,2013-04-27T00:00:00,Adult,M01.060.116
23411743,2013-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23411743,2013-04-27T00:00:00,Insulin,D06.472.699.587.740.625
23411743,2013-04-27T00:00:00,Insulin,D12.644.548.586.740.625
23411743,2013-04-27T00:00:00,Islets of Langerhans Transplantation,E04.270.550
23411743,2013-04-27T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
23411743,2013-04-27T00:00:00,Middle Aged,M01.060.116.630
23411743,2013-04-27T00:00:00,"Pain, Intractable",C10.597.617.788
23411743,2013-04-27T00:00:00,"Pain, Intractable",C23.888.592.612.776
23411743,2013-04-27T00:00:00,"Pain, Intractable",C23.888.646.515
23411743,2013-04-27T00:00:00,Pancreatectomy,E04.210.752
23411743,2013-04-27T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
23411743,2013-04-27T00:00:00,Reoperation,E04.690
23411743,2013-04-27T00:00:00,Tissue and Organ Harvesting,E01.450.865.820
23411743,2013-04-27T00:00:00,Tissue and Organ Harvesting,E04.932
23411743,2013-04-27T00:00:00,Treatment Outcome,E01.789.800
23411743,2013-04-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23411743,2013-04-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23642506,2013-04-30T00:00:00,Aged,M01.060.116.100
23642506,2013-04-30T00:00:00,Angina Pectoris,C14.280.647.187
23642506,2013-04-30T00:00:00,Angina Pectoris,C14.907.585.187
23642506,2013-04-30T00:00:00,Angina Pectoris,C23.888.646.215.500
23642506,2013-04-30T00:00:00,Body Mass Index,E01.370.600.115.100.125
23642506,2013-04-30T00:00:00,Body Mass Index,E05.041.124.125
23642506,2013-04-30T00:00:00,Body Mass Index,G07.100.100.125
23642506,2013-04-30T00:00:00,Body Mass Index,N06.850.505.200.100.175
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.370.050.200
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.370.380.200
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23642506,2013-04-30T00:00:00,Coronary Stenosis,C14.280.647.250.285
23642506,2013-04-30T00:00:00,Coronary Stenosis,C14.907.585.250.285
23642506,2013-04-30T00:00:00,Coronary Vessels,A07.231.114.269
23642506,2013-04-30T00:00:00,Coronary Vessels,A07.231.908.194
23642506,2013-04-30T00:00:00,Heart Failure,C14.280.434
23642506,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23642506,2013-04-30T00:00:00,Lipids,D10
23642506,2013-04-30T00:00:00,Middle Aged,M01.060.116.630
23642506,2013-04-30T00:00:00,Myocardial Infarction,C14.280.647.500
23642506,2013-04-30T00:00:00,Myocardial Infarction,C14.907.585.500
23642506,2013-04-30T00:00:00,Myocardial Ischemia,C14.280.647
23642506,2013-04-30T00:00:00,Myocardial Ischemia,C14.907.585
23642506,2013-04-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23642506,2013-04-30T00:00:00,Risk Factors,N05.715.350.200.700
23642506,2013-04-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23642506,2013-04-30T00:00:00,Risk Factors,N06.850.490.625.750
23642506,2013-04-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23642506,2013-04-30T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
23642506,2013-04-30T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
23646135,2013-04-30T00:00:00,Animals,B01.050
23646135,2013-04-30T00:00:00,Computational Biology,H01.158.273.180
23646135,2013-04-30T00:00:00,Genomics,H01.158.273.180.350
23646135,2013-04-30T00:00:00,Genomics,H01.158.273.343.350
23646135,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23646135,2013-04-30T00:00:00,Internet,L01.224.230.110.500
23646135,2013-04-30T00:00:00,Semantics,L01.143.506.598.745
23646135,2013-04-30T00:00:00,Software,L01.224.900
23646135,2013-04-30T00:00:00,User-Computer Interface,L01.224.900.910
22990049,2013-05-01T00:00:00,Animals,B01.050
22990049,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990049,2013-05-01T00:00:00,Parasitic Diseases,C03
22990049,2013-05-01T00:00:00,Pleura,A04.716
22990049,2013-05-01T00:00:00,Pleura,A10.615.789.736
22990049,2013-05-01T00:00:00,Pleural Diseases,C08.528
23090041,2013-05-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23090041,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090041,2013-05-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
23090041,2013-05-01T00:00:00,Liver Cirrhosis,C06.552.630
23090041,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23117277,2013-05-01T00:00:00,Adult,M01.060.116
23117277,2013-05-01T00:00:00,Aged,M01.060.116.100
23117277,2013-05-01T00:00:00,Amphotericin B,D02.540.505.050
23117277,2013-05-01T00:00:00,Amphotericin B,D04.345.349.050
23117277,2013-05-01T00:00:00,Amphotericin B,D09.408.477.050
23117277,2013-05-01T00:00:00,Antifungal Agents,D27.505.954.122.136
23117277,2013-05-01T00:00:00,Hemoptysis,C08.381.348
23117277,2013-05-01T00:00:00,Hemoptysis,C23.550.414.896
23117277,2013-05-01T00:00:00,Hemoptysis,C23.888.852.430
23117277,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23117277,2013-05-01T00:00:00,Lung,A04.411
23117277,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23117277,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23117277,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23117277,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23117277,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23117277,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23117277,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23117277,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23117277,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23139240,2013-05-01T00:00:00,Adolescent,M01.060.057
23139240,2013-05-01T00:00:00,Child,M01.060.406
23139240,2013-05-01T00:00:00,"Child, Preschool",M01.060.406.448
23139240,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23139240,2013-05-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23139240,2013-05-01T00:00:00,Infant,M01.060.703
23139240,2013-05-01T00:00:00,Questionnaires,E05.318.308.750
23139240,2013-05-01T00:00:00,Questionnaires,L01.280.800
23139240,2013-05-01T00:00:00,Questionnaires,N05.715.360.300.695
23139240,2013-05-01T00:00:00,Questionnaires,N06.850.520.308.750
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E02.037
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E02.190.888.030
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E05.723.136
23187606,2013-05-01T00:00:00,Adult,M01.060.116
23187606,2013-05-01T00:00:00,Age Factors,N05.715.350.075
23187606,2013-05-01T00:00:00,Age Factors,N06.850.490.250
23187606,2013-05-01T00:00:00,Aged,M01.060.116.100
23187606,2013-05-01T00:00:00,Auditory Perception,F02.463.593.071
23187606,2013-05-01T00:00:00,Auditory Threshold,F02.463.593.071.173
23187606,2013-05-01T00:00:00,Auditory Threshold,F02.463.593.710.190
23187606,2013-05-01T00:00:00,Circadian Rhythm,G07.180.562.190
23187606,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F01.145.544
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F02.463.425.475
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F02.739.794.405
23187606,2013-05-01T00:00:00,Noise,G01.595.907.567
23187606,2013-05-01T00:00:00,Noise,G16.500.275.600
23187606,2013-05-01T00:00:00,Noise,N06.230.400
23187606,2013-05-01T00:00:00,Noise,N06.850.460.610
23187606,2013-05-01T00:00:00,Speech Perception,F02.463.593.071.875
23328689,2013-05-01T00:00:00,Aged,M01.060.116.100
23328689,2013-05-01T00:00:00,Angioplasty,E02.148.050
23328689,2013-05-01T00:00:00,Angioplasty,E04.100.814.050
23328689,2013-05-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23328689,2013-05-01T00:00:00,Brain Ischemia,C14.907.253.092
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23328689,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23328689,2013-05-01T00:00:00,Incidence,E05.318.308.985.525.375
23328689,2013-05-01T00:00:00,Incidence,L01.280.975.525.375
23328689,2013-05-01T00:00:00,Incidence,N01.224.935.597.500
23328689,2013-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23328689,2013-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23328689,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23328689,2013-05-01T00:00:00,Postoperative Complications,C23.550.767
23328689,2013-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23328689,2013-05-01T00:00:00,Risk Assessment,N04.452.871.715
23328689,2013-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23328689,2013-05-01T00:00:00,Risk Assessment,N06.850.505.715
23328689,2013-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23328689,2013-05-01T00:00:00,Stents,E07.695.750
23328689,2013-05-01T00:00:00,Stroke,C10.228.140.300.775
23328689,2013-05-01T00:00:00,Stroke,C14.907.253.855
23328689,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23328689,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23328689,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23328689,2013-05-01T00:00:00,United States,Z01.107.567.875
23392271,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23429468,2013-05-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
23429468,2013-05-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
23429468,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493030,2013-05-01T00:00:00,Adult,M01.060.116
23493030,2013-05-01T00:00:00,African Americans,M01.686.508.100.100
23493030,2013-05-01T00:00:00,African Americans,M01.686.754.100
23493030,2013-05-01T00:00:00,Biological Markers,D23.101
23493030,2013-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23493030,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493030,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23493030,2013-05-01T00:00:00,Questionnaires,E05.318.308.750
23493030,2013-05-01T00:00:00,Questionnaires,L01.280.800
23493030,2013-05-01T00:00:00,Questionnaires,N05.715.360.300.695
23493030,2013-05-01T00:00:00,Questionnaires,N06.850.520.308.750
23493030,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23493030,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23493030,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23493030,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23493030,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C04.588.945.418.948
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C13.351.500.852.762
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C13.351.937.418.875
23493030,2013-05-01T00:00:00,Vitamin D,D04.808.812.768
23493030,2013-05-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23507919,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23507919,2013-05-01T00:00:00,Liver Cirrhosis,C06.552.630
23507919,2013-05-01T00:00:00,Liver Diseases,C06.552
23560728,2013-05-01T00:00:00,Animals,B01.050
23560728,2013-05-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
23560728,2013-05-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
23560728,2013-05-01T00:00:00,Gene Expression Regulation,G05.355.315
23560728,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571364,2013-05-01T00:00:00,Adult,M01.060.116
23571364,2013-05-01T00:00:00,Aged,M01.060.116.100
23571364,2013-05-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
23571364,2013-05-01T00:00:00,Copper,D01.268.556.195
23571364,2013-05-01T00:00:00,Copper,D01.268.956.170
23571364,2013-05-01T00:00:00,Copper,D01.552.544.195
23571364,2013-05-01T00:00:00,Cross Infection,C01.539.248
23571364,2013-05-01T00:00:00,Disinfectants,D27.505.954.122.425
23571364,2013-05-01T00:00:00,Disinfectants,D27.720.274
23571364,2013-05-01T00:00:00,Disinfection,N06.850.780.200.450.850.375
23571364,2013-05-01T00:00:00,Environmental Microbiology,H01.158.273.540.274
23571364,2013-05-01T00:00:00,Environmental Microbiology,N06.850.425
23571364,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571364,2013-05-01T00:00:00,Incidence,E05.318.308.985.525.375
23571364,2013-05-01T00:00:00,Incidence,L01.280.975.525.375
23571364,2013-05-01T00:00:00,Incidence,N01.224.935.597.500
23571364,2013-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23571364,2013-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23571364,2013-05-01T00:00:00,Intensive Care Units,N02.278.388.493
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
23571364,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23571364,2013-05-01T00:00:00,Staphylococcal Infections,C01.252.410.868
23571374,2013-05-01T00:00:00,Bacteria,B03
23571374,2013-05-01T00:00:00,Beds,E07.325.220
23571374,2013-05-01T00:00:00,Copper,D01.268.556.195
23571374,2013-05-01T00:00:00,Copper,D01.268.956.170
23571374,2013-05-01T00:00:00,Copper,D01.552.544.195
23571374,2013-05-01T00:00:00,Cross Infection,C01.539.248
23571374,2013-05-01T00:00:00,Disinfectants,D27.505.954.122.425
23571374,2013-05-01T00:00:00,Disinfectants,D27.720.274
23571374,2013-05-01T00:00:00,Disinfection,N06.850.780.200.450.850.375
23571374,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571374,2013-05-01T00:00:00,Intensive Care Units,N02.278.388.493
23588226,2013-05-01T00:00:00,Adolescent,M01.060.057
23588226,2013-05-01T00:00:00,Adult,M01.060.116
23588226,2013-05-01T00:00:00,Aged,M01.060.116.100
23588226,2013-05-01T00:00:00,Depressive Disorder,F03.600.300
23588226,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23588226,2013-05-01T00:00:00,Inpatients,M01.643.470
23588226,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23588226,2013-05-01T00:00:00,"Models, Psychological",E05.599.695
23588226,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23588226,2013-05-01T00:00:00,Psychotherapy,F04.754
23588226,2013-05-01T00:00:00,Time Factors,G01.910.857
23588226,2013-05-01T00:00:00,Young Adult,M01.060.116.815
23597825,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597825,2013-05-01T00:00:00,Smoking,F01.145.466.753
23617869,2013-05-01T00:00:00,Adult,M01.060.116
23617869,2013-05-01T00:00:00,Anxiety Disorders,F03.080
23617869,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23617869,2013-05-01T00:00:00,Mood Disorders,F03.600
23617869,2013-05-01T00:00:00,Opioid-Related Disorders,C21.739.675
23617869,2013-05-01T00:00:00,Opioid-Related Disorders,F03.900.675
23617869,2013-05-01T00:00:00,Pain Measurement,E01.370.376.550.600
23617869,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23617869,2013-05-01T00:00:00,Sleep,F02.830.855
23617869,2013-05-01T00:00:00,Sleep,G11.561.600.815
23620210,2013-05-01T00:00:00,Adult,M01.060.116
23620210,2013-05-01T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
23620210,2013-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23620210,2013-05-01T00:00:00,HIV Infections,C02.782.815.616.400
23620210,2013-05-01T00:00:00,HIV Infections,C02.800.801.400
23620210,2013-05-01T00:00:00,HIV Infections,C20.673.480
23620210,2013-05-01T00:00:00,Health Care Costs,N03.219.151.400
23620210,2013-05-01T00:00:00,Health Care Costs,N05.300.375
23620210,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23620210,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23620210,2013-05-01T00:00:00,Ritonavir,D02.886.675.653
23620210,2013-05-01T00:00:00,Ritonavir,D03.383.129.708.653
23620210,2013-05-01T00:00:00,Time Factors,G01.910.857
23620210,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23620210,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23620210,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23620210,2013-05-01T00:00:00,United States,Z01.107.567.875
23622926,2013-05-01T00:00:00,Adult,M01.060.116
23622926,2013-05-01T00:00:00,Anesthesiology,H02.403.066
23622926,2013-05-01T00:00:00,Cardiology,H02.403.429.163
23622926,2013-05-01T00:00:00,Echocardiography,E01.370.350.850.220
23622926,2013-05-01T00:00:00,Echocardiography,E01.370.370.380.220
23622926,2013-05-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23622926,2013-05-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23622926,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23622926,2013-05-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
23622926,2013-05-01T00:00:00,"Quality Assurance, Health Care",N05.700
23622926,2013-05-01T00:00:00,Thoracic Injuries,C21.866.891
23622926,2013-05-01T00:00:00,United States,Z01.107.567.875
23632936,2013-05-01T00:00:00,Coroners and Medical Examiners,M01.526.485.230
23632936,2013-05-01T00:00:00,Coroners and Medical Examiners,N02.360.230
23632936,2013-05-01T00:00:00,Curriculum,I02.158
23632936,2013-05-01T00:00:00,Educational Measurement,I02.399
23632936,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23632936,2013-05-01T00:00:00,"Licensure, Medical",N03.706.110.510.410
23632936,2013-05-01T00:00:00,"Licensure, Medical",N05.700.200.450.500
23632936,2013-05-01T00:00:00,Psychiatry,F04.096.544
23632936,2013-05-01T00:00:00,Psychiatry,H02.403.690
23632936,2013-05-01T00:00:00,United States,Z01.107.567.875
23635568,2013-05-01T00:00:00,Appendectomy,E04.210.078
23635568,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635568,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23635568,2013-05-01T00:00:00,Postoperative Complications,C23.550.767
23635576,2013-05-01T00:00:00,Heart Valve Diseases,C14.280.484
23635576,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635576,2013-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
23635577,2013-05-01T00:00:00,Heart Valve Diseases,C14.280.484
23635577,2013-05-01T00:00:00,"History, 20th Century",K01.400.504.968
23635577,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635577,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23635577,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23635577,2013-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
23635725,2013-05-01T00:00:00,Biomedical Research,H01.770.644.145
23635725,2013-05-01T00:00:00,Breast Neoplasms,C04.588.180
23635725,2013-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
23635725,2013-05-01T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
23635725,2013-05-01T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
23635725,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635725,2013-05-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
23635725,2013-05-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
23644638,2013-05-01T00:00:00,Activities of Daily Living,E02.831.067
23644638,2013-05-01T00:00:00,Activities of Daily Living,I03.050
23644638,2013-05-01T00:00:00,Activities of Daily Living,N02.421.784.110
23644638,2013-05-01T00:00:00,Adolescent,M01.060.057
23644638,2013-05-01T00:00:00,Adult,M01.060.116
23644638,2013-05-01T00:00:00,Aged,M01.060.116.100
23644638,2013-05-01T00:00:00,Arthritis,C05.550.114
23644638,2013-05-01T00:00:00,Cost of Illness,I01.137
23644638,2013-05-01T00:00:00,Cost of Illness,N03.219.151.165
23644638,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23644638,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23644638,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23644638,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23644638,2013-05-01T00:00:00,Young Adult,M01.060.116.815
23645725,2013-05-01T00:00:00,Adipocytes,A11.329.114
23645725,2013-05-01T00:00:00,Animals,B01.050
23645725,2013-05-01T00:00:00,Cytokines,D12.644.276.374
23645725,2013-05-01T00:00:00,Cytokines,D12.776.467.374
23645725,2013-05-01T00:00:00,Cytokines,D23.529.374
23645725,2013-05-01T00:00:00,Mouth Neoplasms,C04.588.443.591
23645725,2013-05-01T00:00:00,Mouth Neoplasms,C07.465.565
23645725,2013-05-01T00:00:00,Spleen,A10.549.700
23645725,2013-05-01T00:00:00,Spleen,A15.382.520.604.700
23648897,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23648897,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23648897,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23648897,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23648897,2013-05-01T00:00:00,Molecular Biology,H01.158.201.636
23648897,2013-05-01T00:00:00,Molecular Biology,H01.158.273.343.595
23648897,2013-05-01T00:00:00,Molecular Biology,H01.181.122.650
23649439,2013-05-01T00:00:00,Air Pollution,N06.850.460.100
23649439,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649439,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649439,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649439,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649439,2013-05-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
23649439,2013-05-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
23649439,2013-05-01T00:00:00,Occupational Exposure,N06.850.460.350.600
23649439,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23649439,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23649439,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23649439,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23649439,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23649439,2013-05-01T00:00:00,Smoking,F01.145.466.753
23649439,2013-05-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E04.074.119
23649440,2013-05-01T00:00:00,Bronchoscopy,E01.370.386.105
23649440,2013-05-01T00:00:00,Bronchoscopy,E01.370.388.250.100
23649440,2013-05-01T00:00:00,Bronchoscopy,E04.800.250.100
23649440,2013-05-01T00:00:00,Bronchoscopy,E04.928.600.080
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
23649440,2013-05-01T00:00:00,Endosonography,E01.370.350.850.280
23649440,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649440,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649440,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649440,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649440,2013-05-01T00:00:00,Neoplasm Staging,E01.370.550
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23649453,2013-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
23649453,2013-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23649453,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649453,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649453,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649453,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649453,2013-05-01T00:00:00,Neoplasm Staging,E01.370.550
23649453,2013-05-01T00:00:00,Palliative Care,E02.760.666
23649453,2013-05-01T00:00:00,Palliative Care,N02.421.585.666
23649453,2013-05-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23649453,2013-05-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23649453,2013-05-01T00:00:00,Quality of Life,I01.800
23649453,2013-05-01T00:00:00,Quality of Life,K01.752.400.750
23649453,2013-05-01T00:00:00,"Stress, Psychological",F01.145.126.990
23649453,2013-05-01T00:00:00,"Stress, Psychological",F02.830.900
23649453,2013-05-01T00:00:00,Terminal Care,E02.760.905
23649453,2013-05-01T00:00:00,Terminal Care,N02.421.585.905
23682563,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23682563,2013-05-01T00:00:00,Neurodegenerative Diseases,C10.574
23682563,2013-05-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23682563,2013-05-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23682563,2013-05-01T00:00:00,Vitamin K,D02.455.426.559.847.638.721.374
23682563,2013-05-01T00:00:00,Vitamin K,D02.455.849.291.523.500
23682563,2013-05-01T00:00:00,Vitamin K,D04.615.638.721.374
23690385,2013-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
23690385,2013-05-01T00:00:00,Health Services Accessibility,N05.300.430
23690385,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23690385,2013-05-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23690385,2013-05-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23690385,2013-05-01T00:00:00,Patient Care Team,N04.590.715
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.233.675
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.720
23690385,2013-05-01T00:00:00,Primary Health Care,N04.590.233.727
23759452,2013-05-01T00:00:00,Adult,M01.060.116
23759452,2013-05-01T00:00:00,Depression,F01.145.126.350
23759452,2013-05-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
23759452,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23759452,2013-05-01T00:00:00,Inpatients,M01.643.470
23759452,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23759452,2013-05-01T00:00:00,"Models, Psychological",E05.599.695
23759452,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23759452,2013-05-01T00:00:00,Time Factors,G01.910.857
23759452,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23759452,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23759452,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23809587,2013-05-01T00:00:00,Animals,B01.050
23809587,2013-05-01T00:00:00,Biocompatible Materials,D25.130
23809587,2013-05-01T00:00:00,Biocompatible Materials,D27.720.102.130
23809587,2013-05-01T00:00:00,Biocompatible Materials,J01.637.051.130
23809587,2013-05-01T00:00:00,"Disease Models, Animal",C22.232
23809587,2013-05-01T00:00:00,"Disease Models, Animal",E05.598.500
23809587,2013-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23809587,2013-05-01T00:00:00,Nerve Regeneration,G11.561.600.615
23809587,2013-05-01T00:00:00,Nerve Regeneration,G16.100.856.611
23809587,2013-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23809587,2013-05-01T00:00:00,Recovery of Function,G16.757
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
23809590,2013-05-01T00:00:00,Constipation,C23.888.821.150
23809590,2013-05-01T00:00:00,Digestive System Surgical Procedures,E04.210
23809590,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23809590,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
23809590,2013-05-01T00:00:00,Veterans,M01.930
23841969,2013-05-01T00:00:00,Aged,M01.060.116.100
23841969,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23841969,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23841969,2013-05-01T00:00:00,Motor Activity,F01.145.632
23841969,2013-05-01T00:00:00,Motor Activity,G11.427.590.530.698
23841969,2013-05-01T00:00:00,Postural Balance,G11.427.690
23841969,2013-05-01T00:00:00,Postural Balance,G11.561.600.810.541.595
23841969,2013-05-01T00:00:00,Stroke,C10.228.140.300.775
23841969,2013-05-01T00:00:00,Stroke,C14.907.253.855
23841969,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23841969,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23841969,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23841969,2013-05-01T00:00:00,User-Computer Interface,L01.224.900.910
23841969,2013-05-01T00:00:00,Video Games,I03.450.642.693.930
23841969,2013-05-01T00:00:00,Video Games,L01.224.900.930
23639812,2013-05-02T00:00:00,Animals,B01.050
23639812,2013-05-02T00:00:00,Endothelial Cells,A11.436.275
23639812,2013-05-02T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
23639812,2013-05-02T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
23639812,2013-05-02T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
23639812,2013-05-02T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
23639812,2013-05-02T00:00:00,Gene Expression Regulation,G05.355.315
23639812,2013-05-02T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.700.565
23639812,2013-05-02T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.725.200
23639812,2013-05-02T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.644.360.440
23639812,2013-05-02T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.776.476.440
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.339.387
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.625.550.500
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.625.700.500
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.650.550.587.600
23639812,2013-05-02T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23639812,2013-05-02T00:00:00,Phosphorylation,G02.111.087.677
23639812,2013-05-02T00:00:00,Phosphorylation,G02.149.115.677
23639812,2013-05-02T00:00:00,Phosphorylation,G02.149.465.700
23639812,2013-05-02T00:00:00,Phosphorylation,G02.607.750.700
23639812,2013-05-02T00:00:00,Phosphorylation,G03.495.790
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23639812,2013-05-02T00:00:00,Pyridines,D03.383.725
23639812,2013-05-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23639812,2013-05-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23639812,2013-05-02T00:00:00,Signal Transduction,G02.111.087.800
23639812,2013-05-02T00:00:00,Signal Transduction,G02.149.115.800
23639812,2013-05-02T00:00:00,Signal Transduction,G04.299.880
23641015,2013-05-02T00:00:00,Adolescent,M01.060.057
23641015,2013-05-02T00:00:00,Adult,M01.060.116
23641015,2013-05-02T00:00:00,Age Factors,N05.715.350.075
23641015,2013-05-02T00:00:00,Age Factors,N06.850.490.250
23641015,2013-05-02T00:00:00,Aged,M01.060.116.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C02.256.466.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C02.928.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.557.386.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.557.386.480.150.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.619.935.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.925.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.150.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.150.165
23641015,2013-05-02T00:00:00,Child,M01.060.406
23641015,2013-05-02T00:00:00,"Child, Preschool",M01.060.406.448
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,E05.318.760.535
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,E05.337.250
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23641015,2013-05-02T00:00:00,"Databases, Factual",L01.470.750.750
23641015,2013-05-02T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23641015,2013-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23641015,2013-05-02T00:00:00,Infant,M01.060.703
23641015,2013-05-02T00:00:00,"Infant, Newborn",M01.060.703.520
23641015,2013-05-02T00:00:00,Middle Aged,M01.060.116.630
23641015,2013-05-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23641015,2013-05-02T00:00:00,Risk Factors,N05.715.350.200.700
23641015,2013-05-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23641015,2013-05-02T00:00:00,Risk Factors,N06.850.490.625.750
23641015,2013-05-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23641015,2013-05-02T00:00:00,United States,Z01.107.567.875
23644531,2013-05-03T00:00:00,Animals,B01.050
23644531,2013-05-03T00:00:00,Antineoplastic Agents,D27.505.954.248
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.718.550
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.718.550
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.718.550
23644531,2013-05-03T00:00:00,Interleukin-15,D12.644.276.374.465.515
23644531,2013-05-03T00:00:00,Interleukin-15,D12.776.467.374.465.515
23644531,2013-05-03T00:00:00,Interleukin-15,D23.529.374.465.515
23644531,2013-05-03T00:00:00,Multiple Myeloma,C04.557.595.500
23644531,2013-05-03T00:00:00,Multiple Myeloma,C14.907.454.460
23644531,2013-05-03T00:00:00,Multiple Myeloma,C15.378.147.780.650
23644531,2013-05-03T00:00:00,Multiple Myeloma,C15.378.463.835.460
23644531,2013-05-03T00:00:00,Multiple Myeloma,C20.683.515.845
23644531,2013-05-03T00:00:00,Multiple Myeloma,C20.683.780.650
23644531,2013-05-03T00:00:00,Proteins,D12.776
23651638,2013-05-06T00:00:00,Adolescent,M01.060.057
23651638,2013-05-06T00:00:00,Adult,M01.060.116
23651638,2013-05-06T00:00:00,Age Factors,N05.715.350.075
23651638,2013-05-06T00:00:00,Age Factors,N06.850.490.250
23651638,2013-05-06T00:00:00,Crime Victims,M01.135
23651638,2013-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23651638,2013-05-06T00:00:00,Rape,I01.198.240.748.640
23651638,2013-05-06T00:00:00,Social Support,I01.880.656.600
23651638,2013-05-06T00:00:00,Students,I02.233.748
23651638,2013-05-06T00:00:00,Students,I02.851
23651638,2013-05-06T00:00:00,Students,M01.848
23651638,2013-05-06T00:00:00,Substance-Related Disorders,C21.739
23651638,2013-05-06T00:00:00,Substance-Related Disorders,F03.900
23651638,2013-05-06T00:00:00,Truth Disclosure,F01.145.209.259.800
23651638,2013-05-06T00:00:00,Young Adult,M01.060.116.815
23652265,2013-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23652265,2013-05-07T00:00:00,Stroke,C10.228.140.300.775
23652265,2013-05-07T00:00:00,Stroke,C14.907.253.855
23652265,2013-05-07T00:00:00,United States,Z01.107.567.875
23652265,2013-05-07T00:00:00,Voluntary Health Agencies,N03.540.630.780
23658246,2013-05-08T00:00:00,Adenocarcinoma,C04.557.470.200.025
23658246,2013-05-08T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23658246,2013-05-08T00:00:00,Esophageal Neoplasms,C04.588.443.353
23658246,2013-05-08T00:00:00,Esophageal Neoplasms,C06.301.371.205
23658246,2013-05-08T00:00:00,Esophageal Neoplasms,C06.405.117.430
23658246,2013-05-08T00:00:00,Esophageal Neoplasms,C06.405.249.205
23658246,2013-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23658246,2013-05-08T00:00:00,Peptides,D12.644
23661707,2013-05-09T00:00:00,Angiotensin II,D06.472.699.094.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.400.070.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.456.073.041
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.548.058.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.776.641.650.070.078
23661707,2013-05-09T00:00:00,Angiotensin II,D23.469.050.050.050
23661707,2013-05-09T00:00:00,Animals,B01.050
23661707,2013-05-09T00:00:00,Arrestins,D12.776.306.090
23661707,2013-05-09T00:00:00,Arrestins,D12.776.543.090
23661707,2013-05-09T00:00:00,Calcium,D01.268.552.100
23661707,2013-05-09T00:00:00,Calcium,D01.552.539.288
23661707,2013-05-09T00:00:00,Calcium,D23.119.100
23661707,2013-05-09T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
23661707,2013-05-09T00:00:00,GTP-Binding Proteins,D12.776.157.325
23661707,2013-05-09T00:00:00,Hemodynamics,G09.330.190.400
23661707,2013-05-09T00:00:00,Hemodynamics,G09.330.380
23661707,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23661707,2013-05-09T00:00:00,Kallikreins,D08.811.277.656.300.760.442
23661707,2013-05-09T00:00:00,Kallikreins,D08.811.277.656.959.350.442
23661707,2013-05-09T00:00:00,Kallikreins,D12.776.124.125.597
23661707,2013-05-09T00:00:00,Kallikreins,D23.119.597
23661707,2013-05-09T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23661707,2013-05-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23661707,2013-05-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
23661707,2013-05-09T00:00:00,Signal Transduction,G02.111.087.800
23661707,2013-05-09T00:00:00,Signal Transduction,G02.149.115.800
23661707,2013-05-09T00:00:00,Signal Transduction,G04.299.880
23665373,2013-05-09T00:00:00,Adipocytes,A11.329.114
23665373,2013-05-09T00:00:00,Arteries,A07.231.114
23665373,2013-05-09T00:00:00,Bariatric Surgery,E02.065.062
23665373,2013-05-09T00:00:00,Bariatric Surgery,E04.062
23665373,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23665373,2013-05-09T00:00:00,Inflammation,C23.550.470
23665427,2013-05-09T00:00:00,Animals,B01.050
23665427,2013-05-09T00:00:00,Apoptosis,G04.299.139.160
23665427,2013-05-09T00:00:00,Calcium,D01.268.552.100
23665427,2013-05-09T00:00:00,Calcium,D01.552.539.288
23665427,2013-05-09T00:00:00,Calcium,D23.119.100
23665427,2013-05-09T00:00:00,Hepatocytes,A11.436.348
23665427,2013-05-09T00:00:00,Iron,D01.268.556.412
23665427,2013-05-09T00:00:00,Iron,D01.268.956.287
23665427,2013-05-09T00:00:00,Iron,D01.552.544.412
23665427,2013-05-09T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
23665427,2013-05-09T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
23665427,2013-05-09T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
23665427,2013-05-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23665427,2013-05-09T00:00:00,Reactive Oxygen Species,D01.339.431
23665427,2013-05-09T00:00:00,Reactive Oxygen Species,D01.650.775
23665427,2013-05-09T00:00:00,Reperfusion Injury,C14.907.725
23665427,2013-05-09T00:00:00,Reperfusion Injury,C23.550.767.877
23666671,2013-05-10T00:00:00,Action Potentials,G04.580.100
23666671,2013-05-10T00:00:00,Action Potentials,G07.265.750.100
23666671,2013-05-10T00:00:00,Action Potentials,G11.561.570.100
23666671,2013-05-10T00:00:00,Animals,B01.050
23666671,2013-05-10T00:00:00,Binding Sites,G02.111.570.120
23666671,2013-05-10T00:00:00,Calcium,D01.268.552.100
23666671,2013-05-10T00:00:00,Calcium,D01.552.539.288
23666671,2013-05-10T00:00:00,Calcium,D23.119.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G03.495.166.500.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G04.299.880.800.100
23666671,2013-05-10T00:00:00,Calmodulin,D12.644.360.381.249
23666671,2013-05-10T00:00:00,Calmodulin,D12.776.157.125.412.249
23666671,2013-05-10T00:00:00,Calmodulin,D12.776.476.387.249
23666671,2013-05-10T00:00:00,Cardiomegaly,C14.280.195
23666671,2013-05-10T00:00:00,Cardiomegaly,C23.300.775.250
23666671,2013-05-10T00:00:00,Heart Failure,C14.280.434
23666671,2013-05-10T00:00:00,"Mutation, Missense",G05.365.590.650
23666671,2013-05-10T00:00:00,Myocardial Contraction,G09.330.190.541
23666671,2013-05-10T00:00:00,Myocardial Contraction,G11.427.590.540.570
23666671,2013-05-10T00:00:00,"RNA, Messenger",D13.444.735.544
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
23666671,2013-05-10T00:00:00,S100 Proteins,D12.776.157.125.750
23666671,2013-05-10T00:00:00,S100 Proteins,D12.776.641.655
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G02.111.087.847
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G02.149.115.847
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G05.355.310.700
23889711,2013-05-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23889711,2013-05-10T00:00:00,Blood Pressure,E01.370.600.875.249
23889711,2013-05-10T00:00:00,Blood Pressure,G09.330.380.076
23889711,2013-05-10T00:00:00,Cardiovascular Diseases,C14
23889711,2013-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23889711,2013-05-10T00:00:00,Hypertension,C14.907.489
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C16.320.078
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.276.812.169
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.400.090
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.456.193
23672780,2013-05-11T00:00:00,Bradykinin,D12.776.467.812.169
23672780,2013-05-11T00:00:00,Bradykinin,D12.776.641.650.090
23672780,2013-05-11T00:00:00,Bradykinin,D23.469.050.375.110
23672780,2013-05-11T00:00:00,Bradykinin,D23.529.812.169
23672780,2013-05-11T00:00:00,Factor XII,D12.776.124.125.450
23672780,2013-05-11T00:00:00,Factor XII,D23.119.450
23672780,2013-05-11T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
23672780,2013-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23672780,2013-05-11T00:00:00,Kallikreins,D08.811.277.656.300.760.442
23672780,2013-05-11T00:00:00,Kallikreins,D08.811.277.656.959.350.442
23672780,2013-05-11T00:00:00,Kallikreins,D12.776.124.125.597
23672780,2013-05-11T00:00:00,Kallikreins,D23.119.597
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.644.276.812.654.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.124.125.635.480
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.467.812.654.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.811.420.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.119.630.480
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.469.050.375.425.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.529.812.654.350
23672780,2013-05-11T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
23672780,2013-05-11T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
23672780,2013-05-11T00:00:00,Prekallikrein,D12.776.124.125.597.712
23672780,2013-05-11T00:00:00,Prekallikrein,D23.119.597.712
23512844,2013-05-13T00:00:00,Adult,M01.060.116
23512844,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23512844,2013-05-13T00:00:00,Iron,D01.268.556.412
23512844,2013-05-13T00:00:00,Iron,D01.268.956.287
23512844,2013-05-13T00:00:00,Iron,D01.552.544.412
23512844,2013-05-13T00:00:00,Membrane Proteins,D12.776.543
23512844,2013-05-13T00:00:00,Mutation,G05.365.590
23512844,2013-05-13T00:00:00,Phenotype,G05.695
23665759,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23665759,2013-05-13T00:00:00,Prostatectomy,E04.950.774.860.625
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.294.260.750
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.294.565.625
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.758.409.750
23665759,2013-05-13T00:00:00,Urinary Incontinence,C12.777.934.852
23665759,2013-05-13T00:00:00,Urinary Incontinence,C13.351.968.934.814
23665759,2013-05-13T00:00:00,Urinary Incontinence,C23.888.942.800
23670399,2013-05-13T00:00:00,Adolescent,M01.060.057
23670399,2013-05-13T00:00:00,Adult,M01.060.116
23670399,2013-05-13T00:00:00,Aged,M01.060.116.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.370.388.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.230.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.865.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.865.632.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E04.074.119
23670399,2013-05-13T00:00:00,Combined Modality Therapy,E02.186
23670399,2013-05-13T00:00:00,Head and Neck Neoplasms,C04.588.443
23670399,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670399,2013-05-13T00:00:00,Lymph Nodes,A10.549.400
23670399,2013-05-13T00:00:00,Lymph Nodes,A15.382.520.604.412
23670399,2013-05-13T00:00:00,Middle Aged,M01.060.116.630
23670399,2013-05-13T00:00:00,Neoplasm Invasiveness,C04.697.645
23670399,2013-05-13T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23670399,2013-05-13T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23670399,2013-05-13T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23670399,2013-05-13T00:00:00,Neoplasm Staging,E01.370.550
23670399,2013-05-13T00:00:00,SEER Program,E05.318.308.970.725
23670399,2013-05-13T00:00:00,SEER Program,L01.280.950.725
23670399,2013-05-13T00:00:00,SEER Program,N04.452.859.819.725
23670399,2013-05-13T00:00:00,SEER Program,N05.715.360.300.715.700.725
23670399,2013-05-13T00:00:00,SEER Program,N06.850.520.308.970.725
23670399,2013-05-13T00:00:00,Treatment Outcome,E01.789.800
23670399,2013-05-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23670399,2013-05-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23670399,2013-05-13T00:00:00,Young Adult,M01.060.116.815
23671067,2013-05-13T00:00:00,Animals,B01.050
23671067,2013-05-13T00:00:00,Cues,F02.463.425.234
23671067,2013-05-13T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23671067,2013-05-13T00:00:00,"Microscopy, Confocal",E05.595.395
23671067,2013-05-13T00:00:00,Neuronal Plasticity,G11.561.600.635
23671067,2013-05-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23671067,2013-05-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23671067,2013-05-13T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23671067,2013-05-13T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23671067,2013-05-13T00:00:00,Self Administration,E02.319.890
23671067,2013-05-13T00:00:00,Self Administration,E02.900.890
23671067,2013-05-13T00:00:00,Synapses,A08.850
23671067,2013-05-13T00:00:00,Synapses,A11.284.149.165.420.780
23671067,2013-05-13T00:00:00,Time Factors,G01.910.857
23671067,2013-05-13T00:00:00,Tobacco Use Disorder,C21.739.912
23671067,2013-05-13T00:00:00,Tobacco Use Disorder,F03.900.912
23671277,2013-05-13T00:00:00,Animals,B01.050
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D12.776.543.750.705.408.100.100
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D23.050.301.264.035.111.024
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D23.101.100.110.111.024
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.395.550.200.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.550.200.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.408.200.249
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.408.600.100.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.833.249.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.264.035.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.264.894.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.350.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.101.100.110.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.101.100.894.118
23671277,2013-05-13T00:00:00,Binding Sites,G02.111.570.120
23671277,2013-05-13T00:00:00,Cell Line,A11.251.210
23671277,2013-05-13T00:00:00,Cell Movement,G04.299.283
23671277,2013-05-13T00:00:00,Cell Movement,G07.700.560.500.180
23671277,2013-05-13T00:00:00,Cell Survival,G04.299.316
23671277,2013-05-13T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23671277,2013-05-13T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23671277,2013-05-13T00:00:00,Flow Cytometry,E05.200.500.386.350
23671277,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23671277,2013-05-13T00:00:00,Membrane Glycoproteins,D12.776.395.550
23671277,2013-05-13T00:00:00,Membrane Glycoproteins,D12.776.543.550
23671277,2013-05-13T00:00:00,Molecular Chaperones,D12.776.580
23671277,2013-05-13T00:00:00,Neoplasms,C04
23671277,2013-05-13T00:00:00,Peptides,D12.644
23671277,2013-05-13T00:00:00,RNA Interference,G05.355.315.203.374.790
23716734,2013-05-13T00:00:00,"Education, Pharmacy",I02.358.525
23716734,2013-05-13T00:00:00,Guidelines as Topic,N04.761.700.350
23716734,2013-05-13T00:00:00,Guidelines as Topic,N05.700.350
23716734,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23716734,2013-05-13T00:00:00,Periodicals as Topic,L01.178.682.829.678
23716734,2013-05-13T00:00:00,Research Design,E05.581.500
23716734,2013-05-13T00:00:00,Research Design,H01.770.644.728
23670294,2013-05-14T00:00:00,Animals,B01.050
23670294,2013-05-14T00:00:00,Antineoplastic Agents,D27.505.954.248
23670294,2013-05-14T00:00:00,Apoptosis,G04.299.139.160
23670294,2013-05-14T00:00:00,Disease Progression,C23.550.291.656
23670294,2013-05-14T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23670294,2013-05-14T00:00:00,Flow Cytometry,E05.200.500.386.350
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
23670294,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670294,2013-05-14T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
23670294,2013-05-14T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
23670294,2013-05-14T00:00:00,Stem Cells,A11.872
23670675,2013-05-14T00:00:00,Adult,M01.060.116
23670675,2013-05-14T00:00:00,Aged,M01.060.116.100
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23670675,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670675,2013-05-14T00:00:00,Incidence,E05.318.308.985.525.375
23670675,2013-05-14T00:00:00,Incidence,L01.280.975.525.375
23670675,2013-05-14T00:00:00,Incidence,N01.224.935.597.500
23670675,2013-05-14T00:00:00,Incidence,N06.850.505.400.975.525.375
23670675,2013-05-14T00:00:00,Incidence,N06.850.520.308.985.525.375
23670675,2013-05-14T00:00:00,Middle Aged,M01.060.116.630
23670675,2013-05-14T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23670675,2013-05-14T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23670675,2013-05-14T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23670675,2013-05-14T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23670675,2013-05-14T00:00:00,Pulmonary Embolism,C08.381.746
23670675,2013-05-14T00:00:00,Pulmonary Embolism,C14.907.355.350.700
23670675,2013-05-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23670675,2013-05-14T00:00:00,Risk Factors,N05.715.350.200.700
23670675,2013-05-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23670675,2013-05-14T00:00:00,Risk Factors,N06.850.490.625.750
23670675,2013-05-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23670675,2013-05-14T00:00:00,Venous Thrombosis,C14.907.355.830.925
23671178,2013-05-14T00:00:00,Cooperative Behavior,F01.145.813.115
23671178,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23671178,2013-05-14T00:00:00,Pilot Projects,E05.318.760.750
23671178,2013-05-14T00:00:00,Pilot Projects,E05.337.737
23671178,2013-05-14T00:00:00,Pilot Projects,N05.715.360.775.625
23671178,2013-05-14T00:00:00,Pilot Projects,N06.850.520.450.720
23671178,2013-05-14T00:00:00,Stroke,C10.228.140.300.775
23671178,2013-05-14T00:00:00,Stroke,C14.907.253.855
23671178,2013-05-14T00:00:00,Time Factors,G01.910.857
23671178,2013-05-14T00:00:00,Treatment Outcome,E01.789.800
23671178,2013-05-14T00:00:00,Treatment Outcome,N04.761.559.590.800
23671178,2013-05-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23684943,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23684943,2013-05-14T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23684943,2013-05-14T00:00:00,"Microscopy, Confocal",E05.595.395
23677931,2013-05-15T00:00:00,Animals,B01.050
23677931,2013-05-15T00:00:00,Blood Pressure,E01.370.600.875.249
23677931,2013-05-15T00:00:00,Blood Pressure,G09.330.380.076
23677931,2013-05-15T00:00:00,Pregnancy,G08.686.785.760.769
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.100.047
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.720.600.150
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.750.130
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.750.555.150
23677931,2013-05-15T00:00:00,Vitamin D,D04.808.812.768
23677931,2013-05-15T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23939446,2013-05-15T00:00:00,Adult,M01.060.116
23939446,2013-05-15T00:00:00,"Diagnosis, Differential",E01.171
23939446,2013-05-15T00:00:00,Headache,C10.597.617.470
23939446,2013-05-15T00:00:00,Headache,C23.888.592.612.441
23939446,2013-05-15T00:00:00,Headache,C23.888.646.487
23939446,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23993239,2013-05-15T00:00:00,Animals,B01.050
23993239,2013-05-15T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23993239,2013-05-15T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
23993239,2013-05-15T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
23993239,2013-05-15T00:00:00,Disease Progression,C23.550.291.656
23993239,2013-05-15T00:00:00,Extracellular Matrix,A11.284.295.310
23993239,2013-05-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23993239,2013-05-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
23993239,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23993239,2013-05-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23993239,2013-05-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23993239,2013-05-15T00:00:00,Phenotype,G05.695
23993239,2013-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23993239,2013-05-15T00:00:00,Risk Factors,N05.715.350.200.700
23993239,2013-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23993239,2013-05-15T00:00:00,Risk Factors,N06.850.490.625.750
23993239,2013-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23682710,2013-05-17T00:00:00,Adult,M01.060.116
23682710,2013-05-17T00:00:00,Animals,B01.050
23682710,2013-05-17T00:00:00,Autoimmune Diseases,C20.111
23682710,2013-05-17T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G03.495.166.500.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G04.299.880.800.100
23682710,2013-05-17T00:00:00,Cardiovascular Diseases,C14
23682710,2013-05-17T00:00:00,Cognition Disorders,F03.087.250
23682710,2013-05-17T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23682710,2013-05-17T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23682710,2013-05-17T00:00:00,"Disease Models, Animal",C22.232
23682710,2013-05-17T00:00:00,"Disease Models, Animal",E05.598.500
23682710,2013-05-17T00:00:00,"Disease Models, Animal",E05.599.395.080
23682710,2013-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23682710,2013-05-17T00:00:00,Immune System,A15.382
23682710,2013-05-17T00:00:00,Infant,M01.060.703
23682710,2013-05-17T00:00:00,Lactation,G08.686.702.500
23682710,2013-05-17T00:00:00,Lactation,G08.686.785.420
23682710,2013-05-17T00:00:00,Obesity,C18.654.726.500
23682710,2013-05-17T00:00:00,Obesity,C23.888.144.699.500
23682710,2013-05-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23682710,2013-05-17T00:00:00,Obesity,G07.100.100.160.120.699.500
23682710,2013-05-17T00:00:00,Pregnancy,G08.686.785.760.769
23682710,2013-05-17T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23682710,2013-05-17T00:00:00,Vitamin D,D04.808.812.768
23682710,2013-05-17T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23687123,2013-05-17T00:00:00,Adolescent,M01.060.057
23687123,2013-05-17T00:00:00,Adult,M01.060.116
23687123,2013-05-17T00:00:00,Brain,A08.186.211
23687123,2013-05-17T00:00:00,Carrier Proteins,D12.776.157
23687123,2013-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23687123,2013-05-17T00:00:00,Iron,D01.268.556.412
23687123,2013-05-17T00:00:00,Iron,D01.268.956.287
23687123,2013-05-17T00:00:00,Iron,D01.552.544.412
23687123,2013-05-17T00:00:00,Middle Aged,M01.060.116.630
23687123,2013-05-17T00:00:00,Mutation,G05.365.590
23687123,2013-05-17T00:00:00,Neurodegenerative Diseases,C10.574
23687123,2013-05-17T00:00:00,Young Adult,M01.060.116.815
23690418,2013-05-20T00:00:00,Adult,M01.060.116
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
23690418,2013-05-20T00:00:00,Antineoplastic Agents,D27.505.954.248
23690418,2013-05-20T00:00:00,Antiviral Agents,D27.505.954.122.388
23690418,2013-05-20T00:00:00,Hepacivirus,B04.450.410
23690418,2013-05-20T00:00:00,Hepacivirus,B04.820.250.475
23690418,2013-05-20T00:00:00,Hepacivirus,B04.909.777.310.475
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
23690418,2013-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23690418,2013-05-20T00:00:00,Melanoma,C04.557.465.625.650.510
23690418,2013-05-20T00:00:00,Melanoma,C04.557.580.625.650.510
23690418,2013-05-20T00:00:00,Melanoma,C04.557.665.510
23690418,2013-05-20T00:00:00,Skin Neoplasms,C04.588.805
23690418,2013-05-20T00:00:00,Skin Neoplasms,C17.800.882
23690418,2013-05-20T00:00:00,Treatment Outcome,E01.789.800
23690418,2013-05-20T00:00:00,Treatment Outcome,N04.761.559.590.800
23690418,2013-05-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23706256,2013-05-21T00:00:00,Adenocarcinoma,C04.557.470.200.025
23706256,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.294.260.750
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.294.565.625
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.758.409.750
23706256,2013-05-21T00:00:00,Quality of Life,I01.800
23706256,2013-05-21T00:00:00,Quality of Life,K01.752.400.750
23706701,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706701,2013-05-21T00:00:00,Infant,M01.060.703
23706701,2013-05-21T00:00:00,"Infant, Newborn",M01.060.703.520
23706701,2013-05-21T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
23706701,2013-05-21T00:00:00,"Lenses, Intraocular",E07.632.500.460
23706701,2013-05-21T00:00:00,"Lenses, Intraocular",E07.695.460
23706701,2013-05-21T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23706701,2013-05-21T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23706701,2013-05-21T00:00:00,"Refraction, Ocular",E01.370.380.850.700
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G01.590.770.760
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G01.595.640.760
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G14.760
23706701,2013-05-21T00:00:00,Regression Analysis,E05.318.740.750
23706701,2013-05-21T00:00:00,Regression Analysis,N05.715.360.750.695
23706701,2013-05-21T00:00:00,Regression Analysis,N06.850.520.830.750
23787030,2013-05-21T00:00:00,Adult,M01.060.116
23787030,2013-05-21T00:00:00,Ambulatory Care,E02.760.106
23787030,2013-05-21T00:00:00,Ambulatory Care,N02.421.585.106
23787030,2013-05-21T00:00:00,Counseling,F02.784.176
23787030,2013-05-21T00:00:00,Counseling,F04.408.413
23787030,2013-05-21T00:00:00,Counseling,N02.421.143.303
23787030,2013-05-21T00:00:00,Counseling,N02.421.461.363
23787030,2013-05-21T00:00:00,HIV Infections,C02.782.815.616.400
23787030,2013-05-21T00:00:00,HIV Infections,C02.800.801.400
23787030,2013-05-21T00:00:00,HIV Infections,C20.673.480
23787030,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23787030,2013-05-21T00:00:00,Mass Screening,E01.370.500
23787030,2013-05-21T00:00:00,Mass Screening,E05.318.308.250.580
23787030,2013-05-21T00:00:00,Mass Screening,N02.421.143.827.233.443
23787030,2013-05-21T00:00:00,Mass Screening,N02.421.726.233.443
23787030,2013-05-21T00:00:00,Mass Screening,N05.715.360.300.375.500
23787030,2013-05-21T00:00:00,Mass Screening,N06.850.520.308.250.580
23787030,2013-05-21T00:00:00,Mass Screening,N06.850.780.500
23787030,2013-05-21T00:00:00,"Models, Psychological",E05.599.695
23787030,2013-05-21T00:00:00,Motivation,F01.658
23787030,2013-05-21T00:00:00,Motivation,F01.752.543.500.750
23787030,2013-05-21T00:00:00,Nicotine,D03.132.760.570
23787030,2013-05-21T00:00:00,Nicotine,D03.383.725.518
23787030,2013-05-21T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23787030,2013-05-21T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23787030,2013-05-21T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23787030,2013-05-21T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23787030,2013-05-21T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23787030,2013-05-21T00:00:00,Pilot Projects,E05.318.760.750
23787030,2013-05-21T00:00:00,Pilot Projects,E05.337.737
23787030,2013-05-21T00:00:00,Pilot Projects,N05.715.360.775.625
23787030,2013-05-21T00:00:00,Pilot Projects,N06.850.520.450.720
23787030,2013-05-21T00:00:00,Referral and Consultation,N04.452.758.849
23787030,2013-05-21T00:00:00,Smoking,F01.145.466.753
23787030,2013-05-21T00:00:00,Smoking Cessation,F01.145.940.700
23697546,2013-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23697546,2013-05-22T00:00:00,Stroke,C10.228.140.300.775
23697546,2013-05-22T00:00:00,Stroke,C14.907.253.855
23697546,2013-05-22T00:00:00,United States,Z01.107.567.875
23711965,2013-05-26T00:00:00,Arsenic Poisoning,C10.720.475.150
23711965,2013-05-26T00:00:00,Arsenic Poisoning,C21.613.097
23711965,2013-05-26T00:00:00,Environmental Exposure,N06.850.460.350
23711965,2013-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23711965,2013-05-26T00:00:00,Neoplasms,C04
23711965,2013-05-26T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23722075,2013-05-27T00:00:00,Adult,M01.060.116
23722075,2013-05-27T00:00:00,Aged,M01.060.116.100
23722075,2013-05-27T00:00:00,Early Detection of Cancer,E01.390.500
23722075,2013-05-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23722075,2013-05-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
23722075,2013-05-27T00:00:00,Health Behavior,F01.145.488
23722075,2013-05-27T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23722075,2013-05-27T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23722075,2013-05-27T00:00:00,Health Services Accessibility,N04.590.374.350
23722075,2013-05-27T00:00:00,Health Services Accessibility,N05.300.430
23722075,2013-05-27T00:00:00,Health Surveys,E05.318.308.250
23722075,2013-05-27T00:00:00,Health Surveys,N05.715.360.300.375
23722075,2013-05-27T00:00:00,Health Surveys,N06.850.520.308.250
23722075,2013-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23722075,2013-05-27T00:00:00,Middle Aged,M01.060.116.630
23722075,2013-05-27T00:00:00,Population Surveillance,E05.318.308.250.700
23722075,2013-05-27T00:00:00,Population Surveillance,N05.715.360.300.375.625
23722075,2013-05-27T00:00:00,Population Surveillance,N06.850.520.308.250.700
23722075,2013-05-27T00:00:00,Population Surveillance,N06.850.780.675
23722075,2013-05-27T00:00:00,South Carolina,Z01.107.567.875.075.662
23722075,2013-05-27T00:00:00,South Carolina,Z01.107.567.875.750.700
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
23714399,2013-05-28T00:00:00,Adolescent,M01.060.057
23714399,2013-05-28T00:00:00,Adult,M01.060.116
23714399,2013-05-28T00:00:00,Aged,M01.060.116.100
23714399,2013-05-28T00:00:00,Antineoplastic Agents,D27.505.954.248
23714399,2013-05-28T00:00:00,Graft Rejection,G12.425.901.545.328
23714399,2013-05-28T00:00:00,Graft Survival,G12.425.901.545.340
23714399,2013-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23714399,2013-05-28T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23714399,2013-05-28T00:00:00,Incidence,E05.318.308.985.525.375
23714399,2013-05-28T00:00:00,Incidence,L01.280.975.525.375
23714399,2013-05-28T00:00:00,Incidence,N01.224.935.597.500
23714399,2013-05-28T00:00:00,Incidence,N06.850.505.400.975.525.375
23714399,2013-05-28T00:00:00,Incidence,N06.850.520.308.985.525.375
23714399,2013-05-28T00:00:00,Kidney,A05.810.453
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.210.650
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.936.450.490
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.936.580.490
23714399,2013-05-28T00:00:00,Middle Aged,M01.060.116.630
23714399,2013-05-28T00:00:00,North America,Z01.107.567
23714399,2013-05-28T00:00:00,Treatment Outcome,E01.789.800
23714399,2013-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
23714399,2013-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23714399,2013-05-28T00:00:00,Young Adult,M01.060.116.815
23721819,2013-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23721819,2013-05-28T00:00:00,Pancreatitis,C06.689.750
23719932,2013-05-29T00:00:00,Adenocarcinoma,C04.557.470.200.025
23719932,2013-05-29T00:00:00,Adult,M01.060.116
23719932,2013-05-29T00:00:00,Aged,M01.060.116.100
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C04.588.443.353
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.301.371.205
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.405.117.430
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.405.249.205
23719932,2013-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23719932,2013-05-29T00:00:00,Middle Aged,M01.060.116.630
23719932,2013-05-29T00:00:00,Neoplasm Staging,E01.370.550
23719932,2013-05-29T00:00:00,SEER Program,E05.318.308.970.725
23719932,2013-05-29T00:00:00,SEER Program,L01.280.950.725
23719932,2013-05-29T00:00:00,SEER Program,N04.452.859.819.725
23719932,2013-05-29T00:00:00,SEER Program,N05.715.360.300.715.700.725
23719932,2013-05-29T00:00:00,SEER Program,N06.850.520.308.970.725
23719932,2013-05-29T00:00:00,United States,Z01.107.567.875
23734084,2013-05-29T00:00:00,Animals,B01.050
23734084,2013-05-29T00:00:00,Cone Opsins,D12.776.306.466.249
23734084,2013-05-29T00:00:00,Cone Opsins,D23.767.930.750.249
23734084,2013-05-29T00:00:00,"Models, Biological",E05.599.395
23734084,2013-05-29T00:00:00,Molecular Weight,G02.842.580
23734084,2013-05-29T00:00:00,Phenotype,G05.695
23734084,2013-05-29T00:00:00,Protein Transport,G03.495.166.700
23734084,2013-05-29T00:00:00,Retina,A09.371.729
23734084,2013-05-29T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23734084,2013-05-29T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.047.850
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.849.131.495.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D23.767.261.700.690
23734084,2013-05-29T00:00:00,Rhodopsin,D12.776.543.750.100.955
23734084,2013-05-29T00:00:00,Rhodopsin,D23.767.930.750.500.500
23288037,2013-06-01T00:00:00,Glucose,D09.546.359.448
23288037,2013-06-01T00:00:00,Heart Failure,C14.280.434
23288037,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23288037,2013-06-01T00:00:00,Pleural Effusion,C08.528.652
23288037,2013-06-01T00:00:00,Proteins,D12.776
23436272,2013-06-01T00:00:00,Adolescent,M01.060.057
23436272,2013-06-01T00:00:00,African Americans,M01.686.508.100.100
23436272,2013-06-01T00:00:00,African Americans,M01.686.754.100
23436272,2013-06-01T00:00:00,Alleles,G05.360.340.024.340.030
23436272,2013-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
23436272,2013-06-01T00:00:00,Blood Pressure,G09.330.380.076
23436272,2013-06-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
23436272,2013-06-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
23436272,2013-06-01T00:00:00,Circadian Rhythm,G07.180.562.190
23436272,2013-06-01T00:00:00,Discrimination (Psychology),F02.463.593.257
23436272,2013-06-01T00:00:00,Endothelin-1,D12.644.276.400.225
23436272,2013-06-01T00:00:00,Endothelin-1,D12.776.467.400.225
23436272,2013-06-01T00:00:00,Endothelin-1,D23.529.400.225
23436272,2013-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23436272,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23436272,2013-06-01T00:00:00,Hypertension,C14.907.489
23436272,2013-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23436272,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23564430,2013-06-01T00:00:00,AIDS-Related Opportunistic Infections,C01.539.597.050
23564430,2013-06-01T00:00:00,AIDS-Related Opportunistic Infections,C02.597.050
23564430,2013-06-01T00:00:00,AIDS-Related Opportunistic Infections,C02.782.815.616.400.100
23564430,2013-06-01T00:00:00,AIDS-Related Opportunistic Infections,C03.684.050
23564430,2013-06-01T00:00:00,AIDS-Related Opportunistic Infections,C20.673.480.100
23564430,2013-06-01T00:00:00,Adult,M01.060.116
23564430,2013-06-01T00:00:00,African Americans,M01.686.508.100.100
23564430,2013-06-01T00:00:00,African Americans,M01.686.754.100
23564430,2013-06-01T00:00:00,Aged,M01.060.116.100
23564430,2013-06-01T00:00:00,Awareness,F02.463.188.150
23564430,2013-06-01T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
23564430,2013-06-01T00:00:00,HIV Seropositivity,C02.800.801.400.500
23564430,2013-06-01T00:00:00,HIV Seropositivity,C20.673.480.500
23564430,2013-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23564430,2013-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23564430,2013-06-01T00:00:00,Health Literacy,I02.233.332.186.500
23564430,2013-06-01T00:00:00,Health Literacy,N02.421.143.827.407.228.500
23564430,2013-06-01T00:00:00,Health Literacy,N02.421.726.407.228.500
23564430,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23564430,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23564430,2013-06-01T00:00:00,Papillomavirus Infections,C02.256.650
23564430,2013-06-01T00:00:00,Papillomavirus Infections,C02.928.725
23564430,2013-06-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
23564430,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23640069,2013-06-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23640069,2013-06-01T00:00:00,Biological Transport,G03.495.166
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23640069,2013-06-01T00:00:00,Drug Discovery,E05.295
23640069,2013-06-01T00:00:00,Drug Discovery,H01.158.703.007.675
23640069,2013-06-01T00:00:00,Drug Discovery,H01.181.466.675
23640069,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23640069,2013-06-01T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23640069,2013-06-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23673393,2013-06-01T00:00:00,Adolescent,M01.060.057
23673393,2013-06-01T00:00:00,Adult,M01.060.116
23673393,2013-06-01T00:00:00,Breast Neoplasms,C04.588.180
23673393,2013-06-01T00:00:00,Breast Neoplasms,C17.800.090.500
23673393,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23673393,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.233.675
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.720
23673393,2013-06-01T00:00:00,Survivors,M01.643.836
23673393,2013-06-01T00:00:00,Survivors,M01.860
23673393,2013-06-01T00:00:00,United States,Z01.107.567.875
23673685,2013-06-01T00:00:00,Adult,M01.060.116
23673685,2013-06-01T00:00:00,Device Removal,E04.199
23673685,2013-06-01T00:00:00,Gastroplasty,E02.065.062.750
23673685,2013-06-01T00:00:00,Gastroplasty,E04.062.750
23673685,2013-06-01T00:00:00,Gastroplasty,E04.210.485
23673685,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23673685,2013-06-01T00:00:00,Incidence,E05.318.308.985.525.375
23673685,2013-06-01T00:00:00,Incidence,L01.280.975.525.375
23673685,2013-06-01T00:00:00,Incidence,N01.224.935.597.500
23673685,2013-06-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23673685,2013-06-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23673685,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23673685,2013-06-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23673685,2013-06-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23673685,2013-06-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23673685,2013-06-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23673685,2013-06-01T00:00:00,Postoperative Complications,C23.550.767
23673685,2013-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23673685,2013-06-01T00:00:00,Risk Factors,N05.715.350.200.700
23673685,2013-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23673685,2013-06-01T00:00:00,Risk Factors,N06.850.490.625.750
23673685,2013-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23673685,2013-06-01T00:00:00,Time Factors,G01.910.857
23673685,2013-06-01T00:00:00,Weight Loss,C23.888.144.243.963
23673685,2013-06-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23677878,2013-06-01T00:00:00,Animals,B01.050
23677878,2013-06-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23677878,2013-06-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23677878,2013-06-01T00:00:00,"Genes, Homeobox",G05.360.340.024.340.230.500
23677878,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.260.600
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.660.600
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.930.600
23677878,2013-06-01T00:00:00,Phenotype,G05.695
23687070,2013-06-01T00:00:00,Alkynes,D02.455.326.397
23687070,2013-06-01T00:00:00,Azides,D01.625.100
23687070,2013-06-01T00:00:00,Azides,D02.159
23687070,2013-06-01T00:00:00,Carbohydrates,D09
23687070,2013-06-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23687070,2013-06-01T00:00:00,Glycoproteins,D09.400.430
23687070,2013-06-01T00:00:00,Glycoproteins,D12.776.395
23687070,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23687070,2013-06-01T00:00:00,Stromal Cells,A11.329.830
23687070,2013-06-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
23694883,2013-06-01T00:00:00,Adolescent,M01.060.057
23694883,2013-06-01T00:00:00,Adult,M01.060.116
23694883,2013-06-01T00:00:00,Aged,M01.060.116.100
23694883,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23694883,2013-06-01T00:00:00,Intensive Care Units,N02.278.388.493
23694883,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23694883,2013-06-01T00:00:00,Patient Discharge,E02.760.400.610
23694883,2013-06-01T00:00:00,Patient Discharge,N02.421.585.400.610
23694883,2013-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23694883,2013-06-01T00:00:00,Risk Factors,N05.715.350.200.700
23694883,2013-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23694883,2013-06-01T00:00:00,Risk Factors,N06.850.490.625.750
23694883,2013-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23694883,2013-06-01T00:00:00,Sex Factors,N05.715.350.675
23694883,2013-06-01T00:00:00,Sex Factors,N06.850.490.875
23694883,2013-06-01T00:00:00,Time Factors,G01.910.857
23694883,2013-06-01T00:00:00,Wounds and Injuries,C21.866
23694883,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23706430,2013-06-01T00:00:00,Adult,M01.060.116
23706430,2013-06-01T00:00:00,"Anastomosis, Surgical",E04.035
23706430,2013-06-01T00:00:00,Clinical Competence,I02.399.630.210
23706430,2013-06-01T00:00:00,Clinical Competence,N04.761.210
23706430,2013-06-01T00:00:00,Computer Simulation,L01.224.160
23706430,2013-06-01T00:00:00,Coronary Vessels,A07.231.114.269
23706430,2013-06-01T00:00:00,Coronary Vessels,A07.231.908.194
23706430,2013-06-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23706430,2013-06-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23706430,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706430,2013-06-01T00:00:00,Internship and Residency,I02.358.399.644
23706430,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23706430,2013-06-01T00:00:00,Needs Assessment,I02.594
23706430,2013-06-01T00:00:00,Needs Assessment,N03.349.380.565
23706430,2013-06-01T00:00:00,Needs Assessment,N05.300.537
23706430,2013-06-01T00:00:00,Questionnaires,E05.318.308.750
23706430,2013-06-01T00:00:00,Questionnaires,L01.280.800
23706430,2013-06-01T00:00:00,Questionnaires,N05.715.360.300.695
23706430,2013-06-01T00:00:00,Questionnaires,N06.850.520.308.750
23706430,2013-06-01T00:00:00,Thoracic Surgical Procedures,E04.928
23706430,2013-06-01T00:00:00,United States,Z01.107.567.875
23706430,2013-06-01T00:00:00,Video Recording,L01.240.960
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase I as Topic",E05.318.760.535.200
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase I as Topic",E05.337.250.200
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase I as Topic",N05.715.360.775.235.200
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase I as Topic",N06.850.520.450.535.200
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase II as Topic",E05.318.760.535.210
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase II as Topic",E05.337.250.210
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase II as Topic",N05.715.360.775.235.210
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase II as Topic",N06.850.520.450.535.210
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
23709704,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709704,2013-06-01T00:00:00,Research Design,E05.581.500
23709704,2013-06-01T00:00:00,Research Design,H01.770.644.728
23709704,2013-06-01T00:00:00,Stroke,C10.228.140.300.775
23709704,2013-06-01T00:00:00,Stroke,C14.907.253.855
23709704,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23709704,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23709704,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23709726,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23709726,2013-06-01T00:00:00,Neurosurgical Procedures,E04.525
23709726,2013-06-01T00:00:00,Research Design,E05.581.500
23709726,2013-06-01T00:00:00,Research Design,H01.770.644.728
23709726,2013-06-01T00:00:00,Stents,E07.695.750
23709726,2013-06-01T00:00:00,Stroke,C10.228.140.300.775
23709726,2013-06-01T00:00:00,Stroke,C14.907.253.855
23709726,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23709726,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23709726,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23709726,2013-06-01T00:00:00,Vascular Surgical Procedures,E04.100.814
23736180,2013-06-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23736180,2013-06-01T00:00:00,Hospitalization,E02.760.400
23736180,2013-06-01T00:00:00,Hospitalization,N02.421.585.400
23736180,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23736180,2013-06-01T00:00:00,Information Dissemination,F01.145.209.364
23736180,2013-06-01T00:00:00,Information Dissemination,L01.143.443
23736180,2013-06-01T00:00:00,United States,Z01.107.567.875
23736180,2013-06-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23736180,2013-06-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23805571,2013-06-01T00:00:00,Animals,B01.050
23805571,2013-06-01T00:00:00,Vitamin D,D04.808.812.768
23930384,2013-06-01T00:00:00,Adolescent,M01.060.057
23930384,2013-06-01T00:00:00,Equipment Failure Analysis,E05.325.192
23930384,2013-06-01T00:00:00,Extracorporeal Circulation,E04.292
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.100.376.475
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.928.220.390
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.936.450.475
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E04.050.430
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E07.695.300.300
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
23930384,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23930384,2013-06-01T00:00:00,Magnetics,H01.671.493
23930384,2013-06-01T00:00:00,Pediatrics,H02.403.670
23930384,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23930384,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23930384,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23930384,2013-06-01T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
24015481,2013-06-01T00:00:00,Animals,B01.050
24015481,2013-06-01T00:00:00,Cartilage,A02.165
24015481,2013-06-01T00:00:00,Cartilage,A10.165.382
24015481,2013-06-01T00:00:00,Computer Simulation,L01.224.160
24015481,2013-06-01T00:00:00,Finite Element Analysis,E05.355
24015481,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24015481,2013-06-01T00:00:00,"Models, Biological",E05.599.395
24015481,2013-06-01T00:00:00,Regeneration,G16.100.856
23743354,2013-06-03T00:00:00,Animals,B01.050
23743354,2013-06-03T00:00:00,"Antigens, CD147",D12.776.395.550.045
23743354,2013-06-03T00:00:00,"Antigens, CD147",D12.776.543.550.188
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.050.285.040
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.101.100.110.247
23743354,2013-06-03T00:00:00,Cell Movement,G04.299.283
23743354,2013-06-03T00:00:00,Cell Movement,G07.700.560.500.180
23743354,2013-06-03T00:00:00,Disease Progression,C23.550.291.656
23743354,2013-06-03T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23743354,2013-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23743354,2013-06-03T00:00:00,Neoplasm Invasiveness,C04.697.645
23743354,2013-06-03T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23743354,2013-06-03T00:00:00,Signal Transduction,G02.111.087.800
23743354,2013-06-03T00:00:00,Signal Transduction,G02.149.115.800
23743354,2013-06-03T00:00:00,Signal Transduction,G04.299.880
23736306,2013-06-05T00:00:00,Adolescent,M01.060.057
23736306,2013-06-05T00:00:00,Blood Glucose,D09.546.359.448.500
23736306,2013-06-05T00:00:00,Blood Pressure,E01.370.600.875.249
23736306,2013-06-05T00:00:00,Blood Pressure,G09.330.380.076
23736306,2013-06-05T00:00:00,Child,M01.060.406
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D10.532.432.400
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
23736306,2013-06-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23736306,2013-06-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
23736306,2013-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23736306,2013-06-05T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23736306,2013-06-05T00:00:00,Metabolic Syndrome X,C18.452.625
23736306,2013-06-05T00:00:00,Mexican Americans,M01.686.754.441.500
23736306,2013-06-05T00:00:00,Overweight,C23.888.144.699
23736306,2013-06-05T00:00:00,Overweight,E01.370.600.115.100.160.120.699
23736306,2013-06-05T00:00:00,Overweight,G07.100.100.160.120.699
23736306,2013-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23736306,2013-06-05T00:00:00,Risk Factors,N05.715.350.200.700
23736306,2013-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23736306,2013-06-05T00:00:00,Risk Factors,N06.850.490.625.750
23736306,2013-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23738693,2013-06-05T00:00:00,Arabidopsis,B01.650.388.100.157.100
23738693,2013-06-05T00:00:00,Gene Expression Profiling,E05.393.332
23738693,2013-06-05T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23738693,2013-06-05T00:00:00,"Genes, Plant",G05.360.340.024.340.393
23738693,2013-06-05T00:00:00,"Genes, Plant",G05.360.340.365.500
23740367,2013-06-06T00:00:00,Aged,M01.060.116.100
23740367,2013-06-06T00:00:00,Computer Simulation,L01.224.160
23740367,2013-06-06T00:00:00,Electromyography,E01.370.405.255
23740367,2013-06-06T00:00:00,Electromyography,E01.370.530.255
23740367,2013-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23740367,2013-06-06T00:00:00,Leg,A01.378.610.500
23740367,2013-06-06T00:00:00,"Models, Neurological",E05.599.395.642
23740367,2013-06-06T00:00:00,Muscle Contraction,G11.427.590.540
23740367,2013-06-06T00:00:00,"Muscle, Skeletal",A02.633.567
23740367,2013-06-06T00:00:00,"Muscle, Skeletal",A10.690.552.500
23740367,2013-06-06T00:00:00,Walking,G11.427.590.530.568.900
23740367,2013-06-06T00:00:00,Walking,G11.427.590.530.698.940
23740367,2013-06-06T00:00:00,Walking,I03.450.642.845.940
23749868,2013-06-07T00:00:00,Aged,M01.060.116.100
23749868,2013-06-07T00:00:00,Case-Control Studies,E05.318.760.500.500
23749868,2013-06-07T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23749868,2013-06-07T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23749868,2013-06-07T00:00:00,Ceramides,D02.065.313
23749868,2013-06-07T00:00:00,Ceramides,D09.400.410.420.525.200
23749868,2013-06-07T00:00:00,Ceramides,D10.390.470.675.200
23749868,2013-06-07T00:00:00,Ceramides,D10.570.877.360.612.200
23749868,2013-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23749868,2013-06-07T00:00:00,Lung Neoplasms,C04.588.894.797.520
23749868,2013-06-07T00:00:00,Lung Neoplasms,C08.381.540
23749868,2013-06-07T00:00:00,Lung Neoplasms,C08.785.520
23749868,2013-06-07T00:00:00,Lysophospholipids,D10.570.755.375.760.550
23749868,2013-06-07T00:00:00,Middle Aged,M01.060.116.630
23749868,2013-06-07T00:00:00,Sphingolipids,D10.570.877
23749868,2013-06-07T00:00:00,Sphingolipids,D10.808
23749868,2013-06-07T00:00:00,Sphingosine,D02.033.100.700
23749868,2013-06-07T00:00:00,Sphingosine,D02.033.455.843
23749868,2013-06-07T00:00:00,Sphingosine,D02.092.063.700
23749868,2013-06-07T00:00:00,"Tumor Markers, Biological",D23.101.840
23759513,2013-06-10T00:00:00,Animals,B01.050
23759513,2013-06-10T00:00:00,Central Nervous System,A08.186
23759513,2013-06-10T00:00:00,Cytokines,D12.644.276.374
23759513,2013-06-10T00:00:00,Cytokines,D12.776.467.374
23759513,2013-06-10T00:00:00,Cytokines,D23.529.374
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23759513,2013-06-10T00:00:00,Neuroglia,A08.637
23759513,2013-06-10T00:00:00,Neuroglia,A11.650
23759513,2013-06-10T00:00:00,Oligodendroglia,A08.637.600
23759513,2013-06-10T00:00:00,Oligodendroglia,A11.650.600
23759513,2013-06-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23759513,2013-06-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23759513,2013-06-10T00:00:00,Reactive Oxygen Species,D01.339.431
23759513,2013-06-10T00:00:00,Reactive Oxygen Species,D01.650.775
23759513,2013-06-10T00:00:00,Signal Transduction,G02.111.087.800
23759513,2013-06-10T00:00:00,Signal Transduction,G02.149.115.800
23759513,2013-06-10T00:00:00,Signal Transduction,G04.299.880
23696608,2013-06-12T00:00:00,Animals,B01.050
23696608,2013-06-12T00:00:00,"Disease Models, Animal",C22.232
23696608,2013-06-12T00:00:00,"Disease Models, Animal",E05.598.500
23696608,2013-06-12T00:00:00,"Disease Models, Animal",E05.599.395.080
23696608,2013-06-12T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
23696608,2013-06-12T00:00:00,Reperfusion Injury,C14.907.725
23696608,2013-06-12T00:00:00,Reperfusion Injury,C23.550.767.877
23696608,2013-06-12T00:00:00,Retina,A09.371.729
23696608,2013-06-12T00:00:00,Retinal Degeneration,C11.768.585
23756689,2013-06-12T00:00:00,Brain Ischemia,C10.228.140.300.150
23756689,2013-06-12T00:00:00,Brain Ischemia,C14.907.253.092
23756689,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23756689,2013-06-12T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23756689,2013-06-12T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23756689,2013-06-12T00:00:00,Recovery of Function,G16.757
23756689,2013-06-12T00:00:00,Stroke,C10.228.140.300.775
23756689,2013-06-12T00:00:00,Stroke,C14.907.253.855
23760299,2013-06-12T00:00:00,Animals,B01.050
23760299,2013-06-12T00:00:00,Butterflies,B01.050.500.131.617.561.200
23760299,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23788812,2013-06-12T00:00:00,Career Choice,F02.463.785.373.346.400
23788812,2013-06-12T00:00:00,Curriculum,I02.158
23788812,2013-06-12T00:00:00,Faculty,I02.463
23788812,2013-06-12T00:00:00,Faculty,M01.526.339
23788812,2013-06-12T00:00:00,Feedback,L01.143.283.425
23788812,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23788812,2013-06-12T00:00:00,"Internship, Nonmedical",I02.358.750
23788812,2013-06-12T00:00:00,Program Development,N04.452.760
23788812,2013-06-12T00:00:00,Program Evaluation,E05.337.820
23788812,2013-06-12T00:00:00,Program Evaluation,N04.761.685
23788812,2013-06-12T00:00:00,Program Evaluation,N05.715.360.650
23788812,2013-06-12T00:00:00,"Schools, Pharmacy",I02.783.660.694
23788812,2013-06-12T00:00:00,Teaching,I02.903
23788812,2013-06-12T00:00:00,Time Factors,G01.910.857
23943931,2013-06-12T00:00:00,Attitude of Health Personnel,F01.100.050
23943931,2013-06-12T00:00:00,Attitude of Health Personnel,N05.300.100
23943931,2013-06-12T00:00:00,Clinical Competence,I02.399.630.210
23943931,2013-06-12T00:00:00,Clinical Competence,N04.761.210
23943931,2013-06-12T00:00:00,Cooperative Behavior,F01.145.813.115
23943931,2013-06-12T00:00:00,Diffusion of Innovation,L01.143.320
23943931,2013-06-12T00:00:00,Forecasting,I01.320
23943931,2013-06-12T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23943931,2013-06-12T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23943931,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,F01.145.209.381
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,L01.143.474
23943931,2013-06-12T00:00:00,Motivation,F01.658
23943931,2013-06-12T00:00:00,Motivation,F01.752.543.500.750
23943931,2013-06-12T00:00:00,Patient Care Team,N04.590.715
23943931,2013-06-12T00:00:00,Pharmaceutical Services,N02.421.668
23943931,2013-06-12T00:00:00,Professional-Patient Relations,F01.829.401.650
23943931,2013-06-12T00:00:00,Professional-Patient Relations,N05.300.660
23943931,2013-06-12T00:00:00,Time Factors,G01.910.857
23943931,2013-06-12T00:00:00,Workload,N04.452.677.950
23766515,2013-06-13T00:00:00,Animals,B01.050
23766515,2013-06-13T00:00:00,Cell Line,A11.251.210
23766515,2013-06-13T00:00:00,Diet,E05.272
23766515,2013-06-13T00:00:00,Diet,G07.610.240
23766515,2013-06-13T00:00:00,Interleukin-6,D12.644.276.374.465.506
23766515,2013-06-13T00:00:00,Interleukin-6,D12.776.467.374.465.506
23766515,2013-06-13T00:00:00,Interleukin-6,D23.529.374.465.506
23766515,2013-06-13T00:00:00,"Muscle, Skeletal",A02.633.567
23766515,2013-06-13T00:00:00,"Muscle, Skeletal",A10.690.552.500
23766515,2013-06-13T00:00:00,Obesity,C18.654.726.500
23766515,2013-06-13T00:00:00,Obesity,C23.888.144.699.500
23766515,2013-06-13T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23766515,2013-06-13T00:00:00,Obesity,G07.100.100.160.120.699.500
23766515,2013-06-13T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23766515,2013-06-13T00:00:00,Signal Transduction,G02.111.087.800
23766515,2013-06-13T00:00:00,Signal Transduction,G02.149.115.800
23766515,2013-06-13T00:00:00,Signal Transduction,G04.299.880
23770374,2013-06-14T00:00:00,Constipation,C23.888.821.150
23770374,2013-06-14T00:00:00,Encopresis,C23.888.821.266
23770374,2013-06-14T00:00:00,Encopresis,F01.145.126.837
23770374,2013-06-14T00:00:00,Encopresis,F03.550.375.300
23770374,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905826,2013-06-14T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23905826,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905826,2013-06-14T00:00:00,Infant,M01.060.703
23905826,2013-06-14T00:00:00,"Infant, Newborn",M01.060.703.520
23905826,2013-06-14T00:00:00,Laryngomalacia,C05.182.310
23905826,2013-06-14T00:00:00,Laryngomalacia,C08.360.563
23905826,2013-06-14T00:00:00,Laryngomalacia,C09.400.563
23905826,2013-06-14T00:00:00,Laryngomalacia,C16.131.621.568
23905826,2013-06-14T00:00:00,Laryngomalacia,C17.300.182.310
23905826,2013-06-14T00:00:00,Laryngoscopy,E01.370.386.460
23905826,2013-06-14T00:00:00,Laryngoscopy,E01.370.388.250.525
23905826,2013-06-14T00:00:00,Laryngoscopy,E04.580.373
23905826,2013-06-14T00:00:00,Laryngoscopy,E04.800.250.525
23905826,2013-06-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23905826,2013-06-14T00:00:00,Risk Factors,N05.715.350.200.700
23905826,2013-06-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23905826,2013-06-14T00:00:00,Risk Factors,N06.850.490.625.750
23905826,2013-06-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23773363,2013-06-18T00:00:00,Albumins,D12.776.034
23773363,2013-06-18T00:00:00,Alleles,G05.360.340.024.340.030
23773363,2013-06-18T00:00:00,Animals,B01.050
23773363,2013-06-18T00:00:00,Gene Expression Regulation,G05.355.315
23773363,2013-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23773363,2013-06-18T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
23773363,2013-06-18T00:00:00,Membrane Proteins,D12.776.543
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23773363,2013-06-18T00:00:00,Protein Transport,G03.495.166.700
23785141,2013-06-19T00:00:00,Animals,B01.050
23785141,2013-06-19T00:00:00,Circadian Rhythm,G07.180.562.190
23785141,2013-06-19T00:00:00,Color,G01.201.875.770.578.199
23785141,2013-06-19T00:00:00,Color,G01.590.540.199
23785141,2013-06-19T00:00:00,"Electrodes, Implanted",E07.305.250.319
23785141,2013-06-19T00:00:00,Electroencephalography,E01.370.376.300
23785141,2013-06-19T00:00:00,Electroencephalography,E01.370.405.245
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D06.472.699.327
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.644.400.400
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.644.548.365
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.776.641.650.405
23785141,2013-06-19T00:00:00,Hypothalamus,A08.186.211.464.482
23785141,2013-06-19T00:00:00,Hypothalamus,A08.186.211.730.317.357
23785141,2013-06-19T00:00:00,Melanins,D12.125.072.050.875.379
23785141,2013-06-19T00:00:00,Melanins,D23.767.620
23785141,2013-06-19T00:00:00,Neurons,A08.663
23785141,2013-06-19T00:00:00,Neurons,A11.671
23785141,2013-06-19T00:00:00,Photic Stimulation,E05.723.729
23785141,2013-06-19T00:00:00,Pituitary Hormones,D06.472.699.631
23785141,2013-06-19T00:00:00,Pituitary Hormones,D12.644.548.691
23785141,2013-06-19T00:00:00,Plasmids,G05.360.600
23785141,2013-06-19T00:00:00,Rhodopsin,D12.776.543.750.100.955
23785141,2013-06-19T00:00:00,Rhodopsin,D23.767.930.750.500.500
23785141,2013-06-19T00:00:00,Sleep,F02.830.855
23785141,2013-06-19T00:00:00,Sleep,G11.561.600.815
23785141,2013-06-19T00:00:00,"Sleep, REM",F02.830.855.796.671
23785141,2013-06-19T00:00:00,"Sleep, REM",G11.561.600.815.754.671
23785141,2013-06-19T00:00:00,Wakefulness,F02.830.104.821
23785141,2013-06-19T00:00:00,Wakefulness,G11.561.600.042.738
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23782182,2013-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23782182,2013-06-20T00:00:00,Stroke,C10.228.140.300.775
23782182,2013-06-20T00:00:00,Stroke,C14.907.253.855
23782182,2013-06-20T00:00:00,Thrombectomy,E04.100.814.842
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D23.119.970
23791160,2013-06-21T00:00:00,Adult,M01.060.116
23791160,2013-06-21T00:00:00,Aged,M01.060.116.100
23791160,2013-06-21T00:00:00,Animals,B01.050
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis,E07.695.110
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
23791160,2013-06-21T00:00:00,Case-Control Studies,E05.318.760.500.500
23791160,2013-06-21T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23791160,2013-06-21T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23791160,2013-06-21T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23791160,2013-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791160,2013-06-21T00:00:00,Lung Neoplasms,C04.588.894.797.520
23791160,2013-06-21T00:00:00,Lung Neoplasms,C08.381.540
23791160,2013-06-21T00:00:00,Lung Neoplasms,C08.785.520
23791160,2013-06-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23791160,2013-06-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23791160,2013-06-21T00:00:00,Middle Aged,M01.060.116.630
23791160,2013-06-21T00:00:00,Neoplasm Invasiveness,C04.697.645
23791160,2013-06-21T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23791160,2013-06-21T00:00:00,Pneumonectomy,E04.928.600.600
23791160,2013-06-21T00:00:00,Prosthesis Failure,C23.550.767.865
23791160,2013-06-21T00:00:00,Prosthesis Failure,E05.325.771
23791160,2013-06-21T00:00:00,Reconstructive Surgical Procedures,E04.680
23791160,2013-06-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23791160,2013-06-21T00:00:00,Risk Assessment,N04.452.871.715
23791160,2013-06-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23791160,2013-06-21T00:00:00,Risk Assessment,N06.850.505.715
23791160,2013-06-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23791160,2013-06-21T00:00:00,Time Factors,G01.910.857
23791160,2013-06-21T00:00:00,Treatment Outcome,E01.789.800
23791160,2013-06-21T00:00:00,Treatment Outcome,N04.761.559.590.800
23791160,2013-06-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23791160,2013-06-21T00:00:00,Vascular Patency,G09.330.920
23791160,2013-06-21T00:00:00,"Vena Cava, Superior",A07.231.908.949.815
23806824,2013-06-24T00:00:00,Extremities,A01.378
23806824,2013-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23806824,2013-06-24T00:00:00,Lymph Node Excision,E04.446
23806824,2013-06-24T00:00:00,Middle Aged,M01.060.116.630
23806824,2013-06-24T00:00:00,Neoplasm Invasiveness,C04.697.645
23806824,2013-06-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23806824,2013-06-24T00:00:00,Neoplasm Staging,E01.370.550
23806824,2013-06-24T00:00:00,SEER Program,E05.318.308.970.725
23806824,2013-06-24T00:00:00,SEER Program,L01.280.950.725
23806824,2013-06-24T00:00:00,SEER Program,N04.452.859.819.725
23806824,2013-06-24T00:00:00,SEER Program,N05.715.360.300.715.700.725
23806824,2013-06-24T00:00:00,SEER Program,N06.850.520.308.970.725
23806824,2013-06-24T00:00:00,Sarcoma,C04.557.450.795
23806824,2013-06-24T00:00:00,United States,Z01.107.567.875
23800882,2013-06-25T00:00:00,Animals,B01.050
23800882,2013-06-25T00:00:00,"Antigens, CD",D23.050.301.264.035
23800882,2013-06-25T00:00:00,"Antigens, CD",D23.101.100.110
23800882,2013-06-25T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23800882,2013-06-25T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23800882,2013-06-25T00:00:00,Cell Adhesion,G04.299.117
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D23.050.301.350
23800882,2013-06-25T00:00:00,"Endothelium, Vascular",A07.231.330
23800882,2013-06-25T00:00:00,"Endothelium, Vascular",A10.272.491.355
23800882,2013-06-25T00:00:00,Macrophages,A11.329.372
23800882,2013-06-25T00:00:00,Macrophages,A11.627.482
23800882,2013-06-25T00:00:00,Macrophages,A11.733.397
23800882,2013-06-25T00:00:00,Macrophages,A15.382.680.397
23800882,2013-06-25T00:00:00,Macrophages,A15.382.812.522
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.339.387
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.625.550.500
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.625.700.500
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.650.550.587.600
23800882,2013-06-25T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23800882,2013-06-25T00:00:00,Oxidative Stress,G03.495.710
23800882,2013-06-25T00:00:00,Oxidative Stress,G07.700.830.750
23800882,2013-06-25T00:00:00,RNA Interference,G05.355.315.203.374.790
23800882,2013-06-25T00:00:00,Signal Transduction,G02.111.087.800
23800882,2013-06-25T00:00:00,Signal Transduction,G02.149.115.800
23800882,2013-06-25T00:00:00,Signal Transduction,G04.299.880
23801650,2013-06-25T00:00:00,Chromosome Aberrations,C23.550.210
23801650,2013-06-25T00:00:00,Chromosome Aberrations,G05.365.590.175
23801650,2013-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
23801650,2013-06-25T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23801650,2013-06-25T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
23804395,2013-06-26T00:00:00,Adenoidectomy,E04.580.068
23804395,2013-06-26T00:00:00,Age Factors,N05.715.350.075
23804395,2013-06-26T00:00:00,Age Factors,N06.850.490.250
23804395,2013-06-26T00:00:00,"Child, Preschool",M01.060.406.448
23804395,2013-06-26T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
23804395,2013-06-26T00:00:00,"Databases, Factual",L01.470.750.750
23804395,2013-06-26T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23804395,2013-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23804395,2013-06-26T00:00:00,Infant,M01.060.703
23804395,2013-06-26T00:00:00,"Monitoring, Physiologic",E01.370.520
23804395,2013-06-26T00:00:00,Oxygen Consumption,G03.730
23804395,2013-06-26T00:00:00,Polysomnography,E01.370.520.625
23804395,2013-06-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
23804395,2013-06-26T00:00:00,Risk Assessment,N04.452.871.715
23804395,2013-06-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23804395,2013-06-26T00:00:00,Risk Assessment,N06.850.505.715
23804395,2013-06-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23804395,2013-06-26T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
23804395,2013-06-26T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
23804395,2013-06-26T00:00:00,Tonsillectomy,E04.580.848
23804395,2013-06-26T00:00:00,Tracheostomy,E04.579.935
23804395,2013-06-26T00:00:00,Tracheostomy,E04.580.900
23804395,2013-06-26T00:00:00,Tracheostomy,E04.928.780
23804395,2013-06-26T00:00:00,Treatment Outcome,E01.789.800
23804395,2013-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
23804395,2013-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23811330,2013-06-26T00:00:00,Animals,B01.050
23811330,2013-06-26T00:00:00,Cell Survival,G04.299.316
23811330,2013-06-26T00:00:00,Environmental Pollutants,D27.888.284
23811330,2013-06-26T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
23811330,2013-06-26T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23811330,2013-06-26T00:00:00,Mitochondria,A11.284.835.626
23811330,2013-06-26T00:00:00,Oxygen Consumption,G03.730
23811330,2013-06-26T00:00:00,Rabbits,B01.050.150.900.649.521.700
23811330,2013-06-26T00:00:00,Small Molecule Libraries,D27.720.470.765
23812826,2013-06-29T00:00:00,Adult,M01.060.116
23812826,2013-06-29T00:00:00,Aged,M01.060.116.100
23812826,2013-06-29T00:00:00,Ascitic Fluid,A12.207.119
23812826,2013-06-29T00:00:00,Biological Markers,D23.101
23812826,2013-06-29T00:00:00,Case-Control Studies,E05.318.760.500.500
23812826,2013-06-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23812826,2013-06-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23812826,2013-06-29T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23812826,2013-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23812826,2013-06-29T00:00:00,Liver Transplantation,E04.210.650
23812826,2013-06-29T00:00:00,Liver Transplantation,E04.936.450.490
23812826,2013-06-29T00:00:00,Liver Transplantation,E04.936.580.490
23812826,2013-06-29T00:00:00,Middle Aged,M01.060.116.630
23820626,2013-06-29T00:00:00,Cardiac Surgical Procedures,E04.100.376
23820626,2013-06-29T00:00:00,Cardiac Surgical Procedures,E04.928.220
23820626,2013-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23820626,2013-06-29T00:00:00,Stroke,C10.228.140.300.775
23820626,2013-06-29T00:00:00,Stroke,C14.907.253.855
23905932,2013-06-29T00:00:00,Emergencies,C23.550.291.781
23905932,2013-06-29T00:00:00,Emergencies,N06.230.100.083
23905932,2013-06-29T00:00:00,Emergencies,N06.850.376
23905932,2013-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,F01.145.209.381
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,L01.143.474
23905932,2013-06-29T00:00:00,Kidney,A05.810.453
23905932,2013-06-29T00:00:00,Multiple Trauma,C21.866.640
23905932,2013-06-29T00:00:00,Urethra,A05.360.444.492.726
23905932,2013-06-29T00:00:00,Urethra,A05.810.876
23905932,2013-06-29T00:00:00,Urinary Bladder,A05.810.890
23320737,2013-07-01T00:00:00,Animals,B01.050
23320737,2013-07-01T00:00:00,Bone Marrow,A15.382.216
23320737,2013-07-01T00:00:00,Cell Differentiation,G04.299.151
23320737,2013-07-01T00:00:00,Cell Line,A11.251.210
23320737,2013-07-01T00:00:00,Dendritic Cells,A11.066.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A11.436.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A15.382.066.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A15.382.812.260
23320737,2013-07-01T00:00:00,Macrophages,A11.329.372
23320737,2013-07-01T00:00:00,Macrophages,A11.627.482
23320737,2013-07-01T00:00:00,Macrophages,A11.733.397
23320737,2013-07-01T00:00:00,Macrophages,A15.382.680.397
23320737,2013-07-01T00:00:00,Macrophages,A15.382.812.522
23320737,2013-07-01T00:00:00,Membrane Proteins,D12.776.543
23320737,2013-07-01T00:00:00,Monocytes,A11.118.637.555.652
23320737,2013-07-01T00:00:00,Monocytes,A11.148.580
23320737,2013-07-01T00:00:00,Monocytes,A11.627.624
23320737,2013-07-01T00:00:00,Monocytes,A11.733.547
23320737,2013-07-01T00:00:00,Monocytes,A15.145.229.637.555.652
23320737,2013-07-01T00:00:00,Monocytes,A15.378.316.580
23320737,2013-07-01T00:00:00,Monocytes,A15.382.490.555.652
23320737,2013-07-01T00:00:00,Monocytes,A15.382.680.547
23320737,2013-07-01T00:00:00,Monocytes,A15.382.812.547
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
23320737,2013-07-01T00:00:00,Spleen,A10.549.700
23320737,2013-07-01T00:00:00,Spleen,A15.382.520.604.700
23388845,2013-07-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
23388845,2013-07-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
23388845,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23388845,2013-07-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23388845,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23715884,2013-07-01T00:00:00,Central Nervous System Diseases,C10.228
23715884,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23715884,2013-07-01T00:00:00,Malnutrition,C18.654.521
23715884,2013-07-01T00:00:00,Mental Disorders,F03
23715884,2013-07-01T00:00:00,Peripheral Nervous System Diseases,C10.668.829
23715884,2013-07-01T00:00:00,Vision Disorders,C10.597.751.941
23715884,2013-07-01T00:00:00,Vision Disorders,C11.966
23715884,2013-07-01T00:00:00,Vision Disorders,C23.888.592.763.941
23733664,2013-07-01T00:00:00,Agriculture,J01.040
23733664,2013-07-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23733664,2013-07-01T00:00:00,Environmental Monitoring,N06.850.780.375
23733664,2013-07-01T00:00:00,Environmental Pollutants,D27.888.284
23733664,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23778441,2013-07-01T00:00:00,Adult,M01.060.116
23778441,2013-07-01T00:00:00,"Embolization, Therapeutic",E02.520.360
23778441,2013-07-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,L01.280.975.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N01.224.935.698.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23778441,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23778441,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23778441,2013-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23778441,2013-07-01T00:00:00,Risk Assessment,N04.452.871.715
23778441,2013-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23778441,2013-07-01T00:00:00,Risk Assessment,N06.850.505.715
23778441,2013-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23778441,2013-07-01T00:00:00,Salvage Therapy,E02.186.800
23778441,2013-07-01T00:00:00,Salvage Therapy,E02.895
23778441,2013-07-01T00:00:00,Spleen,A10.549.700
23778441,2013-07-01T00:00:00,Spleen,A15.382.520.604.700
23778441,2013-07-01T00:00:00,Splenectomy,E04.726
23778441,2013-07-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23778441,2013-07-01T00:00:00,Trauma Centers,N02.421.297.195.480
23778441,2013-07-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23778441,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23778441,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23778441,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23778441,2013-07-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
23791135,2013-07-01T00:00:00,Anesthesiology,H02.403.066
23791135,2013-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23791135,2013-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23791135,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791135,2013-07-01T00:00:00,Perioperative Care,E02.760.722
23791135,2013-07-01T00:00:00,Perioperative Care,E04.604
23791135,2013-07-01T00:00:00,Perioperative Care,N02.421.585.722
23791135,2013-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23791135,2013-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23791324,2013-07-01T00:00:00,Adult,M01.060.116
23791324,2013-07-01T00:00:00,African Americans,M01.686.508.100.100
23791324,2013-07-01T00:00:00,African Americans,M01.686.754.100
23791324,2013-07-01T00:00:00,Exercise,G11.427.590.237
23791324,2013-07-01T00:00:00,Exercise,I03.350
23791324,2013-07-01T00:00:00,Health Behavior,F01.145.488
23791324,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791324,2013-07-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23791324,2013-07-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23791324,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23791324,2013-07-01T00:00:00,Patient Compliance,F01.145.488.500
23791324,2013-07-01T00:00:00,Patient Compliance,N05.300.150.600.600
23809281,2013-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
23809281,2013-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
23809281,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23809281,2013-07-01T00:00:00,Nephrology,H02.403.429.580
23809281,2013-07-01T00:00:00,Patient Education as Topic,I02.233.332.500
23809281,2013-07-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23809281,2013-07-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
23809281,2013-07-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23809281,2013-07-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23809281,2013-07-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23809281,2013-07-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23809281,2013-07-01T00:00:00,United States,Z01.107.567.875
23815999,2013-07-01T00:00:00,Adolescent,M01.060.057
23815999,2013-07-01T00:00:00,Adult,M01.060.116
23815999,2013-07-01T00:00:00,Aged,M01.060.116.100
23815999,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23815999,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23815999,2013-07-01T00:00:00,Hyperglycemia,C18.452.394.952
23815999,2013-07-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23815999,2013-07-01T00:00:00,Insulin,D06.472.699.587.740.625
23815999,2013-07-01T00:00:00,Insulin,D12.644.548.586.740.625
23815999,2013-07-01T00:00:00,Islets of Langerhans Transplantation,E04.270.550
23815999,2013-07-01T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
23815999,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23815999,2013-07-01T00:00:00,Pancreatectomy,E04.210.752
23815999,2013-07-01T00:00:00,Pancreatitis,C06.689.750
23815999,2013-07-01T00:00:00,Postoperative Complications,C23.550.767
23815999,2013-07-01T00:00:00,Quality of Life,I01.800
23815999,2013-07-01T00:00:00,Quality of Life,K01.752.400.750
23815999,2013-07-01T00:00:00,Questionnaires,E05.318.308.750
23815999,2013-07-01T00:00:00,Questionnaires,L01.280.800
23815999,2013-07-01T00:00:00,Questionnaires,N05.715.360.300.695
23815999,2013-07-01T00:00:00,Questionnaires,N06.850.520.308.750
23815999,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23815999,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23815999,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23816068,2013-07-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
23816068,2013-07-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
23816068,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816068,2013-07-01T00:00:00,Thoracic Surgery,H02.403.810.803
23816151,2013-07-01T00:00:00,Adult,M01.060.116
23816151,2013-07-01T00:00:00,Age Factors,N05.715.350.075
23816151,2013-07-01T00:00:00,Age Factors,N06.850.490.250
23816151,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816151,2013-07-01T00:00:00,Military Personnel,M01.526.625
23816151,2013-07-01T00:00:00,Questionnaires,E05.318.308.750
23816151,2013-07-01T00:00:00,Questionnaires,L01.280.800
23816151,2013-07-01T00:00:00,Questionnaires,N05.715.360.300.695
23816151,2013-07-01T00:00:00,Questionnaires,N06.850.520.308.750
23816151,2013-07-01T00:00:00,Rape,I01.198.240.748.640
23816151,2013-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23816151,2013-07-01T00:00:00,Risk Factors,N05.715.350.200.700
23816151,2013-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23816151,2013-07-01T00:00:00,Risk Factors,N06.850.490.625.750
23816151,2013-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23816151,2013-07-01T00:00:00,"Stress, Psychological",F01.145.126.990
23816151,2013-07-01T00:00:00,"Stress, Psychological",F02.830.900
23816151,2013-07-01T00:00:00,War,I01.880.735.944
23816151,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23817821,2013-07-01T00:00:00,Adult,M01.060.116
23817821,2013-07-01T00:00:00,Aged,M01.060.116.100
23817821,2013-07-01T00:00:00,Cardiovascular Diseases,C14
23817821,2013-07-01T00:00:00,Confidentiality,F04.096.544.335.240
23817821,2013-07-01T00:00:00,Confidentiality,I01.880.604.473.650.500
23817821,2013-07-01T00:00:00,Confidentiality,I01.880.604.583.080
23817821,2013-07-01T00:00:00,Confidentiality,N03.706.437.650.124
23817821,2013-07-01T00:00:00,Confidentiality,N03.706.535.230
23817821,2013-07-01T00:00:00,Critical Care,E02.760.190
23817821,2013-07-01T00:00:00,Critical Care,N02.421.585.190
23817821,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23817821,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23817821,2013-07-01T00:00:00,Perception,F02.463.593
23817821,2013-07-01T00:00:00,Qualitative Research,H01.770.644.241.850
23818434,2013-07-01T00:00:00,Algorithms,G17.035
23818434,2013-07-01T00:00:00,Algorithms,L01.224.050
23818434,2013-07-01T00:00:00,Bias (Epidemiology),N05.715.350.150
23818434,2013-07-01T00:00:00,Bias (Epidemiology),N06.850.490.500
23818434,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23818434,2013-07-01T00:00:00,"Models, Statistical",E05.318.740.500
23818434,2013-07-01T00:00:00,"Models, Statistical",E05.599.835
23818434,2013-07-01T00:00:00,"Models, Statistical",N05.715.360.750.530
23818434,2013-07-01T00:00:00,"Models, Statistical",N06.850.520.830.500
23818434,2013-07-01T00:00:00,Patient Dropouts,M01.643.673
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23835820,2013-07-01T00:00:00,Adult,M01.060.116
23835820,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23835820,2013-07-01T00:00:00,Community-Based Participatory Research,N05.425.104
23835820,2013-07-01T00:00:00,Health Services Accessibility,N04.590.374.350
23835820,2013-07-01T00:00:00,Health Services Accessibility,N05.300.430
23835820,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23835820,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23835820,2013-07-01T00:00:00,Office Visits,N04.452.758.635
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.233.675
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.720
23835820,2013-07-01T00:00:00,Primary Health Care,N04.590.233.727
23835820,2013-07-01T00:00:00,Quality of Health Care,N04.761
23835820,2013-07-01T00:00:00,Quality of Health Care,N05.715
23835820,2013-07-01T00:00:00,United States,Z01.107.567.875
23835820,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23863529,2013-07-01T00:00:00,Adult,M01.060.116
23863529,2013-07-01T00:00:00,Aged,M01.060.116.100
23863529,2013-07-01T00:00:00,Body Burden,E05.799.638.231
23863529,2013-07-01T00:00:00,Body Burden,N06.850.460.200
23863529,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863529,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23863529,2013-07-01T00:00:00,Radiation Dosage,E05.799.513
23863529,2013-07-01T00:00:00,Radiation Dosage,G01.201.875.740
23863529,2013-07-01T00:00:00,Radiation Dosage,N06.850.810.250
23863529,2013-07-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23863529,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23868436,2013-07-01T00:00:00,"Child, Preschool",M01.060.406.448
23868436,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23868436,2013-07-01T00:00:00,"Diagnosis, Differential",E01.171
23868436,2013-07-01T00:00:00,"Histiocytosis, Langerhans-Cell",C08.381.483.375
23868436,2013-07-01T00:00:00,"Histiocytosis, Langerhans-Cell",C15.604.250.400
23868436,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23868436,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23868436,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24152838,2013-07-01T00:00:00,Animals,B01.050
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
24152838,2013-07-01T00:00:00,Kidney,A05.810.453
24152838,2013-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24152838,2013-07-01T00:00:00,Reactive Oxygen Species,D01.339.431
24152838,2013-07-01T00:00:00,Reactive Oxygen Species,D01.650.775
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
24218870,2013-07-01T00:00:00,Adolescent,M01.060.057
24218870,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24218870,2013-07-01T00:00:00,Parenting,F01.829.263.370.310
24218870,2013-07-01T00:00:00,Pregnancy,G08.686.785.760.769
24218870,2013-07-01T00:00:00,Pregnancy in Adolescence,G08.686.785.760.769.494
24218870,2013-07-01T00:00:00,Urban Population,N01.600.900
23817481,2013-07-02T00:00:00,Adult,M01.060.116
23817481,2013-07-02T00:00:00,Aged,M01.060.116.100
23817481,2013-07-02T00:00:00,Blood Pressure,E01.370.600.875.249
23817481,2013-07-02T00:00:00,Blood Pressure,G09.330.380.076
23817481,2013-07-02T00:00:00,Cholesterol,D04.808.247.222.284
23817481,2013-07-02T00:00:00,Cholesterol,D04.808.247.808.197
23817481,2013-07-02T00:00:00,Cholesterol,D10.570.938.208
23817481,2013-07-02T00:00:00,Cholesterol,D10.851.208
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23817481,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23817481,2013-07-02T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
23817481,2013-07-02T00:00:00,Hypertension,C14.907.489
23817481,2013-07-02T00:00:00,Middle Aged,M01.060.116.630
23817481,2013-07-02T00:00:00,Nutrition Surveys,E05.318.308.250.600
23817481,2013-07-02T00:00:00,Nutrition Surveys,E05.318.308.585.550
23817481,2013-07-02T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23817481,2013-07-02T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23817481,2013-07-02T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23817481,2013-07-02T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23817481,2013-07-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23817481,2013-07-02T00:00:00,Risk Factors,N05.715.350.200.700
23817481,2013-07-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23817481,2013-07-02T00:00:00,Risk Factors,N06.850.490.625.750
23817481,2013-07-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23817481,2013-07-02T00:00:00,United States,Z01.107.567.875
23821232,2013-07-02T00:00:00,Forecasting,I01.320
23821232,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23838935,2013-07-09T00:00:00,Animals,B01.050
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23838935,2013-07-09T00:00:00,Apoptosis,G04.299.139.160
23838935,2013-07-09T00:00:00,Cell Differentiation,G04.299.151
23838935,2013-07-09T00:00:00,Cell Movement,G04.299.283
23838935,2013-07-09T00:00:00,Cell Movement,G07.700.560.500.180
23838935,2013-07-09T00:00:00,Cell Proliferation,G04.299.233.750
23838935,2013-07-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23838935,2013-07-09T00:00:00,Fibroblasts,A11.329.228
23838935,2013-07-09T00:00:00,Fibroblasts,A11.872.228
23838935,2013-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23838935,2013-07-09T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
23838935,2013-07-09T00:00:00,"Mammary Neoplasms, Animal",C22.520
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C04.588.322.455
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C19.344.410
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C19.391.630.705
23838935,2013-07-09T00:00:00,Phenotype,G05.695
23838935,2013-07-09T00:00:00,"RNA, Messenger",D13.444.735.544
23847251,2013-07-11T00:00:00,African Continental Ancestry Group,M01.686.508.100
23847251,2013-07-11T00:00:00,Aged,M01.060.116.100
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23847251,2013-07-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
23847251,2013-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23847251,2013-07-11T00:00:00,Middle Aged,M01.060.116.630
23847251,2013-07-11T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23847251,2013-07-11T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
23850191,2013-07-11T00:00:00,Animals,B01.050
23850191,2013-07-11T00:00:00,Phosphoproteins,D12.776.744
23850191,2013-07-11T00:00:00,Phosphorylation,G02.111.087.677
23850191,2013-07-11T00:00:00,Phosphorylation,G02.149.115.677
23850191,2013-07-11T00:00:00,Phosphorylation,G02.149.465.700
23850191,2013-07-11T00:00:00,Phosphorylation,G02.607.750.700
23850191,2013-07-11T00:00:00,Phosphorylation,G03.495.790
23850191,2013-07-11T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23850191,2013-07-11T00:00:00,Signal Transduction,G02.111.087.800
23850191,2013-07-11T00:00:00,Signal Transduction,G02.149.115.800
23850191,2013-07-11T00:00:00,Signal Transduction,G04.299.880
23856688,2013-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23856688,2013-07-16T00:00:00,Lung Neoplasms,C04.588.894.797.520
23856688,2013-07-16T00:00:00,Lung Neoplasms,C08.381.540
23856688,2013-07-16T00:00:00,Lung Neoplasms,C08.785.520
23856688,2013-07-16T00:00:00,Mass Screening,E01.370.500
23856688,2013-07-16T00:00:00,Mass Screening,E05.318.308.250.580
23856688,2013-07-16T00:00:00,Mass Screening,N02.421.143.827.233.443
23856688,2013-07-16T00:00:00,Mass Screening,N02.421.726.233.443
23856688,2013-07-16T00:00:00,Mass Screening,N05.715.360.300.375.500
23856688,2013-07-16T00:00:00,Mass Screening,N06.850.520.308.250.580
23856688,2013-07-16T00:00:00,Mass Screening,N06.850.780.500
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23863051,2013-07-18T00:00:00,Aged,M01.060.116.100
23863051,2013-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863051,2013-07-18T00:00:00,Lung,A04.411
23863051,2013-07-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
23863051,2013-07-18T00:00:00,Lung Neoplasms,C08.381.540
23863051,2013-07-18T00:00:00,Lung Neoplasms,C08.785.520
23863051,2013-07-18T00:00:00,Mass Screening,E01.370.500
23863051,2013-07-18T00:00:00,Mass Screening,E05.318.308.250.580
23863051,2013-07-18T00:00:00,Mass Screening,N02.421.143.827.233.443
23863051,2013-07-18T00:00:00,Mass Screening,N02.421.726.233.443
23863051,2013-07-18T00:00:00,Mass Screening,N05.715.360.300.375.500
23863051,2013-07-18T00:00:00,Mass Screening,N06.850.520.308.250.580
23863051,2013-07-18T00:00:00,Mass Screening,N06.850.780.500
23863051,2013-07-18T00:00:00,Middle Aged,M01.060.116.630
23863051,2013-07-18T00:00:00,Radiation Dosage,E05.799.513
23863051,2013-07-18T00:00:00,Radiation Dosage,G01.201.875.740
23863051,2013-07-18T00:00:00,Radiation Dosage,N06.850.810.250
23863051,2013-07-18T00:00:00,Smoking,F01.145.466.753
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23870125,2013-07-18T00:00:00,Animals,B01.050
23870125,2013-07-18T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23870125,2013-07-18T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23870125,2013-07-18T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23870125,2013-07-18T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
23870125,2013-07-18T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23870125,2013-07-18T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23870125,2013-07-18T00:00:00,Retinoids,D02.455.326.271.665.202.495
23870125,2013-07-18T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23870125,2013-07-18T00:00:00,Retinoids,D02.455.849.131.495
23870125,2013-07-18T00:00:00,Retinoids,D23.767.261.700
23870125,2013-07-18T00:00:00,"Vision, Ocular",F02.830.816.964
23870125,2013-07-18T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G04.299.880.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G11.561.600.810.964
23870125,2013-07-18T00:00:00,"Vision, Ocular",G14.640.816
23878296,2013-07-22T00:00:00,Antineoplastic Agents,D27.505.954.248
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,E05.318.760.535
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,E05.337.250
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23878296,2013-07-22T00:00:00,"Databases, Factual",L01.470.750.750
23878296,2013-07-22T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23878296,2013-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886031,2013-07-22T00:00:00,Adolescent,M01.060.057
23886031,2013-07-22T00:00:00,Adult,M01.060.116
23886031,2013-07-22T00:00:00,Cardiopulmonary Bypass,E04.292.413
23886031,2013-07-22T00:00:00,Child,M01.060.406
23886031,2013-07-22T00:00:00,"Child, Preschool",M01.060.406.448
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C14.240.400
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C14.280.400
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.100.376.475
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.928.220.390
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.936.450.475
23886031,2013-07-22T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,L01.280.975.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N01.224.935.698.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23886031,2013-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886031,2013-07-22T00:00:00,Infant,M01.060.703
23886031,2013-07-22T00:00:00,"Infant, Newborn",M01.060.703.520
23886031,2013-07-22T00:00:00,Renal Dialysis,E02.870.300
23886031,2013-07-22T00:00:00,Renal Dialysis,E02.912.800
23886031,2013-07-22T00:00:00,Renal Insufficiency,C12.777.419.780
23886031,2013-07-22T00:00:00,Renal Insufficiency,C13.351.968.419.780
23886031,2013-07-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
23886031,2013-07-22T00:00:00,Risk Assessment,N04.452.871.715
23886031,2013-07-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23886031,2013-07-22T00:00:00,Risk Assessment,N06.850.505.715
23886031,2013-07-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23886031,2013-07-22T00:00:00,Risk Factors,E05.318.740.600.800.725
23886031,2013-07-22T00:00:00,Risk Factors,N05.715.350.200.700
23886031,2013-07-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23886031,2013-07-22T00:00:00,Risk Factors,N06.850.490.625.750
23886031,2013-07-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23886031,2013-07-22T00:00:00,South Carolina,Z01.107.567.875.075.662
23886031,2013-07-22T00:00:00,South Carolina,Z01.107.567.875.750.700
23886031,2013-07-22T00:00:00,Time Factors,G01.910.857
23886031,2013-07-22T00:00:00,Treatment Outcome,E01.789.800
23886031,2013-07-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23886031,2013-07-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23886031,2013-07-22T00:00:00,Young Adult,M01.060.116.815
23910619,2013-07-23T00:00:00,Biological Markers,D23.101
23910619,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23910619,2013-07-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23910619,2013-07-23T00:00:00,"Scleroderma, Diffuse",C17.300.799.602
23910619,2013-07-23T00:00:00,"Scleroderma, Diffuse",C17.800.784.602
23890780,2013-07-24T00:00:00,Adult,M01.060.116
23890780,2013-07-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
23890780,2013-07-24T00:00:00,Body Mass Index,E05.041.124.125
23890780,2013-07-24T00:00:00,Body Mass Index,G07.100.100.125
23890780,2013-07-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
23890780,2013-07-24T00:00:00,Breast Neoplasms,C04.588.180
23890780,2013-07-24T00:00:00,Breast Neoplasms,C17.800.090.500
23890780,2013-07-24T00:00:00,Cooperative Behavior,F01.145.813.115
23890780,2013-07-24T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
23890780,2013-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863716,2013-07-25T00:00:00,Animals,B01.050
23863716,2013-07-25T00:00:00,Apoptosis,G04.299.139.160
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
23887844,2013-07-25T00:00:00,Aged,M01.060.116.100
23887844,2013-07-25T00:00:00,Brain Ischemia,C10.228.140.300.150
23887844,2013-07-25T00:00:00,Brain Ischemia,C14.907.253.092
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,E05.318.760.535
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,E05.337.250
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23887844,2013-07-25T00:00:00,"Databases, Factual",L01.470.750.750
23887844,2013-07-25T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23887844,2013-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23887844,2013-07-25T00:00:00,Internet,L01.224.230.110.500
23887844,2013-07-25T00:00:00,Middle Aged,M01.060.116.630
23887844,2013-07-25T00:00:00,"Models, Biological",E05.599.395
23887844,2013-07-25T00:00:00,Risk Factors,E05.318.740.600.800.725
23887844,2013-07-25T00:00:00,Risk Factors,N05.715.350.200.700
23887844,2013-07-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23887844,2013-07-25T00:00:00,Risk Factors,N06.850.490.625.750
23887844,2013-07-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23887844,2013-07-25T00:00:00,Stroke,C10.228.140.300.775
23887844,2013-07-25T00:00:00,Stroke,C14.907.253.855
23887844,2013-07-25T00:00:00,Thrombolytic Therapy,E02.319.913
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D23.119.970
23887844,2013-07-25T00:00:00,Treatment Outcome,E01.789.800
23887844,2013-07-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23887844,2013-07-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23897908,2013-07-29T00:00:00,Cooperative Behavior,F01.145.813.115
23897908,2013-07-29T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23897908,2013-07-29T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23897908,2013-07-29T00:00:00,Health Manpower,N02.350
23897908,2013-07-29T00:00:00,Health Manpower,N05.300.420.400
23897908,2013-07-29T00:00:00,Health Policy,I01.880.604.825.608.400
23897908,2013-07-29T00:00:00,Health Policy,N03.706.825.608.428
23897908,2013-07-29T00:00:00,Health Services Accessibility,N04.590.374.350
23897908,2013-07-29T00:00:00,Health Services Accessibility,N05.300.430
23897908,2013-07-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,F01.145.209.381
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,L01.143.474
23897908,2013-07-29T00:00:00,Nurse Practitioners,M01.526.485.650.640
23897908,2013-07-29T00:00:00,Nurse Practitioners,N02.360.650.640
23897908,2013-07-29T00:00:00,Patient Care Team,N04.590.715
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.233.675
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.233.727.407
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.720
23897908,2013-07-29T00:00:00,Pediatrics,H02.403.670
23897908,2013-07-29T00:00:00,Physician Assistants,M01.526.485.067.740
23897908,2013-07-29T00:00:00,Physician Assistants,N02.360.067.740
23897908,2013-07-29T00:00:00,United States,Z01.107.567.875
23360256,2013-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
23360256,2013-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
23360256,2013-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
23360256,2013-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
23360256,2013-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
23360256,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360256,2013-08-01T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
23360256,2013-08-01T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
23360256,2013-08-01T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
23360256,2013-08-01T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
23360256,2013-08-01T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
23360256,2013-08-01T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
23360256,2013-08-01T00:00:00,Physostigmine,D02.241.081.251.583.682
23360256,2013-08-01T00:00:00,Physostigmine,D03.132.436.545
23360256,2013-08-01T00:00:00,Physostigmine,D03.438.473.402.545
23360256,2013-08-01T00:00:00,"Receptors, Nicotinic",D12.776.543.750.720.360.550
23360256,2013-08-01T00:00:00,alpha-Synuclein,D12.776.641.860.500
23526211,2013-08-01T00:00:00,Animals,B01.050
23526211,2013-08-01T00:00:00,Antibodies,D12.776.124.486.485.114
23526211,2013-08-01T00:00:00,Antibodies,D12.776.124.790.651.114
23526211,2013-08-01T00:00:00,Antibodies,D12.776.377.715.548.114
23526211,2013-08-01T00:00:00,Complement Activation,G12.425.255
23526211,2013-08-01T00:00:00,Complement System Proteins,D12.776.124.486.274
23526211,2013-08-01T00:00:00,Lung,A04.411
23526211,2013-08-01T00:00:00,Orthomyxoviridae Infections,C02.782.620
23722353,2013-08-01T00:00:00,Animals,B01.050
23722353,2013-08-01T00:00:00,Collagen,D05.750.078.280
23722353,2013-08-01T00:00:00,Collagen,D12.776.860.300.250
23722353,2013-08-01T00:00:00,Hemodynamics,G09.330.190.400
23722353,2013-08-01T00:00:00,Hemodynamics,G09.330.380
23722353,2013-08-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
23722353,2013-08-01T00:00:00,"Stress, Mechanical",G01.374.676.830
23722353,2013-08-01T00:00:00,"Stress, Mechanical",G01.595.540.830
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23785065,2013-08-01T00:00:00,Documentation,L01.453.245
23785065,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23785065,2013-08-01T00:00:00,Information Management,L01.399
23785065,2013-08-01T00:00:00,Informed Consent,I01.880.604.473.650.718
23785065,2013-08-01T00:00:00,Informed Consent,I01.880.604.583.427
23785065,2013-08-01T00:00:00,Informed Consent,N03.706.437.650.312
23785065,2013-08-01T00:00:00,Informed Consent,N03.706.535.489
23785065,2013-08-01T00:00:00,Patient Selection,E05.581.500.653
23785065,2013-08-01T00:00:00,Patient Selection,N04.590.731
23785065,2013-08-01T00:00:00,Pilot Projects,E05.318.760.750
23785065,2013-08-01T00:00:00,Pilot Projects,E05.337.737
23785065,2013-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
23785065,2013-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
23785065,2013-08-01T00:00:00,Software,L01.224.900
23785065,2013-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23785065,2013-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23785065,2013-08-01T00:00:00,User-Computer Interface,L01.224.900.910
23849147,2013-08-01T00:00:00,Adolescent,M01.060.057
23849147,2013-08-01T00:00:00,Adult,M01.060.116
23849147,2013-08-01T00:00:00,Aged,M01.060.116.100
23849147,2013-08-01T00:00:00,Anticonvulsants,D27.505.954.427.080
23849147,2013-08-01T00:00:00,Bayes Theorem,E05.318.740.600.200
23849147,2013-08-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23849147,2013-08-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23849147,2013-08-01T00:00:00,Child,M01.060.406
23849147,2013-08-01T00:00:00,"Child, Preschool",M01.060.406.448
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23849147,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23849147,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23849147,2013-08-01T00:00:00,"Models, Statistical",E05.318.740.500
23849147,2013-08-01T00:00:00,"Models, Statistical",E05.599.835
23849147,2013-08-01T00:00:00,"Models, Statistical",N05.715.360.750.530
23849147,2013-08-01T00:00:00,"Models, Statistical",N06.850.520.830.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23849147,2013-08-01T00:00:00,Research Design,E05.581.500
23849147,2013-08-01T00:00:00,Research Design,H01.770.644.728
23849147,2013-08-01T00:00:00,Status Epilepticus,C10.228.140.490.690
23849147,2013-08-01T00:00:00,Treatment Outcome,E01.789.800
23849147,2013-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23849147,2013-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23849147,2013-08-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
23849147,2013-08-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
23849147,2013-08-01T00:00:00,Young Adult,M01.060.116.815
23908060,2013-08-01T00:00:00,Animals,B01.050
23908060,2013-08-01T00:00:00,Bibliometrics,L01.178.682.099.325
23908060,2013-08-01T00:00:00,Bibliometrics,L01.453.183.291
23908060,2013-08-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
23908060,2013-08-01T00:00:00,Cerebrovascular Disorders,C14.907.253
23908060,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23908060,2013-08-01T00:00:00,Peer Review,F01.829.316.549
23908060,2013-08-01T00:00:00,Peer Review,I01.880.604.640
23908060,2013-08-01T00:00:00,Peer Review,N03.706.700
23908060,2013-08-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23912400,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23912400,2013-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
23912400,2013-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
23912400,2013-08-01T00:00:00,Regression Analysis,E05.318.740.750
23912400,2013-08-01T00:00:00,Regression Analysis,N05.715.360.750.695
23912400,2013-08-01T00:00:00,Regression Analysis,N06.850.520.830.750
23913833,2013-08-01T00:00:00,Animals,B01.050
23913833,2013-08-01T00:00:00,"Cartilage, Articular",A02.165.407.150
23913833,2013-08-01T00:00:00,"Cartilage, Articular",A02.835.583.192
23913833,2013-08-01T00:00:00,Glycosaminoglycans,D09.698.373
23913833,2013-08-01T00:00:00,Swine,B01.050.150.900.649.077.880
23913833,2013-08-01T00:00:00,X-Rays,G01.201.875.750.918
24021498,2013-08-01T00:00:00,Aged,M01.060.116.100
24021498,2013-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
24021498,2013-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
24021498,2013-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
24021498,2013-08-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
24021498,2013-08-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
24021498,2013-08-01T00:00:00,Double-Blind Method,E05.318.780.300
24021498,2013-08-01T00:00:00,Double-Blind Method,E05.581.500.300
24021498,2013-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
24021498,2013-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
24021498,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24021498,2013-08-01T00:00:00,Methylphenidate,D02.241.223.601.600
24021498,2013-08-01T00:00:00,Methylphenidate,D03.383.621.460
24021498,2013-08-01T00:00:00,Neuropsychological Tests,F04.711.513
24021498,2013-08-01T00:00:00,Psychometrics,F04.711.780
23918255,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23918255,2013-08-05T00:00:00,Operating Rooms,N02.278.388.700
23918255,2013-08-05T00:00:00,Patient Care Team,N04.590.715
23918255,2013-08-05T00:00:00,United States,Z01.107.567.875
23918752,2013-08-05T00:00:00,African Americans,M01.686.508.100.100
23918752,2013-08-05T00:00:00,African Americans,M01.686.754.100
23918752,2013-08-05T00:00:00,Aged,M01.060.116.100
23918752,2013-08-05T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23918752,2013-08-05T00:00:00,Blood Pressure,E01.370.600.875.249
23918752,2013-08-05T00:00:00,Blood Pressure,G09.330.380.076
23918752,2013-08-05T00:00:00,Community Health Services,N02.421.143
23918752,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23918752,2013-08-05T00:00:00,Hypertension,C14.907.489
23918752,2013-08-05T00:00:00,Medication Adherence,F01.145.488.500.500
23918752,2013-08-05T00:00:00,Medication Adherence,N05.300.150.600.600.500
23918752,2013-08-05T00:00:00,Middle Aged,M01.060.116.630
23918752,2013-08-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23918752,2013-08-05T00:00:00,Risk Factors,N05.715.350.200.700
23918752,2013-08-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23918752,2013-08-05T00:00:00,Risk Factors,N06.850.490.625.750
23918752,2013-08-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23918752,2013-08-05T00:00:00,United States,Z01.107.567.875
23921144,2013-08-06T00:00:00,Animals,B01.050
23921144,2013-08-06T00:00:00,Cell Line,A11.251.210
23921144,2013-08-06T00:00:00,Inflammation,C23.550.470
23921144,2013-08-06T00:00:00,Interleukin-6,D12.644.276.374.465.506
23921144,2013-08-06T00:00:00,Interleukin-6,D12.776.467.374.465.506
23921144,2013-08-06T00:00:00,Interleukin-6,D23.529.374.465.506
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D09.400.500
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D09.698.718.450
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D10.494
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D23.050.161.616.525
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D23.946.123.329.500
23921144,2013-08-06T00:00:00,Macrophages,A11.329.372
23921144,2013-08-06T00:00:00,Macrophages,A11.627.482
23921144,2013-08-06T00:00:00,Macrophages,A11.733.397
23921144,2013-08-06T00:00:00,Macrophages,A15.382.680.397
23921144,2013-08-06T00:00:00,Macrophages,A15.382.812.522
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.260.600
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.660.600
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.930.600
23921144,2013-08-06T00:00:00,Signal Transduction,G02.111.087.800
23921144,2013-08-06T00:00:00,Signal Transduction,G02.149.115.800
23921144,2013-08-06T00:00:00,Signal Transduction,G04.299.880
23921144,2013-08-06T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
23921144,2013-08-06T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
23926298,2013-08-07T00:00:00,Animals,B01.050
23926298,2013-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23926298,2013-08-07T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23926298,2013-08-07T00:00:00,Janus Kinase 2,D08.811.913.696.620.682.725.124.200
23926298,2013-08-07T00:00:00,Janus Kinase 2,D12.776.476.393.200
23926298,2013-08-07T00:00:00,Janus Kinase 2,D12.776.624.664.700.117
23926298,2013-08-07T00:00:00,Leukemia,C04.557.337
23926298,2013-08-07T00:00:00,Mutation,G05.365.590
23926298,2013-08-07T00:00:00,Propylene Glycols,D02.033.455.706
23926298,2013-08-07T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D12.644.360.583
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D12.776.476.561
23926298,2013-08-07T00:00:00,RNA Interference,G05.355.315.203.374.790
23926298,2013-08-07T00:00:00,Signal Transduction,G02.111.087.800
23926298,2013-08-07T00:00:00,Signal Transduction,G02.149.115.800
23926298,2013-08-07T00:00:00,Signal Transduction,G04.299.880
23926298,2013-08-07T00:00:00,Sphingosine,D02.033.100.700
23926298,2013-08-07T00:00:00,Sphingosine,D02.033.455.843
23926298,2013-08-07T00:00:00,Sphingosine,D02.092.063.700
23926298,2013-08-07T00:00:00,Treatment Outcome,E01.789.800
23926298,2013-08-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23926298,2013-08-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23932491,2013-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23932491,2013-08-08T00:00:00,Learning,F02.463.425
23932491,2013-08-08T00:00:00,Learning,F02.784.629.529
23932491,2013-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23932491,2013-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
23932491,2013-08-08T00:00:00,Photic Stimulation,E05.723.729
23932491,2013-08-08T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
23932491,2013-08-08T00:00:00,Visual Perception,F02.463.593.932
23941992,2013-08-11T00:00:00,Antineoplastic Agents,D27.505.954.248
23941992,2013-08-11T00:00:00,Apoptosis,G04.299.139.160
23941992,2013-08-11T00:00:00,Cell Differentiation,G04.299.151
23941992,2013-08-11T00:00:00,Cell Movement,G04.299.283
23941992,2013-08-11T00:00:00,Cell Movement,G07.700.560.500.180
23941992,2013-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
23941992,2013-08-11T00:00:00,"RNA, Messenger",D13.444.735.544
23879743,2013-08-14T00:00:00,Allosteric Regulation,G02.111.087.040
23879743,2013-08-14T00:00:00,Allosteric Regulation,G02.149.115.040
23879743,2013-08-14T00:00:00,Catalytic Domain,G02.111.570.120.704
23879743,2013-08-14T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
23879743,2013-08-14T00:00:00,Crystallization,E05.196.300
23879743,2013-08-14T00:00:00,Crystallization,G02.149.767.505
23879743,2013-08-14T00:00:00,Crystallization,G02.842.750.505
23879743,2013-08-14T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
23879743,2013-08-14T00:00:00,"Models, Molecular",E05.599.595
23879743,2013-08-14T00:00:00,Sulfates,D01.248.497.158.845
23879743,2013-08-14T00:00:00,Sulfates,D01.875.800.800.850
23946297,2013-08-14T00:00:00,Adolescent,M01.060.057
23946297,2013-08-14T00:00:00,Adult,M01.060.116
23946297,2013-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23946297,2013-08-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23946297,2013-08-14T00:00:00,Risk Factors,N05.715.350.200.700
23946297,2013-08-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23946297,2013-08-14T00:00:00,Risk Factors,N06.850.490.625.750
23946297,2013-08-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23946297,2013-08-14T00:00:00,Stroke,C10.228.140.300.775
23946297,2013-08-14T00:00:00,Stroke,C14.907.253.855
23946297,2013-08-14T00:00:00,Young Adult,M01.060.116.815
23847313,2013-08-15T00:00:00,Adolescent,M01.060.057
23847313,2013-08-15T00:00:00,Adult,M01.060.116
23847313,2013-08-15T00:00:00,Aged,M01.060.116.100
23847313,2013-08-15T00:00:00,Aging,G07.700.320.124
23847313,2013-08-15T00:00:00,Biological Markers,D23.101
23847313,2013-08-15T00:00:00,Child,M01.060.406
23847313,2013-08-15T00:00:00,"Child, Preschool",M01.060.406.448
23847313,2013-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23847313,2013-08-15T00:00:00,Infant,M01.060.703
23847313,2013-08-15T00:00:00,"Infant, Newborn",M01.060.703.520
23847313,2013-08-15T00:00:00,Middle Aged,M01.060.116.630
23847313,2013-08-15T00:00:00,Pyridinium Compounds,D03.383.725.762
23847313,2013-08-15T00:00:00,Retinal Degeneration,C11.768.585
23847313,2013-08-15T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23847313,2013-08-15T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23847313,2013-08-15T00:00:00,Retinoids,D02.455.326.271.665.202.495
23847313,2013-08-15T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23847313,2013-08-15T00:00:00,Retinoids,D02.455.849.131.495
23847313,2013-08-15T00:00:00,Retinoids,D23.767.261.700
23847313,2013-08-15T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
23847313,2013-08-15T00:00:00,Young Adult,M01.060.116.815
23968766,2013-08-20T00:00:00,"Anastomosis, Surgical",E04.035
23968766,2013-08-20T00:00:00,Animals,B01.050
23968766,2013-08-20T00:00:00,"Disease Models, Animal",C22.232
23968766,2013-08-20T00:00:00,"Disease Models, Animal",E05.598.500
23968766,2013-08-20T00:00:00,"Disease Models, Animal",E05.599.395.080
23968766,2013-08-20T00:00:00,Endothelial Cells,A11.436.275
23968766,2013-08-20T00:00:00,"Endothelium, Vascular",A07.231.330
23968766,2013-08-20T00:00:00,"Endothelium, Vascular",A10.272.491.355
23968766,2013-08-20T00:00:00,Phenotype,G05.695
23968766,2013-08-20T00:00:00,Pulmonary Artery,A07.231.114.715
23968766,2013-08-20T00:00:00,Swine,B01.050.150.900.649.077.880
23968766,2013-08-20T00:00:00,Vascular Surgical Procedures,E04.100.814
23966687,2013-08-21T00:00:00,Animals,B01.050
23966687,2013-08-21T00:00:00,Cocaine,D02.145.074.722.388
23966687,2013-08-21T00:00:00,Cocaine,D03.132.889.354
23966687,2013-08-21T00:00:00,Cocaine,D03.605.869.388
23966687,2013-08-21T00:00:00,Cocaine,D04.075.080.875.099.722.388
23966687,2013-08-21T00:00:00,"Conditioning, Operant",F02.463.425.179.509
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23966687,2013-08-21T00:00:00,Electric Stimulation,E05.723.402
23966687,2013-08-21T00:00:00,Green Fluorescent Proteins,D12.776.532.265
23966687,2013-08-21T00:00:00,Neural Pathways,A08.612
23966687,2013-08-21T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23966687,2013-08-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23966687,2013-08-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23966687,2013-08-21T00:00:00,Self Administration,E02.319.890
23966687,2013-08-21T00:00:00,Self Administration,E02.900.890
23966687,2013-08-21T00:00:00,"Transduction, Genetic",E05.393.350.800
23966687,2013-08-21T00:00:00,"Transduction, Genetic",G05.355.760.850
23972371,2013-08-22T00:00:00,African Continental Ancestry Group,M01.686.508.100
23972371,2013-08-22T00:00:00,Blood Pressure,E01.370.600.875.249
23972371,2013-08-22T00:00:00,Blood Pressure,G09.330.380.076
23972371,2013-08-22T00:00:00,"Databases, Genetic",L01.470.750.750.325
23972371,2013-08-22T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
23972371,2013-08-22T00:00:00,Genetic Loci,G05.360.340.024.380
23972371,2013-08-22T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23972371,2013-08-22T00:00:00,Genetic Predisposition to Disease,G05.380.355
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.318.416.249
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.318.780.392
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.385.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.522.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23972371,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23972371,2013-08-22T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23972722,2013-08-22T00:00:00,Aged,M01.060.116.100
23972722,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23972722,2013-08-22T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23972722,2013-08-22T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23972722,2013-08-22T00:00:00,"Phantoms, Imaging",E07.671
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D23.050.285.625
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D23.101.840.625
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
23972722,2013-08-22T00:00:00,"Quality Assurance, Health Care",N04.761.700
23972722,2013-08-22T00:00:00,"Quality Assurance, Health Care",N05.700
23972722,2013-08-22T00:00:00,Questionnaires,E05.318.308.750
23972722,2013-08-22T00:00:00,Questionnaires,L01.280.800
23972722,2013-08-22T00:00:00,Questionnaires,N05.715.360.300.695
23972722,2013-08-22T00:00:00,Questionnaires,N06.850.520.308.750
23972722,2013-08-22T00:00:00,Radiotherapy Dosage,E02.815.639
23972722,2013-08-22T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
23972722,2013-08-22T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
23972722,2013-08-22T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
23972722,2013-08-22T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
23972722,2013-08-22T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
23972722,2013-08-22T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
23972722,2013-08-22T00:00:00,Salvage Therapy,E02.186.800
23972722,2013-08-22T00:00:00,Salvage Therapy,E02.895
23972722,2013-08-22T00:00:00,Urinary Bladder,A05.810.890
23979626,2013-08-27T00:00:00,Adult,M01.060.116
23979626,2013-08-27T00:00:00,Aged,M01.060.116.100
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.695.175
23979626,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23979626,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
23979626,2013-08-27T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23979626,2013-08-27T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23979626,2013-08-27T00:00:00,Treatment Outcome,E01.789.800
23979626,2013-08-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23979626,2013-08-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23988638,2013-08-29T00:00:00,Delivery of Health Care,N04.590.374
23988638,2013-08-29T00:00:00,Delivery of Health Care,N05.300
23988638,2013-08-29T00:00:00,Health Policy,I01.880.604.825.608.400
23988638,2013-08-29T00:00:00,Health Policy,N03.706.825.608.428
23988638,2013-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23988638,2013-08-29T00:00:00,Stroke,C10.228.140.300.775
23988638,2013-08-29T00:00:00,Stroke,C14.907.253.855
23989715,2013-08-30T00:00:00,Animals,B01.050
23989715,2013-08-30T00:00:00,Biological Markers,D23.101
23989715,2013-08-30T00:00:00,Extracellular Matrix,A11.284.295.310
23989715,2013-08-30T00:00:00,Heart Failure,C14.280.434
23989715,2013-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23989715,2013-08-30T00:00:00,MicroRNAs,D13.150.650.319
23989715,2013-08-30T00:00:00,MicroRNAs,D13.444.735.150.319
23989715,2013-08-30T00:00:00,MicroRNAs,D13.444.735.790.099
23989715,2013-08-30T00:00:00,Myocardium,A02.633.580
23989715,2013-08-30T00:00:00,Myocardium,A07.541.704
23989715,2013-08-30T00:00:00,Myocardium,A10.690.552.750
23553658,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23553658,2013-09-01T00:00:00,Measles virus,B04.820.455.600.650.500.500
23553658,2013-09-01T00:00:00,Measles virus,B04.909.777.455.600.650.500.500
23553658,2013-09-01T00:00:00,Osteitis Deformans,C05.116.692
23553658,2013-09-01T00:00:00,Osteoclasts,A11.329.372.700
23553658,2013-09-01T00:00:00,Osteoclasts,A11.627.482.700
23553658,2013-09-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.644.276.972.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.776.467.972.562
23553658,2013-09-01T00:00:00,RANK Ligand,D23.529.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D23.529.972.562
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
23553658,2013-09-01T00:00:00,Stromal Cells,A11.329.830
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
23709270,2013-09-01T00:00:00,Adult,M01.060.116
23709270,2013-09-01T00:00:00,African Americans,M01.686.508.100.100
23709270,2013-09-01T00:00:00,African Americans,M01.686.754.100
23709270,2013-09-01T00:00:00,Aged,M01.060.116.100
23709270,2013-09-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
23709270,2013-09-01T00:00:00,Depressive Disorder,F03.600.300
23709270,2013-09-01T00:00:00,Disasters,N06.230.100
23709270,2013-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23709270,2013-09-01T00:00:00,Hispanic Americans,M01.686.754.441
23709270,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709270,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23709270,2013-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23709270,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23733527,2013-09-01T00:00:00,Adolescent,M01.060.057
23733527,2013-09-01T00:00:00,Adult,M01.060.116
23733527,2013-09-01T00:00:00,Age Factors,N05.715.350.075
23733527,2013-09-01T00:00:00,Age Factors,N06.850.490.250
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
23733527,2013-09-01T00:00:00,Child,M01.060.406
23733527,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23733527,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
23903770,2013-09-01T00:00:00,Acetylcysteine,D02.886.030.230.259
23903770,2013-09-01T00:00:00,Acetylcysteine,D12.125.166.230.259
23903770,2013-09-01T00:00:00,Animals,B01.050
23903770,2013-09-01T00:00:00,Brain,A08.186.211
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23903770,2013-09-01T00:00:00,"Disease Models, Animal",C22.232
23903770,2013-09-01T00:00:00,"Disease Models, Animal",E05.598.500
23903770,2013-09-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.067.750
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.119.450
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.427.300
23903770,2013-09-01T00:00:00,Substance-Related Disorders,C21.739
23903770,2013-09-01T00:00:00,Substance-Related Disorders,F03.900
23921866,2013-09-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23921866,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23921866,2013-09-01T00:00:00,Infant Mortality,E05.318.308.985.550.475
23921866,2013-09-01T00:00:00,Infant Mortality,L01.280.975.550.475
23921866,2013-09-01T00:00:00,Infant Mortality,N01.224.935.698.489
23921866,2013-09-01T00:00:00,Infant Mortality,N06.850.505.400.975.550.475
23921866,2013-09-01T00:00:00,Infant Mortality,N06.850.520.308.985.550.475
23921866,2013-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
23921866,2013-09-01T00:00:00,Postpartum Period,G08.686.702
23921866,2013-09-01T00:00:00,Pregnancy,G08.686.785.760.769
23921866,2013-09-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23921866,2013-09-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23931426,2013-09-01T00:00:00,Adult,M01.060.116
23931426,2013-09-01T00:00:00,Aged,M01.060.116.100
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23931426,2013-09-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
23931426,2013-09-01T00:00:00,Cyclophosphamide,D02.705.670.243
23931426,2013-09-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
23931426,2013-09-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
23931426,2013-09-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
23931426,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23931426,2013-09-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
23931426,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23931426,2013-09-01T00:00:00,Phospholipids,D10.570.755
23931426,2013-09-01T00:00:00,Phospholipids,D10.695
23931426,2013-09-01T00:00:00,Prednisone,D04.808.745.432.719.702
23931426,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
23931426,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23931426,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23931426,2013-09-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23931426,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23957969,2013-09-01T00:00:00,Dermatology,H02.403.225
23957969,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23957969,2013-09-01T00:00:00,Internet,L01.224.230.110.500
23957969,2013-09-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
23957969,2013-09-01T00:00:00,Publishing,L01.737
23962940,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23962940,2013-09-01T00:00:00,"Intubation, Intratracheal",E05.497.578
23966648,2013-09-01T00:00:00,Anesthesia,E03.155
23966648,2013-09-01T00:00:00,Anesthesiology,H02.403.066
23966648,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23966648,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23966648,2013-09-01T00:00:00,Heart,A07.541
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23966648,2013-09-01T00:00:00,Heart Valve Diseases,C14.280.484
23966648,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23966648,2013-09-01T00:00:00,Neurosurgical Procedures,E04.525
23966648,2013-09-01T00:00:00,Perioperative Care,E02.760.722
23966648,2013-09-01T00:00:00,Perioperative Care,E04.604
23966648,2013-09-01T00:00:00,Perioperative Care,N02.421.585.722
23966648,2013-09-01T00:00:00,Pulmonary Embolism,C08.381.746
23966648,2013-09-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
23966648,2013-09-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
23966648,2013-09-01T00:00:00,"Quality Assurance, Health Care",N05.700
23966648,2013-09-01T00:00:00,United States,Z01.107.567.875
23966648,2013-09-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23971448,2013-09-01T00:00:00,Adult,M01.060.116
23971448,2013-09-01T00:00:00,Aged,M01.060.116.100
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23971448,2013-09-01T00:00:00,Contrast Media,D27.720.259
23971448,2013-09-01T00:00:00,Endosonography,E01.370.350.850.280
23971448,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23971448,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23971448,2013-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
23971448,2013-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
23971448,2013-09-01T00:00:00,Referral and Consultation,N04.452.758.849
24001084,2013-09-01T00:00:00,Adolescent,M01.060.057
24001084,2013-09-01T00:00:00,Adult,M01.060.116
24001084,2013-09-01T00:00:00,Aged,M01.060.116.100
24001084,2013-09-01T00:00:00,Anticonvulsants,D27.505.954.427.080
24001084,2013-09-01T00:00:00,Child,M01.060.406
24001084,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24001084,2013-09-01T00:00:00,Double-Blind Method,E05.318.780.300
24001084,2013-09-01T00:00:00,Double-Blind Method,E05.581.500.300
24001084,2013-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
24001084,2013-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
24001084,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24001084,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24001084,2013-09-01T00:00:00,Research Design,E05.581.500
24001084,2013-09-01T00:00:00,Research Design,H01.770.644.728
24001084,2013-09-01T00:00:00,Status Epilepticus,C10.228.140.490.690
24001084,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
24001084,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24001084,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24001084,2013-09-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
24001084,2013-09-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
24001084,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24004703,2013-09-01T00:00:00,Adolescent,M01.060.057
24004703,2013-09-01T00:00:00,Adult,M01.060.116
24004703,2013-09-01T00:00:00,Aged,M01.060.116.100
24004703,2013-09-01T00:00:00,Chronic Disease,C23.550.291.500
24004703,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24004703,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24004703,2013-09-01T00:00:00,Primary Health Care,N04.590.233.727
24004703,2013-09-01T00:00:00,United States,Z01.107.567.875
24004703,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
24023328,2013-09-01T00:00:00,Combined Modality Therapy,E02.186
24023328,2013-09-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
24023328,2013-09-01T00:00:00,Cyclophosphamide,D02.705.670.243
24023328,2013-09-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
24023328,2013-09-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
24023328,2013-09-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
24023328,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24023328,2013-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
24023328,2013-09-01T00:00:00,Lung Neoplasms,C08.381.540
24023328,2013-09-01T00:00:00,Lung Neoplasms,C08.785.520
24023328,2013-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24023328,2013-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24023328,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24051744,2013-09-01T00:00:00,Aged,M01.060.116.100
24051744,2013-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
24051744,2013-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
24051744,2013-09-01T00:00:00,Dextrans,D05.750.078.562.272
24051744,2013-09-01T00:00:00,Dextrans,D09.698.365.272
24051744,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24051744,2013-09-01T00:00:00,Lymph Nodes,A10.549.400
24051744,2013-09-01T00:00:00,Lymph Nodes,A15.382.520.604.412
24051744,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24051744,2013-09-01T00:00:00,Mouth Neoplasms,C04.588.443.591
24051744,2013-09-01T00:00:00,Mouth Neoplasms,C07.465.565
24051744,2013-09-01T00:00:00,Neoplasm Invasiveness,C04.697.645
24051744,2013-09-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
24051744,2013-09-01T00:00:00,Neoplasm Staging,E01.370.550
24051744,2013-09-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24069979,2013-09-01T00:00:00,Animals,B01.050
24069979,2013-09-01T00:00:00,Appendectomy,E04.210.078
24069979,2013-09-01T00:00:00,Appendicitis,C06.405.205.099
24069979,2013-09-01T00:00:00,Appendicitis,C06.405.469.110.207
24069979,2013-09-01T00:00:00,Appendix,A03.556.124.526.209.290
24069979,2013-09-01T00:00:00,Appendix,A03.556.249.249.209.290
24069979,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24069979,2013-09-01T00:00:00,"Diagnosis, Differential",E01.171
24069979,2013-09-01T00:00:00,Enterobiasis,C03.335.508.700.550.550.375
24069979,2013-09-01T00:00:00,Enterobius,B01.050.500.500.294.700.500.500.308
24069979,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069985,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24069985,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069985,2013-09-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
24069986,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069986,2013-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
24069986,2013-09-01T00:00:00,Pregnancy,G08.686.785.760.769
24069986,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23999433,2013-09-03T00:00:00,Animals,B01.050
23999433,2013-09-03T00:00:00,Antineoplastic Agents,D27.505.954.248
23999433,2013-09-03T00:00:00,Apoptosis,G04.299.139.160
23999433,2013-09-03T00:00:00,Cell Proliferation,G04.299.233.750
23999433,2013-09-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23999433,2013-09-03T00:00:00,Cell Survival,G04.299.316
23999433,2013-09-03T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A11.148.378
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A11.872.378
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
23999433,2013-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23999433,2013-09-03T00:00:00,Janus Kinase 2,D08.811.913.696.620.682.725.124.200
23999433,2013-09-03T00:00:00,Janus Kinase 2,D12.776.476.393.200
23999433,2013-09-03T00:00:00,Janus Kinase 2,D12.776.624.664.700.117
23999433,2013-09-03T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
23999433,2013-09-03T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
23999433,2013-09-03T00:00:00,Neoplastic Stem Cells,A11.872.650
23999433,2013-09-03T00:00:00,Propylene Glycols,D02.033.455.706
23999433,2013-09-03T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D12.644.360.583
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D12.776.476.561
23999433,2013-09-03T00:00:00,Sphingosine,D02.033.100.700
23999433,2013-09-03T00:00:00,Sphingosine,D02.033.455.843
23999433,2013-09-03T00:00:00,Sphingosine,D02.092.063.700
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.091.249
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.220.145.500
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.930.130
24008577,2013-09-05T00:00:00,Adolescent,M01.060.057
24008577,2013-09-05T00:00:00,Adult,M01.060.116
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
24008577,2013-09-05T00:00:00,Child,M01.060.406
24008577,2013-09-05T00:00:00,"Child, Preschool",M01.060.406.448
24008577,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24008577,2013-09-05T00:00:00,Infant,M01.060.703
24008577,2013-09-05T00:00:00,"Infant, Newborn",M01.060.703.520
24008577,2013-09-05T00:00:00,Stroke,C10.228.140.300.775
24008577,2013-09-05T00:00:00,Stroke,C14.907.253.855
24030405,2013-09-10T00:00:00,Animals,B01.050
24030405,2013-09-10T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
24030405,2013-09-10T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
24030405,2013-09-10T00:00:00,"Disease Models, Animal",C22.232
24030405,2013-09-10T00:00:00,"Disease Models, Animal",E05.598.500
24030405,2013-09-10T00:00:00,"Disease Models, Animal",E05.599.395.080
24030405,2013-09-10T00:00:00,Swine,B01.050.150.900.649.077.880
24032670,2013-09-13T00:00:00,Adult,M01.060.116
24032670,2013-09-13T00:00:00,Brain,A08.186.211
24032670,2013-09-13T00:00:00,Case-Control Studies,E05.318.760.500.500
24032670,2013-09-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24032670,2013-09-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E05.278
24032670,2013-09-13T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
24032670,2013-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24032670,2013-09-13T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
24032670,2013-09-13T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
24091326,2013-09-16T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
24091326,2013-09-16T00:00:00,Amides,D02.065
24091326,2013-09-16T00:00:00,Animals,B01.050
24091326,2013-09-16T00:00:00,Gene Expression,G05.355.310
24091326,2013-09-16T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24091326,2013-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24091326,2013-09-16T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
24091326,2013-09-16T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
24091326,2013-09-16T00:00:00,Propanolamines,D02.033.100.624
24091326,2013-09-16T00:00:00,Propanolamines,D02.033.755.624
24091326,2013-09-16T00:00:00,Propanolamines,D02.092.063.624
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
24091326,2013-09-16T00:00:00,Sphingolipids,D10.570.877
24091326,2013-09-16T00:00:00,Sphingolipids,D10.808
23608928,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608928,2013-10-01T00:00:00,Hypercalcemia,C18.452.174.451
23608928,2013-10-01T00:00:00,Hypercalcemia,C18.452.950.340
23608928,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23608928,2013-10-01T00:00:00,Thyroid Crisis,C19.874.397.685.905
23608928,2013-10-01T00:00:00,Thyroid Crisis,C19.874.902.905
23608928,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23608928,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23608928,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23924348,2013-10-01T00:00:00,Animals,B01.050
23924348,2013-10-01T00:00:00,Apoptosis,G04.299.139.160
23924348,2013-10-01T00:00:00,Caveolin 1,D12.644.360.024.264
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.157.057.010
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.476.024.280
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.543.990.100.500
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.744.287
23924348,2013-10-01T00:00:00,"Disease Models, Animal",C22.232
23924348,2013-10-01T00:00:00,"Disease Models, Animal",E05.598.500
23924348,2013-10-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23924348,2013-10-01T00:00:00,Gene Expression Profiling,E05.393.332
23924348,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23924348,2013-10-01T00:00:00,Idiopathic Pulmonary Fibrosis,C08.381.483.487.500
23924348,2013-10-01T00:00:00,Idiopathic Pulmonary Fibrosis,C08.381.765.500
23924348,2013-10-01T00:00:00,"Macrophages, Alveolar",A11.329.372.600
23924348,2013-10-01T00:00:00,"Macrophages, Alveolar",A11.627.482.600
23924348,2013-10-01T00:00:00,"Macrophages, Alveolar",A11.733.397.600
23924348,2013-10-01T00:00:00,"Macrophages, Alveolar",A15.382.680.397.600
23924348,2013-10-01T00:00:00,"Macrophages, Alveolar",A15.382.812.522.600
23924348,2013-10-01T00:00:00,Signal Transduction,G02.111.087.800
23924348,2013-10-01T00:00:00,Signal Transduction,G02.149.115.800
23924348,2013-10-01T00:00:00,Signal Transduction,G04.299.880
23924348,2013-10-01T00:00:00,Tissue Array Analysis,E05.196.630.570.850
23924348,2013-10-01T00:00:00,Tissue Array Analysis,E05.588.570.850
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23969353,2013-10-01T00:00:00,Career Choice,F02.463.785.373.346.400
23969353,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23969353,2013-10-01T00:00:00,Life Style,F01.829.458
23969353,2013-10-01T00:00:00,Primary Health Care,N04.590.233.727
23969353,2013-10-01T00:00:00,Questionnaires,E05.318.308.750
23969353,2013-10-01T00:00:00,Questionnaires,L01.280.800
23969353,2013-10-01T00:00:00,Questionnaires,N05.715.360.300.695
23969353,2013-10-01T00:00:00,Questionnaires,N06.850.520.308.750
23969353,2013-10-01T00:00:00,"Students, Medical",I02.851.686.602
23969353,2013-10-01T00:00:00,"Students, Medical",M01.848.769.602
23969353,2013-10-01T00:00:00,United States,Z01.107.567.875
24046400,2013-10-01T00:00:00,Animals,B01.050
24046400,2013-10-01T00:00:00,Chick Embryo,A13.350.150
24046400,2013-10-01T00:00:00,Chick Embryo,A16.331.200
24046400,2013-10-01T00:00:00,Chickens,B01.050.150.900.248.350.150
24046400,2013-10-01T00:00:00,Chickens,B01.050.150.900.248.617.192
24054098,2013-10-01T00:00:00,Ascitic Fluid,A12.207.119
24054098,2013-10-01T00:00:00,"Hernia, Umbilical",C16.614.378
24054098,2013-10-01T00:00:00,"Hernia, Umbilical",C23.300.707.374.937.500
24054098,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24054098,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24054098,2013-10-01T00:00:00,Syndrome,C23.550.288.500
24054098,2013-10-01T00:00:00,Umbilicus,A01.047.849
24059877,2013-10-01T00:00:00,Adolescent,M01.060.057
24059877,2013-10-01T00:00:00,African Americans,M01.686.508.100.100
24059877,2013-10-01T00:00:00,African Americans,M01.686.754.100
24059877,2013-10-01T00:00:00,HIV Infections,C02.782.815.616.400
24059877,2013-10-01T00:00:00,HIV Infections,C02.800.801.400
24059877,2013-10-01T00:00:00,HIV Infections,C20.673.480
24059877,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
24059877,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
24059877,2013-10-01T00:00:00,Health Promotion,N02.370
24059877,2013-10-01T00:00:00,Health Promotion,N02.421.726.507
24059877,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24059877,2013-10-01T00:00:00,Internet,L01.224.230.110.500
24059877,2013-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
24059877,2013-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
24059877,2013-10-01T00:00:00,Sexual Behavior,F01.145.802
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C02.800
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
24059877,2013-10-01T00:00:00,United States,Z01.107.567.875
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
24065790,2013-10-01T00:00:00,Diabetic Angiopathies,C14.907.320
24065790,2013-10-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
24065790,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24065790,2013-10-01T00:00:00,Hyperglycemia,C18.452.394.952
24065790,2013-10-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
24081287,2013-10-01T00:00:00,Anticoagulants,D27.505.954.502.119
24081287,2013-10-01T00:00:00,Brain Ischemia,C10.228.140.300.150
24081287,2013-10-01T00:00:00,Brain Ischemia,C14.907.253.092
24081287,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
24081287,2013-10-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
24081287,2013-10-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
24081287,2013-10-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
24081287,2013-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24081287,2013-10-01T00:00:00,Risk Assessment,N04.452.871.715
24081287,2013-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24081287,2013-10-01T00:00:00,Risk Assessment,N06.850.505.715
24081287,2013-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24081287,2013-10-01T00:00:00,Stroke,C10.228.140.300.775
24081287,2013-10-01T00:00:00,Stroke,C14.907.253.855
24081287,2013-10-01T00:00:00,Ticlopidine,D02.886.778.834
24081287,2013-10-01T00:00:00,Ticlopidine,D03.383.903.834
24088440,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24088440,2013-10-01T00:00:00,Robotics,H01.671.293.643
24088440,2013-10-01T00:00:00,Robotics,J01.897.104.834
24088440,2013-10-01T00:00:00,Robotics,L01.224.065.630
24088440,2013-10-01T00:00:00,Thoracic Surgery,H02.403.810.803
24088440,2013-10-01T00:00:00,Thoracic Surgical Procedures,E04.928
24088981,2013-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.117.500.500
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.404.812
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.831.600
24030463,2013-10-09T00:00:00,Astrocytes,A08.637.200
24030463,2013-10-09T00:00:00,Astrocytes,A11.650.200
24030463,2013-10-09T00:00:00,Enzyme Inhibitors,D27.505.519.389
24030463,2013-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.260.600
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.660.600
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.930.600
24030463,2013-10-09T00:00:00,Piperazines,D03.383.606
24030463,2013-10-09T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.100.620.200
24030463,2013-10-09T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.720.600.610.200
24030463,2013-10-09T00:00:00,"Receptors, Opioid, delta",D12.776.543.750.750.555.610.200
24030463,2013-10-09T00:00:00,Sesquiterpenes,D02.455.849.765
24030463,2013-10-09T00:00:00,Signal Transduction,G02.111.087.800
24030463,2013-10-09T00:00:00,Signal Transduction,G02.149.115.800
24030463,2013-10-09T00:00:00,Signal Transduction,G04.299.880
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23800176,2013-11-01T00:00:00,Animals,B01.050
23800176,2013-11-01T00:00:00,Apolipoproteins E,D10.532.091.500
23800176,2013-11-01T00:00:00,Apolipoproteins E,D12.776.070.400.500
23800176,2013-11-01T00:00:00,Apolipoproteins E,D12.776.521.120.500
23800176,2013-11-01T00:00:00,Gene Expression Regulation,G05.355.315
23800176,2013-11-01T00:00:00,Glucose,D09.546.359.448
23800176,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.718.550
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.718.550
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.718.550
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D09.400.500
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D09.698.718.450
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D10.494
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
23800176,2013-11-01T00:00:00,Monocytes,A11.118.637.555.652
23800176,2013-11-01T00:00:00,Monocytes,A11.148.580
23800176,2013-11-01T00:00:00,Monocytes,A11.627.624
23800176,2013-11-01T00:00:00,Monocytes,A11.733.547
23800176,2013-11-01T00:00:00,Monocytes,A15.145.229.637.555.652
23800176,2013-11-01T00:00:00,Monocytes,A15.378.316.580
23800176,2013-11-01T00:00:00,Monocytes,A15.382.490.555.652
23800176,2013-11-01T00:00:00,Monocytes,A15.382.680.547
23800176,2013-11-01T00:00:00,Monocytes,A15.382.812.547
23800176,2013-11-01T00:00:00,Signal Transduction,G02.111.087.800
23800176,2013-11-01T00:00:00,Signal Transduction,G02.149.115.800
23800176,2013-11-01T00:00:00,Signal Transduction,G04.299.880
23800176,2013-11-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
24092682,2013-11-01T00:00:00,Adult,M01.060.116
24092682,2013-11-01T00:00:00,Aged,M01.060.116.100
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
24092682,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24092682,2013-11-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
24092682,2013-11-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
24092682,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24092682,2013-11-01T00:00:00,"Scleroderma, Systemic",C17.300.799
24092682,2013-11-01T00:00:00,"Scleroderma, Systemic",C17.800.784
24092682,2013-11-01T00:00:00,United States,Z01.107.567.875
